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Abstract 
Limited research has been conducted in the area of blood transfusion policy in Africa. Prior 
to this study, it was unclear how many countries had a national blood policy in place, if they 
differed from other policies and if so to what extent.  The aim of this study was, therefore, to 
better understand the Ghanaian national blood policy in an African context, identify its 
strengths and weaknesses and make appropriate policy recommendations.  
 
Following a literature review, WHO policy documents and African national policies were 
obtained via a web search in French and English, and by contacting representatives of 
national blood services. Policy documents were analysed qualitatively, and a list of 
commonly accepted policies was generated and compared with the evidence. Guidelines 
relating to blood donation, blood screening, blood grouping and component usage were 
common to more than half of the national blood policies reviewed. 
 
The common recommendations listed above were compared to current blood transfusion 
service practices at the Komfo Anokye Teaching Hospital, and areas of policy requiring 
further research, to improve policy implementation and better meet the local population’s 
needs, were identified.  As a result, the following sub-objectives were identified: 1) 
Determine the most common reasons for donor deferral 2) Determine what information 
donors are interested in receiving during pre and post-donation counselling to improve 
donor satisfaction and potentially increase blood supply; 3) Better understand component 
demand and usage and its influencing factors as well as determine whether current 
component production rates are appropriate; 4) Understand the patient experience in 
obtaining a blood transfusion and securing a replacement donor.  
 
Results from this study showed that blood donors were most commonly deferred due to a 
low haemoglobin level or hepatitis B infection. Blood donors seek more information 
regarding their health and whether their blood is found to have any infections. In addition, 
they would like to know more about the blood donation process ahead of time, such as what 
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steps are involved, if donating will be painful and how long the entire process will take.  
Based on interviews with clinicians and data obtained from the blood bank, while component 
production was found to be increasing at KATH, there were still instances when demand of 
blood components exceeded supply. In spite of this, patients did not find it difficult to obtain 
blood for their transfusion, but some expressed interest in learning more about the risks and 
benefits of transfusion. 
 
Clinicians and policy makers should therefore work together to determine whether certain 
biological criteria currently implemented can safely be adjusted to be more inclusive and 
maximise the number of blood units donated. Future donor counselling sessions should aim 
to better communicate with donors the blood donation process and reassure blood donors 
of their health status. Component production should continue to increase at KATH given its 
demand, but only providing the blood bank has the resources to maintain production 
without affecting supply and patient outcomes. Finally, clinicians should increase their 
efforts to maintain good communication with their patients regarding transfusions, their 
risks and benefits, and ensure consent is always sought.  
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Terms and Definitions 
ABO Grouped – Blood tested to determine which antigens, if any, are on the surface of the 
red blood cell 
 
Cross matched – A test performed prior to a blood transfusion to determine whether the 
patient’s blood is compatible with the donated unit. 
 
Donor counselling – Information and advice provided to blood donors prior to (pre-
donation) or after (post-donation) blood donation. 
 
Paid Donor – Blood donor who receives compensation for his/her donation that is of 
significant value (in this study a significant value was seen as anything more than return 
transport costs + the cost of a meal) and seen to be an incentive  
 
Pre-Screening – Screening blood donors for transfusion transmitted infections (TTIs) 
prior to donating blood 
 
Replacement Donor – Any blood donor who donates blood on behalf of a patient who has 
or will be receiving a blood transfusion and who receives no compensation.  
 
Vein-to-vein process - Covers all aspects from when the donor enters the donor clinic to 
the completion of the patient’s blood transfusion and, if applicable, management of any 
transfusion related complications 
 
Voluntary Non-Remunerated Donors (VNRD) – Blood donors who donate for completely 
altruistic purposes and receive no compensation. Note, it can be argued that replacement 
donors are also VNRD as their donation can still be for altruistic purposes and they may 
receive no compensation, but for the purposes of this study they will be categorised 
separately 
 18 
Chapter 1 - Introduction 
1.1 Introduction  
This study was developed as a result of the paucity of qualitative data and limited policy-
based research regarding blood transfusions in Africa. To create a focused and in depth 
study, it was decided that it would be best to concentrate on one location. The Komfo Anokye 
Teaching Hospital (KATH) in Kumasi, Ghana was chosen as it not only collects and tests all 
of its own blood units, it also distributes some units to other hospitals in the Ashanti region. 
Thus, it is a hospital-based system with some of the qualities of a distributive centre. This is 
in contrast to other countries where blood is either collected by a national blood service and 
distributed nationally via regional centres or where individual hospitals collect and test 
blood for their individual needs. 
 
The focus of this study was to evaluate current blood transfusion services in Ghana, identify 
common strengths, weaknesses and gaps in policy and address the gaps and weaknesses by 
observing current practice and conducting further research in Ghana. The project’s aim was 
to review blood transfusion services vein-to-vein (i.e. from donation to transfusion), 
including previously untouched subjects like patient experience alongside well-known 
issues such as blood supply, and based on the results make appropriate policy 
recommendations. 
 
1.2 Study background 
 
Timely blood transfusions treat many critical injuries and illnesses such as anaemia, and 
haemorrhaging, and are necessary to maintain population health. Anaemia, in particular, 
places a heavy burden on blood services (Allain et al., 2004; Bugge et al., 2012 and Jacobs 
and Mercer, 1999) and is one of the most ‘common cause of disability’ in the world (Murray 
and Lopez, 1996). The non-availability of blood can have lethal effects. For example, the 
World Health Organization (WHO) estimates that lack of timely blood transfusions is 
responsible for 25% of maternal deaths and 15% of child mortality in southern Africa (WHO, 
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2003). These figures illustrate the importance of blood transfusions in health care and thus, 
the availability of blood, or lack thereof, is a major concern.  
 
Blood donation and blood safety play an integral role in the success of transfusion services, 
but it can be difficult for low and middle-income countries (LMIC) to sustain their costs. 
Countries in Africa suffer from low blood donation rates (see Figure 1.1). Given the region’s 
high prevalence of infectious diseases like HIV and Hepatitis B, ensuring blood safety, while 
critical, is challenging. Blood services need to identify high risk donors early on in the process 
given the wide window period infectious diseases carry. Additionally, the high number of 
haemorrhaging incidents and malaria-related anaemia cases amplifies the demand for blood 
in Africa. In fact, the WHO estimates that in Africa nearly half of all malaria related deaths in 
children are due to severe anaemia and that one third of maternal mortalities are a result of 
haemorrhaging (WHO 2005; WHO 2012). The latter statement is likely an underestimation 
given that many women do not have access to a health facility and consequently cases go 
unreported (Dolea et al., 2003). Efficient transfusion services are therefore crucial to public 
health in Africa.  
Figure 1.1: Blood donations per 1000 population in 2007. Image courtesy of WHO, 2009 
(http://www.who.int/mediacentre/factsheets/donations_per1000_population_20091110.pdf ) 
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1.3 Justification for the study 
 
While there are studies reporting on blood donation and blood safety, there is a lack of 
research evaluating transfusion policy and services in Africa from a holistic point of view – 
i.e. from the different perspectives of the people involved, such as blood donors, patients, 
clinicians, laboratory staff and management. This study focused on addressing gaps in the 
current blood transfusion policies and conducting research aimed at strengthening policies 
and filling in the gaps. Using both quantitative and qualitative methods, the strengths and 
weaknesses of all aspects of transfusion services (including donation, blood testing and 
grouping, delivery of blood, transfusion etc.) from the perspectives of patients and their 
families, hospital staff and donors were explored.  To ensure transfusion services are 
effective, it is essential that policy makers and health care providers understand the 
interactions between the various players involved. The purpose of the study was to use the 
results to make appropriate policy suggestions to improve blood services, with the ultimate 
aim of reducing the number of deaths due to lack of blood for transfusion.  
 
To better understand blood transfusion services at KATH and develop appropriate study 
objectives that would best address the overall aim of the study, a six-week pilot study was 
conducted. Due to the limited information in the literature on the vein-to-vein process, this 
pilot study allowed me to witness it first-hand in Kumasi as well as pilot some questionnaires 
and semi-structured interview guides I had planned for the main study. Based on the results 
of the pilot study I could document the vein-to-vein process, compare it to existing policies 
and identify areas requiring further research, which would form the focus of my sub-
objectives for objective 3 (see section 1.4).  The methods for the follow up study, which 
formed the main portion of my fieldwork, were then adjusted to meet sub-objectives 1-4. 
 
1.4 Aims and objectives 
 
The overall aim of this study was to better understand local blood transfusion service  
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needs and provide context-specific guidelines for existing blood transfusion policies to 
improve blood transfusion practice in Kumasi, Ghana 
 
Objective 1: Examine the Ghana national blood transfusion policy in an African context and 
identify the strengths, weaknesses and evidences gaps 
Objective 2: Compare practice to policy in Kumasi and identify factors affecting policy 
implementation 
Objective 3: Identify the areas of blood transfusion policy in Kumasi that require further 
research and generate local evidence to improve policy implementation and better address 
local population needs. 
 
Areas identified (during the pilot study) : 
 Sub-objective 1: Identify the most common reason(s) for donor deferrals and 
determine if current donor criteria should be re-evaluated to maximise blood 
supply. 
 Sub-objective 2: Determine what information donors are interested in 
receiving during pre and post-donation counselling to improve donor 
satisfaction and potentially increase blood supply. 
 Sub-objective 3: Quantify component usage and demand, understand its 
influencing factors and determine whether the appropriate amount of 
resources is being utilised. 
 Sub-objective 4: Understand the patient experience in obtaining a blood 
transfusion and securing a replacement donor. 
 
Objective 4: Generate a list of guidelines for each of the areas of policy identified in Objective 
3, based on the local evidence, to improve the practice of current blood transfusion services 
in Kumasi.  
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1.5 Methodological approach 
 
To examine blood transfusion services and policies from the vein-to-vein process (from 
blood donation to blood transfusion) with emphasis on the hospital, patient and donor 
perspectives, a single method alone would not have sufficed. A mixed-methods approach 
was, therefore, used. The collection of quantitative data provided an overview of the current 
situation while qualitative data provided rich details that may otherwise have been missed. 
In some cases, qualitative data was used to identify topics and areas for quantitative study. 
 
Prior to starting this project, I did not have any haematological knowledge or experience. My 
previous research during my Master’s in International Public Health had focused on health 
inequalities and health policy. It is my interest in using health policy to make population 
health changes that led me to my interest in this PhD project. Thus, in the initial stages of my 
PhD I focused heavily on developing my knowledge base around blood transfusion and its 
policies by reading literature published by national blood services and reviewing evidence 
based articles. Conducting the six-week pilot study was also key in helping me visualise and 
understand how transfusion services work at KATH. It provided me with the specific 
knowledge needed on of how KATH functions and aided me in further developing and fine-
tuning the study design. 
 
1.6 Project design 
 
The project was completed in two phases. Phase 1 included a pilot study (for a period of six 
weeks), provided the foundation for the study allowing for a better understanding of current 
blood service practices at KATH and the opportunity to pilot questionnaires and semi-
structured interviews based on previously identified objectives. The pilot study addressed 
objective 3 and provided insight as to what areas of the vein-to-vein process required further 
research. Based on these results, sub-objectives 1-4 were developed. The aim of Phase 2 was 
to collect the data required to address these sub-objectives. The fieldwork for Phase 2 took 
place over a period of eleven months, exclusively in Kumasi, Ghana. Data was initially 
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gathered through observation, hospital records, questionnaires and semi-structured 
interviews. Following analyses of the questionnaires, additional data was obtained via focus 
groups. 
 
1.7 Thesis outline 
 
Chapter 2 presents the literature review and provides background information about Ghana, 
its health care system and blood services; and places it in the context of blood transfusion 
services in sub-Saharan Africa. Objective 1 is addressed in Chapter 3, where a review of 
national blood policies in Africa, including Ghana, and WHO blood policy documents is 
presented and compared to blood services practice in Kumasi. Chapter 4 presents the 
methodology for the study, and provides context and the details of both the qualitative and 
quantitative data collection tools used. Chapter 5 presents the findings from the interviews 
with donors and donor clinic staff, focusing on donors’ pre- and post-donation counselling 
experiences and the implications of these results. Chapter 6 presents the findings regarding 
reasons for donor deferrals at the KATH donor clinic and discusses whether donor criteria 
should be re-assessed. Chapter 7 describes and discusses blood component usage at KATH, 
relying on multiple sources of data such as physician interviews and hospital records. 
Chapter 8 presents and discusses the findings of patient interviews and incorporates some 
responses from physicians to better understand patients’ experiences in obtaining a 
transfusion and, where relevant, securing replacement blood donors. Chapter 9 concludes 
this thesis with a summary of the study’s findings and suggested guidelines aimed at 
complementing existing policy and improving the vein-to-vein process at KATH. 
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Chapter 2 – Description of Ghana and its health services 
and blood services in low and middle income countries, 
including Ghana.  
 
2.1 Introduction 
 
This chapter summarises the current Ghanaian health care system and blood services and 
presents a review of the literature surrounding blood services in Ghana and other low and 
middle income countries. 
 
2.2 Ghana background 
 
Ghana is a country of 238,535km2 located in West Africa and shares borders with Burkina-
Faso, Togo and Cote d’Ivoire (see Figure 2.1). A former British colony, it was the first country 
in sub-Saharan Africa to attain independence in 1957. It has a population of approximately 
25 million {World Bank, 2011} and is considered a middle-income country. The country’s 
economy relies primarily on natural resources such as gold, cocoa and oil. Ghana is a 
democracy that has been hailed internationally for its political stability. Accra is the capital 
city of Ghana. The country is divided in to 10 regions each served by a regional hospital 
(government run) and supported by other district hospitals and private health care facilities.  
In 2003, it established a national health insurance scheme, an initiative aimed at reducing 
inequalities in accessing health care. 
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Figure 2.1 - Map of Ghana (courtesy of lonelyplanet.com) 
 
 
2.2.1 Demographics (StatsGhana, 2012) 
 
According to the 2010 Ghana Population and Household Census, Ghana had a population of 
24,658,823. The survey results show that the Ashanti region, where KATH is located, 
accounts for nearly 20% of the national population. The predominant religions in Ghana are 
Christianity, representing 71.2% of the population, and Islam representing 17.6%. 74.1% of 
those 11 years of age and older are literate, with an estimated 53.7% having attended middle 
or junior high school (JHS).  
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2.2.2 Health system 
 
2.2.2.1 Ghana Health Service 
 
The Ghana Health Service (GHS) was established in 1996 and is ‘responsible for the 
implementation of national policies under the control of the Minister of Health’ (GHS, 2015). 
The GHS is responsible for all district and regional hospitals. Teaching hospitals and private 
hospitals are run separately. The Christian Health Association of Ghana works alongside the 
GHS and consists of ‘183 health facilities and health training institutions’ across the country 
(CHAG, 2015).  Teaching hospitals are managed by their own teaching hospital board (GHS, 
1996 – Act 525). At KATH, the board is made up of ‘4 Non-Executive members (government 
appointees), 6 Executive members and the Dean of the School of Medical Sciences’ (KATH, 
2015). 
 
2.2.2.2 National Health Insurance Scheme (NHIS) 
 
In 2003, the National Health Insurance Authority (NHIA) was established with the aim of 
attaining universal health care (NHIA, 2015). Ghanaians pay a premium based on their 
income to benefit from the National Health Insurance Scheme (NHIS). Those exempt from 
premium payments include children under the age of 18 years, elderly over the age of 70 
years, ‘indigents’ and Social Security and National Insurance Trust (SSNIT) contributors and 
pensioners (ibid). Under the NHIS, all hospital and outpatient visits and some laboratory 
tests and medicines are covered (Drislane et al., 2014). In 2010, roughly half the national 
population was enrolled in the scheme, with poor patient education cited as a potential 
reason for lower enrolment rates (ibid).  
 
The NHIS has improved the affordability and access to health care and prescription drugs 
(Barimah and Mensah, 2013) and a study in Accra found that adult women enrolled in the 
scheme were more likely to make use of health services (Blanchet, Fink and Osei-Akoto, 
2012). However, in the Central and Eastern regions of Ghana enrolment rates are the lowest 
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among the poorest (Kotoh and Van der Geest, 2016), resulting in persisting health 
inequalities. Additionally, there is concern that corruption may affect the financial viability 
of the scheme (Barimah and Mensah, 2013).  
 
2.2.2.3 Medical education in Ghana 
 
Medical doctors are the only hospital staff permitted to prescribe blood transfusions. There 
are five public medical schools in Ghana: the University of Ghana, Accra; the Kwame 
Nkrumah University of Science and Technology (KNUST), in Kumasi; the University of Cape 
Coast in Cape Coast; the University of Health and Allied Services in Ho, and the School of 
Medicine and Health Studies at University of Development Studies in Tamale. There is also a 
private medical school – the Accra College of Medicine. 
 
The majority of graduates come from the Accra and Kumasi institutions (Drislane et al., 
2014). The traditional medical degree programme consists of 6 years of training. A graduate 
entry scheme for those with a Bachelor of Science also exists and consists of 4 years of 
training. Upon completion of medical school, doctors spend two years as house officers 
where they spend 6 months each in paediatrics, surgery, obstetrics and gynaecology (O&G), 
and internal medicine. Two of these rotations are completed in a teaching hospital while the 
remaining two take place in a district hospital. Following completion of their house jobs, 
doctors can move on to specialise in their field of interest. According to a student, up to 70% 
of his classmates had left to practice medicine abroad (ibid), though it is unclear how many 
of these individuals return to Ghana. Nevertheless, this suggests that the country is suffering 
from a considerable ‘brain drain’.  
 
2.2.3 Leading causes of death in Ghana 
 
The average life expectancy in Ghana is 62 years for males and 64 years for females. This is 
higher than in most African countries. The under-five mortality rate is 78 per 1000 live births 
(WHO, 2015). Malaria, HIV and maternal mortality all contribute significantly to the 
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country’s mortality rates. In fact, 9.0% of female deaths in Ghana are deemed to be pregnancy 
related (StatsGhana, 2015), with postpartum haemorrhage being the leading cause; and 
8.3% of all deaths are malaria related (WHO, 2015). In addition, Ghana is experiencing an 
epidemiological transition resulting in an increase in the burden of chronic illnesses such as 
hypertension, obesity and diabetes, thus placing additional weight on the country’s health 
services (de-Graft Aikins, 2007). In 2003, stroke and hypertension were the 4th and 7th 
leading cause of death among in-hospital patients across the country (ibid).  
 
Of note, patients with sickle cell disease are particularly prone to strokes as sickle-shaped 
cells can block blood flow to the brain. Regular red blood cell transfusions in this group can 
reduce the risk of stroke (Wang and Dwan, 2013). 
 
2.2.4 Blood group distribution in Ghana 
 
In recent literature, there are no published figures regarding blood group distribution in 
Ghana, thus making it difficult to quantify the frequency of each blood group. The only 
national statistics that could be found were in a paper published by Yankah (1965) under 
the Ministry of Health in Ghana, which aimed to investigate a possible link between 
inheritance, blood group and leprosy. The blood group distribution among the controls, 400 
blood donors without leprosy, are presented below in Table 2.1. The 400 participants were 
made up of ‘various tribes’ to provide ‘a fair sample of all the tribes in Ghana’ (ibid).  The lack 
of more recent data highlights the potential need for a cross-sectional national study of blood 
group frequencies. This information could prove useful in the future for a national blood 
bank to target appropriate donors for donation, ensuring higher supplies of common blood 
groups and more consistent supplies of less common groups. However, currently, given the 
limited supply of blood, the main aim is to collect from as many donors as possible.   
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Blood 
Group 
A B O AB Rh positive Rh 
negative 
% of Blood 
Donors 
20.75 25.0 51.0 3.25 93.75 6.25 
 
Table 2.1 – Blood group distribution based on percentage frequency among blood donors in Ghana in 1965 
(Yankah, 1965) 
 
2.3 Review of blood services in Ghana and other low- and 
middle-income countries 
 
Currently, Ghana has a hybrid blood transfusion system that is supported by both national 
blood services and individual hospitals. However, based on discussions with the Korle Bu 
Teaching Hospital (KBTH), in Accra, and KATH blood services’ staff, the ultimate goal is to 
consolidate these services under one national blood service (NBS) with specific blood 
collection sites. Currently, the NBS operates within the Ghana Health Service, is based at the 
KBTH in Accra and supplies the Greater Accra region.  
 
2.3.1 Search strategy for literature review 
The main database searched for reviewing literature on blood services in low and middle 
income countries was PubMed. The search terms used are presented below in alphabetical 
order: 
• Africa 
• Blood policy 
• Blood safety 
• Blood screening 
• Blood services  
• Blood supply 
• Blood transfusion 
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• Developing countries 
• Komfo Anokye Teaching Hospital 
• Low and middle income countries 
• National blood policies  
• Paid donors 
• Repeat donor 
• Replacement donor 
• Transfusion services 
• Transfusion transmitted infections 
• Volunteer donors 
The first 100 search results were reviewed. Any papers not in English or French were 
excluded. Where applicable, the original sources for information presented in a paper were 
obtained. Relevant references in each of the papers were followed up and included in the 
literature review. 
 
2.3.2 Central vs. hospital-based blood services 
 
To better understand Ghana’s hybrid blood transfusion system it is important to understand 
how centralised and hospital-based systems work and differ. In a centralised system, which 
represents a more vertical approach, the collection and testing of blood for a given region 
are overseen by a central organisation whereas in a hospital-based system, each hospital 
operates autonomously (Hensher & Jefferys 2000). Unlike most Western countries, not all 
African countries have a centralised system in place (Field & Allain 2007). While centralized 
services allow for better quality management and donor recruitment, hospital-based 
systems have fewer resources, tend to rely on replacement donors and therefore incur less 
cost. Thus, while centralized services present certain advantages, there are few cases in the 
developing world where they have survived without external funding (Bates & Hassall 2010; 
Field & Allain 2007) and consequently hospital-based systems remain widespread. In fact, 
given their sustainability, from a health care perspective, it has been suggested that hospital-
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based systems may be the best option for most African countries (Jacobs & Mercer 1999). On 
the other hand, it can be argued that there is greater stress on patients and their families as 
they are forced to secure their own replacement donor (Bates & Manyasi 2007). 
Unfortunately, there is little information regarding the burden placed on families in search 
of a donor (Lara et al. 2007). 
 
2.3.2.1 National Blood Service in Ghana 
 
Run by the Ghanaian Ministry of Health, the National Blood Service (NBS), based at the Korle 
Bu Teaching Hospital in Accra, aims to ‘ensure an effective and coordinated national 
approach to the provision of safe, adequate and efficacious, blood and blood products […]’ 
(NBS, 2016). The NBS is responsible for blood collection at the Korle Bu Teaching Hospital 
and for the Greater Accra region. Blood collection in the other regions of Ghana remains 
hospital based.  
 
The NBS has also, in collaboration with local and international blood service teams, 
developed a national blood policy document with specific guidelines and recommendations 
for blood transfusion in Ghana. The aim of this document is to ensure a basic standard of care 
is achieved throughout the country. While the policy document is freely available and 
hospitals across Ghana are encouraged to adopt its recommendations, it is not currently 
legally mandatory as it is yet to be approved by parliament. The eventual aim, however, is 
for blood services to be nationalised, with the national blood policy setting the standard for 
all blood services in Ghana. 
 
2.3.2.2 Komfo Anokye Teaching Hospital blood supply 
 
KATH is responsible for its own blood collection, grouping and screening. There is no 
automated stock checking available, thus the number of units grouped and cross-matched 
are hand-counted. However, the counting is not done at specified intervals and not officially 
recorded. The data are mostly used to identify any blood groups with low stock levels, 
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indicating a need for more donors. This is communicated to the transfusion management 
team who organise blood drives and with nurses and doctors in the wards who can 
encourage patients to find replacement donors (see section 2.3.2 for further details on 
replacement donors). In addition, it also helps supply local hospitals, mostly in Kumasi. Some 
of these hospitals do collect their own units of blood too, but as a larger hospital and with a 
strong transfusion management team who organise numerous mobile sessions, the hospital 
is able to collect a greater number of units.  
 
Over the past 10 years KATH has increased the amount of blood it collects and has begun to 
focus on blood component production, though whole blood remains the most commonly 
transfused blood product. In 2008, a new Accident and Emergency (A&E) complex was 
constructed with a specific area dedicated to the blood bank providing place for the 
equipment needed for blood screening, grouping, cross-matching and storage. The inception 
of the A&E complex also increased demand for blood according to the KATH Annual Report 
(2011). In 2007, 14,997 blood donors were screened and 12,441 units were collected (ibid). 
By 2011, 18,065 donors were screened and 15,748 units of blood were collected (ibid). 
Though the report does not indicate the number of transfusions that took place during this 
time, it estimates that 18,849 in-patients’ blood were grouped in 2007 compared to 23,936 
in-patients in 2011. Patients’ blood may be grouped as a precautionary measure to deliver 
blood faster should they need a transfusion, thus it cannot be said for certain that the number 
of transfusions increased during this time, but these numbers do suggest the demand for 
blood may have.  
 
2.3.3 Volunteer vs. replacement blood donors 
 
2.3.3.1 Types of blood donor 
 
According to the WHO (2015), there are three types of blood donor: voluntary non-
remunerated donors (VNRD), family/replacement donors and paid donors. Donors 
considered volunteers are those who receive no compensation and donate altruistically. 
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Family/replacement donors are those who donate blood to replace blood transfused to a 
friend or family member. Paid donors receive compensation for their donation.  
 
For the purpose of this study, the above definitions will be used to characterize donors. 
However, it is important to highlight the gaps in these defined roles, which are presented 
below. 
 
1. Missing from the above list is the autologous donor – donors who donate their blood for 
future personal use.  
2. There is no clear definition of who should be considered a paid donor. Donors may 
receive a thank you gift from the patient receiving blood, be reimbursed for transport 
costs or receive a large lump sum. It is unclear at what point compensation is seen as 
motivating factor to donate. 
3. The distinction between volunteers and replacement donors is that the latter are 
donating to save a known person’s life. However, at the KATH in Ghana, some family 
replacement donors donate blood after the patient has received their transfusion, thus 
the given patient is not relying on the donor and the replacement donor’s blood will be 
used for another patient. It can be argued that these replacement donors are donating for 
purely altruistic reasons, similar to VNRD.  This varies compared to other regions, where 
a donor must first find someone to donate blood before they can receive their 
transfusion. For example, a story from India published online outlines the struggles a son 
faces to obtain blood for his mother. He visits numerous hospitals, and in spite of his 
mother needing blood urgently, he was refused at every hospital unless he was able to 
find a replacement donor (Roysam, 2015). In cases like these, patients and their families 
may become increasingly desperate for a replacement donor and may become willing to 
pay known people or strangers to donate, a practice which is documented to be unsafe 
(Allain, 2011). There is, however, no published evidence regarding the difference in 
impact on patients and their families if blood is provided before or after securing a 
replacement donor. 
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2.3.3.2 Review of blood safety differences between volunteers, paid donors 
and replacement donors 
 
There is considerable debate regarding the safety of blood from volunteer donors vs. 
replacement donors. Currently, the WHO advocates the collection of blood from exclusively 
volunteer donors in order to maximize blood safety (WHO, 2010). Indeed, there is some 
research indicating that the prevalence of blood-borne diseases is lower among volunteer 
donors (Kimani et al. 2011). However, a study in Kumasi, Ghana revealed that there is no 
significant difference in blood safety between volunteer and replacement donors (Allain 
2011). Moreover, according to a study in Guinea, the prevalence of HIV and HBsAg were 
significantly higher among first-time volunteer donors than in replacement donors (Loua & 
NzeNkoure 2010), thus raising the possibility that replacement donors may in fact be safer 
than first-time volunteers. It is unclear whether the Kimani (2011) study stratified their data 
by age which would considerably impact their results, as in not doing so volunteer donors 
would undoubtedly appear safer as they tend to be younger than replacement donors and 
have therefore been exposed to fewer risk factors.  
 
There is strong evidence indicating that blood from repeat donors (regardless of whether 
they are volunteer or replacement donors) is safest (Allain 2011; Reddy 2012) whereas 
blood from paid donors is generally unsafe (Allain 2011). Similar results were uncovered in 
a study in Mali, where among volunteer donors, return donors were found to be safer than 
those donating for the first time (Diarra et al. 2009). These results, along with those from the 
study in Guinea (Loua & NzeNkoure 2010), suggest that replacement donors may only 
appear less safe as they generally consist of first-time donors. A similar thought has been 
echoed by Allain et al. (2011) who suggested that the results observed in the Kimani (2011) 
study may be due to the fact that no distinction was made between first time and repeat 
donors (Allain et al. 2010). Thus, if the group of volunteer donors consisted largely of repeat 
donors, it would give the false impression that blood from volunteers is safer (Allain et al. 
2010; Kimani et al. 2011).  Unfortunately, repeat donors are rare even among volunteers 
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(Tagny et al. 2009).  Further efforts should therefore be made to encourage repeat donations 
among both volunteer and replacement donors. A similar conclusion was made in India, with 
researchers recommending that greater efforts should be directed towards encouraging 
replacement donors to become regular VNRD (Nair and Mammen, 2015).   
 
2.3.4 Ensuring adequate blood supply 
 
One of the main challenges facing transfusion services in developing countries is the limited 
supply of blood. Efforts have been made to increase the number of volunteer donors through 
education programs and the media (Allain et al. 2008). In addition to mobile sessions, mobile 
trucks have been used to help increase blood supply (Tazi-Mokha et al. 2012). For example, 
in Morocco, a six bed mobile truck, ‘driven by a specialised driver to places of interest such 
as main streets, festivals, national events etc.’ collects on average 6000 units of blood per 
year (ibid). Nevertheless, blood shortages persist. The amount of blood collected can also be 
influenced by donation guidelines, which vary by country. For example, some countries 
require longer periods of time between donations. While this can protect donors from 
developing anaemia, blood banks will not be able to capitalise on the available blood (Karp 
& King 2010). 
 
2.3.4.1 Donation and education 
 
Studies show people are often reluctant to donate due to limited education with regards to 
blood donation, cultural taboos and fear of HIV infection (Allain et al. 2004; Salaudeen & 
Odeh 2011; Lownik et al. 2012). In Sierra Leone, one of the main barriers preventing 
transfusions was the public’s attitude towards blood donation (Sengeh et al. 1997). For 
example, people were under the false impression that blood from a stranger would 
negatively affect their mental or physical health (ibid). In addition, the high prevalence rates 
of HIV and hepatitis B as well as increased poverty and malnutrition rates reduce the number 
of eligible donors (Reddy, 2012). In fact, unsurprisingly, most volunteer donors are from 
urban areas and belong to high socioeconomic groups (Cunha et al. 2007). Moreover, studies 
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in Senegal and Cameroon have found a positive association between education and volunteer 
donation (Duboz et al. 2010; Nchinda et al. 2012). Similarly, a study in Iran found a positive 
association between education levels and knowledge and attitudes of blood transfusions 
(Javadzadeh et al., 2006). However, one study in Nigeria revealed that even many literate 
individuals have unfounded theories concerning blood transfusions (for example, transfused 
blood comes from animals), and some have never even heard of blood donation (Olaiya et al. 
2004). While improving blood donation knowledge is certainly an important aspect of 
increasing blood supply it alone will likely not have much effect. Studies have shown that in 
spite of a relatively high proportion of individuals with good knowledge regarding blood 
donation, very few actually donate blood (Salaudeen & Odeh 2011; Agbovi et al. 2006; 
Lownik et al. 2012). It is therefore important to address any other issues preventing people 
from donating blood. 
 
2.3.4.2 Blood donation and gender issues 
 
Female blood donation rates have been traditionally low in Ghana and are estimated to be 
between 5.7-7.7% of all donations (Ampofo et al., 2002 and Walana et al., 2014). This is true 
for other low and middle-income countries and is in contrast to most European countries 
where blood donation rates for men and women are near equal (Bani and Guissani, 2010).  
Male dominance in blood donating is a trend commonly seen in West Africa with countries 
such as Togo, Burkina Faso, Morocco and Nigeria witnessing male donation rates of over 
60%, and in some regions, up to 99% (Agbovi et al., 2006; Nebie et al., 2007; Erhabor et al., 
2013; Tazi-Mokha et al. 2012). This may be due to myths related to menstruation and 
anaemia, pregnancy, breastfeeding, the perception that men are healthier; or the fact that 
since fewer women work they are less likely to come in contact with blood drives (Mbanya 
et al., 2003; Olaiya et al. 2004; Tagny et al. 2010; Tazi-Mokha et al. 2012). Further efforts 
should therefore be directed at recruiting female donors as this could result in a considerable 
increase in blood supply. 
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2.3.4.3 Donor incentives 
 
Donor incentives may have some effect increasing the number of blood donors, but research 
shows that most donors donate for altruistic reasons (Kasraian & Maghsudlu 2012). 
Monetary compensation is usually banned given its association with unsafe blood (Allain 
2011). However, the majority of donors who were interested in donation incentives 
suggested that free glucose/cholesterol tests would be an effective incentive (Kasraian & 
Maghsudlu 2012). This may be an initiative worth considering in recruiting or retaining 
donors. 
 
2.3.4.4 The importance of replacement donors 
 
The WHO recommends that all countries aim for a 100% volunteer based donor programme 
(WHO, 2010). However, in most resource poor settings, the majority of blood donors are 
replacement donors (Allain et al. 2004). Even in countries where blood is exclusively 
collected from volunteers, for example Zimbabwe, the amount collected remains below the 
suggested minimum (AfSBT, 2011). Replacement donors are particularly important in Africa 
due to strong family ties and the willingness of someone to donate for a loved one (Allain et 
al. 2010). Thus, rather than trying to reduce the number of replacement donors, more efforts 
should focus on converting them into repeat donors. 
 
2.3.4.5 Repeat donors 
 
Globally, there is limited research regarding the characteristics of repeat donors. However, 
recently, a study in Iran revealed that those who donated blood soon after the first donation 
were more likely to continue to return as donors (Kasraian & Tavassoli 2012). Moreover, 
they also found men and single individuals were more likely to become repeat donors. 
Interestingly, no association with age or education level was discovered, contrary to what is 
observed in Western countries (ibid). Lownik et al. (2012) emphasise the importance of first 
time experiences and suggest this is likely to influence a donor’s decision to return.  
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In Iran, special efforts were made to retain donors by providing them with a ‘reminder call’ 
3-6 months post donation (Maghsudlu et al. 2009). These efforts were somewhat rewarded 
with 35% of those receiving a call from a recruiter returning based on a survey of 3167 blood 
donors. However, of those receiving an automated phone call, only 15.7% returned. This 
study illustrates how simple retaining strategies can have a significant effect.  
 
In Cote d’Ivoire, one issue involving repeat donors was that they were more common among 
deferred donors, usually as a result of low haemoglobin levels (Kouao et al. 2012). This 
suggests that repeat donors must be encouraged to maintain proper haemoglobin levels 
through education, diet and supplements. Not doing this can reduce the amount of available 
blood.  
 
2.3.4.6 Other barriers 
 
The fact that blood donation generally occurs during working hours can deter those who are 
not keen on taking leave. In fact, in Nigeria, proper facilities, trained staff, and the ability to 
donate during evenings and weekend coupled with adequate blood transfusion service (BTS) 
education was shown to increase the number of voluntary donors (Nwagbo et al. 1997). 
 
2.3.4.7 Interventions aimed at increasing blood donor recruitment and 
retention 
 
As outlined in the above sections, maintaining adequate blood supply and retaining donors 
are challenging yet vital to treating a variety of health conditions such as blood loss via 
trauma, post-partum haemorrhage and malaria related anaemia. A single blind randomised 
trial, in the United States, explored several interventions to identify which interventions 
were most successful in encouraging donors to return (Reich et al., 2006). Email recruitment 
was seen to be less effective than telephone (13.2% vs. 27.8%; RR, 0.48; 95% CI, 0.40-0.57). 
A complimentary t-shirt showed no increase in donor return rates compared to no incentive 
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(20.5% vs. 20.6%; RR, 0.99; 95% CI, 0.91-1.09) (ibid). The study also compared two 
recruitment message scripts delivered via telephone (Scripts A and B). Both thanked the 
donor for their previous donation and both requested a subsequent donation using a current 
patient’s story whose blood type matched the donors (ibid). The difference between the 
scripts was that Script B also mentioned that a complimentary T-shirt would be provided. 
Interestingly, Script A proved more effective than Script B (22.2% vs. 18.9%; RR, 1.18; 95% 
CI, 1.07-1.29) (ibid).  
 
While these results may not apply to other countries, similar studies should be conducted 
elsewhere to better identify which interventions work in a local context. For example, one 
might assume that a complimentary t-shirt would either have no effect or increase donation 
rates, but when comparing Scripts A and B, it seems the patient’s story alone was more 
successful in recruiting past donors. This, however, may not be the case in a different local 
context. 
 
 
2.3.5 Blood safety 
 
Blood safety is a critical concern with regard to blood transfusion, particularly in Africa, 
where the prevalence of blood-borne diseases such as HIV, hepatitis B, hepatitis C and 
syphilis remain high. Donors between aged between 30-35 years represent the highest risk 
group (Allain et al. 2010; Tagny et al. 2008). There is evidence indicating that the prevalence 
of transfusion transmitted infections (TTI) is lower for blood processed by centralised blood 
services compared to hospital-based systems (Bates & Hassall 2010). However, the high 
costs associated with a centralised system make it unsustainable for most low-income 
countries (ibid).  
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2.3.5.1 Minimising the collection of infected blood 
 
Pre-donation screening 
Generally, to prevent collecting unsafe blood, blood collection services will conduct a risk 
assessment (usually via a questionnaire) prior to donation and high risk donors are deferred 
from donating. Donated blood is then tested for TTIs. This method can reduce the cost 
associated with blood testing. Note, however, a study in Cote d’Ivoire administered a risk 
assessment questionnaire prior to and post donation and revealed that certain risk 
behaviours, particularly those related to sexual habits, were under-reported prior to 
donation (Minga et al. 2010). Given the association between certain risk behaviours and 
sexually transmitted infections (STIs) this can result in higher collection rates of infected 
blood. While the authors acknowledged the possibility that the respondents’ behaviours may 
have changed after donation, reporting bias should remain a concern when relying on self-
assessment tools to evaluate risk. 
 
At KATH, blood is tested with rapid screening tests prior to donation (Owusu-Ofori et al. 
2005), which can be costly but reduces the expense of blood bags as less blood is collected 
and stored. Pre-screening also results in less blood wastage (Mbanya et al., 2003). Moreover, 
from a public health perspective, pre-donation screening is advantageous as people are 
informed of their test results earlier (ibid) thus preventing further transmission of infectious 
diseases. However, it does not eliminate the risk of TTIs as there is a window period during 
which infections are undetectable but still infectious. Moreover, donors deferred after pre-
screening may feel uncomfortable or embarrassed in front of their peers.  
 
2.3.5.2 Screening collected blood 
 
At KATH, all prospective blood donors are tested for HIV, hepatitis B, hepatitis C and syphilis, 
but in countries where pre-donation testing does not occur, collected blood is tested most 
commonly for HIV and hepatitis B in order to prevent TTIs. HIV screening has been shown 
to be cost-effective as it reduces the number of disability adjusted life years (DALYS) and 
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overall costs simultaneously (van Hulst et al. 2008). There is, however, concern relating to 
the quality of screening. For example, in spite of screening, a study in Kenya estimated that 
2% of blood transfusions resulted in HIV infection (Moore et al. 2001). It is possible that 
these TTIs occur during the ‘window period’ when the virus is present and undetectable, but 
was not the case in this study. However, one study found poor sensitivity for both HBV and 
HIV screening which, in the case of HBV, the authors attributed primarily to the use of rapid 
tests as the main form of screening (Laperche, 2012)   
 
Note that there are many other infectious agents for which blood is not routinely screened 
for in Africa. Examples include malaria, syphilis and filariasis (Adjei et al. 2003; Tagny et al. 
2010). However, given the high prevalence of some of these diseases, additional screening 
would further reduce the supply of blood (Adjei et al. 2003). Moreover, in some cases as with 
for example malaria, a considerable portion of the African population has some level of 
naturally acquired immunity (Osaro and Adias, 2011), and therefore the risk of infection 
through transfusion is low.  
 
2.3.5.3 Addressing blood safety 
 
Given the debate concerning the safety of blood from volunteer and replacement donors, it 
remains unclear how best to address blood safety. Reddy (2012) suggests that two key 
factors in ensuring blood safety are retaining low risk volunteer donors and a national 
coordinated blood service. Others, however, have suggested that increasing the number of 
return donors is an integral part of blood safety and that more efforts should be directed at 
retaining donors (Allain et al. 2010).  
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2.3.6 Barriers to adequate blood supplies 
 
2.3.6.1 Recruiting donors 
 
As mentioned above, ensuring adequate supply of blood is one of the major challenges facing 
blood transfusion services globally. Both education and gender issues appear to influence 
blood donation patterns. However, other reasons for not donating exist. For example, people 
may be unable to afford time off from work and thus be unwilling to become volunteer 
donors, as is believed to be the case in northern Nigeria (Ahmed et al. 2007). Financial 
problems and the fear of testing HIV positive also appear to deter replacement donors (ibid). 
In Iran, lack of time and difficulty in accessing blood drives were cited as major reasons for 
not donating (Javadzadeh Shahshahani, 2007). The same study revealed that nearly half the 
population did not donate due to perception of anaemia, fear or unawareness of the 
importance of blood (ibid). In some cases, even family members are unwilling to act as 
replacement donors (Bates & Manyasi 2007). All the above factors should be taken into 
consideration when developing recruiting schemes. 
 
2.3.6.2 Financial barriers 
 
The cost of donor recruitment, testing, equipment and staff all contribute to the cost of blood. 
The cost per unit of replacement blood ranges from $12 to $16 whereas that of volunteer 
blood is $26 to $60 (Allain 2011). As mentioned above, the main reasons for the difference 
in cost between replacement and volunteer blood are the costs associated with quality 
management and donor recruitment (Lara et al. 2007). Collecting user fees from all in 
patients has been suggested as a potential mode of funding and it is believed that the costs 
could be minimal and would therefore not affect health care access (Hensher and Jefferys 
2000). However, it is not clear whether such costs would deter individuals from seeking 
medical care and potentially increase the health inequalities gap. Particularly, since from the 
patient perspective, inability to pay in advance remains a major obstacle (Bates & Hassall 
2010). In some cases, countries like Rwanda, Burkina Faso and Cote d’Ivoire have reduced 
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the financial burden by obtaining support from international partners (Tagny et al. 2008). 
While external support can be useful in establishing a blood transfusion system, there is 
always the possibility that these funds will cease to exist and governments should therefore 
avoid relying on them long-term.  
 
2.3.6.3 Unnecessary transfusions 
 
It is believed that the future of the efficient use of blood relies on the ability of health workers 
to reduce the number of unnecessary transfusions (Allain 2011). Unnecessary transfusions 
remain a major problem and pose a considerable burden on the blood system. Research 
suggests that adherence to strict guidelines and protocol can help limit unnecessary 
transfusions by up to 75% (Bates & Manyasi 2007), which will consequently reduce the 
amount of blood required. Additionally, given that severe anaemia is one of the most 
common reasons for blood transfusion, it has been suggested that iron supplements at an 
earlier stage may be a cost-effective solution (Osaro and Adias, 2011).  
 
2.3.6.4 Limited knowledge among staff 
 
A study in the United Arab Emirates revealed that many of the nurses involved in transfusion 
lacked sufficient knowledge and training (Hijji et al. 2012). For example, only 19% of the 
study’s participants were ‘aware of basic ABO terminology’ and less than half (43%) knew 
they should ensure the patient’s identification details on the blood bag matched those on the 
blood request form (ibid). 90% were unsure as to how often they should record vital signs 
in a patient undergoing a blood transfusion (ibid). A similar problem was found among 
laboratory staff in Burkina Faso (Nébié et al. 2011). Limited knowledge among staff may 
result in errors, blood wastage (e.g. blood bag has spent too long at room temperature due 
to delays in transfusion and is therefore no longer viable) and TTIs and should be addressed 
by ensuring all staff members receive adequate training.  
 
As blood transfusion protocols vary between hospitals, hospitals’ blood services 
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departments should hold regular induction and refresher training sessions with all staff 
involved in blood transfusions (e.g. doctors, nurses, and laboratory staff) to ensure staff 
members are up-to-date with the hospital’s blood transfusion protocol. This should include 
information about blood component storage, production, grouping and cross-matching (how 
grouping and cross-matching is performed and its significance), component usage (e.g. when 
to use each of the components), blood safety (e.g. needle stick injuries and ensuring proper 
patient identification) and transfusion monitoring (e.g. how often vitals should be recorded 
for patients undergoing a transfusion).  
 
In addition to increased training, hospitals should regularly assess how well current blood 
transfusion protocols are being adhered to and in cases where they may not be followed the 
hospital should aim to identify the cause(s) for this and address it. 
 
2.4 Blood component preparation and usage 
 
The WHO and many of the African national blood policy documents reviewed (see Chapter 
3) recommend the use of blood components. The process of separating blood into its 
components was first developed in 1960, allowing production of packed red blood cells 
(PRBC), fresh frozen plasma (FFP) and platelet concentrates (PC) using a heavy spin 
refrigerated centrifuge (Basu and Kulkarni, 2014). Preparing PRBC and FFP is a one step 
process, however, the preparation of PRBC, FFP and PC requires a two-step centrifugation 
(ibid).  
 
2.4.1 Advantages of Blood Components 
 
There are two main arguments supporting the use of blood components. The first is that 
patients can receive specifically what they need (NHS Blood and Transplant, 2016), which 
can have positive effects on their outcome. For example, in patients with cancer, the bone 
marrow can be affected thus reducing platelet production and increasing the risk of severe 
bleeding. These patients can benefit from an increase in platelets specifically, but do not 
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require an increase in blood volume or other components found in blood. The second 
advantage of blood component usage is that a single unit of collected blood may be used to 
treat several individuals (ibid) (for example, one patient may receive the PRBC and another 
the FFP). Therefore, one blood donation can benefit multiple people. 
 
2.4.2 Disadvantages of Blood Components 
 
The preparation of blood components is costly (for example, equipment maintenance) and 
energy demanding (e.g. electricity required by refrigerated centrifuge and freezers to store 
FFP)  – two scarce resources, particularly in low and middle-income countries. The increase 
in cost may be justified given that components can be used to treat multiple patients. 
However, the more relevant factor when considering cost-efficiency is how many component 
units a blood bank is producing. For example, component production may cost considerably 
more per whole blood unit in a blood bank processing 100 units compared to one processing 
10 000 units.  
 
An additional factor to consider is the individual blood bank’s needs. A cancer hospital, for 
example, may require more platelets, while a hospital whose blood usage is mainly for 
trauma injuries may benefit more from whole blood. In fact, U.S. Military hospitals in 
Afghanistan and Iraq have returned to using fresh whole blood. A study comparing 
component therapy and warm fresh whole blood (WFWB) treatments in military patients 
with trauma and haemorrhagic shock showed that the 30-day survival rate for patients was 
significantly higher in those receiving WFWB (Spinella et al., 2009). Thus, even in cases 
where components have been traditionally used as treatment, fresh whole blood may be just 
as or more effective. However, this is also dependent on having quick access to fresh whole 
blood.  
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2.4.3 Blood component production at KATH 
 
According to blood bank laboratory staff members, the KATH blood bank aims to convert an 
estimated 30% of whole blood units into blood components. The main components 
produced are PRBC and FFP, though PC are also produced on demand.  A double blood bag 
system is used for separation of whole blood into the two main components – an added cost 
to the blood bank. FFP units are stored at -40 degrees Celsius for up to one year. PRBC are 
stored under the same conditions as whole blood – up to 30 days at 4 degrees Celsius.  
 
It is clear that the blood bank is moving towards greater component production. The blood 
bank’s aim is to increase the proportion of whole blood units converted into components 
each year, as according to blood bank staff there is high demand for components and also, a 
unit of blood can serve more purposes. However, it is unclear how projected component 
production goals are determined. According to the KATH’s 2013 transfusion medicine 
review, 16,247 units of blood were collected and 2131 units of FFP were produced. As shown 
below in Figure 2.2, there has been a consistent increase in FFP production. In four years, 
FFP production has increased approximately 400%., with the Obstetrics and Gynaecology 
(O&G) unit responsible for approximately 45% of FFP usage in 2013 Interestingly, the 
review made no mention of PRBC production and usage. 
 
Figure 2.2 – Fresh frozen plasma production at KATH between 2009-2013 
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2.5 Conclusion 
 
There are unique challenges that blood services in low and middle-income countries face, 
and these vary by region. It is important to identify these challenges in local areas and 
develop and implement policies aimed at addressing them. In addition, it is equally 
important to observe the successful aspects of different blood service departments and 
determine whether similar strategies can encounter be successful elsewhere.  
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Chapter 3 – Comparing policy and practice and 
identifying discrepancies between the two 
 
3.1 Introduction 
 
As mentioned in the introduction, this study was divided into two phases. Phase 1 consisted 
of preliminary mapping via a pilot study, which took place over a period of 6 weeks, and 
included obtaining and reviewing African national blood policies, WHO documents and other 
literature. Questionnaires and semi-structured interview tools which were used in Phase 
two to collected qualitative information from donors and patients were also piloted during 
this period. Areas where participants’ responses were too vague were adjusted to include 
specific follow up questions in order to obtain more information (see Appendix 8).  
 
Further objectives and sub-objectives were developed based on the results of Phase 1 and 
were addressed in Phase 2. This chapter focuses on the first phase of the study and the 
methodology used to address Objectives 1 and 2: 
 
Objective 1: Examine the Ghana national blood transfusion policy in an African context 
and identify the strengths, weaknesses and evidences gaps 
 
Objective 2: Compare practice to policy in Kumasi and identify factors affecting policy 
implementation 
 
This chapter will firstly outline the recommended vein-to-vein blood transfusion process 
based on current African national policies, literature and WHO policy documents. Secondly, 
this chapter will summarise Ghana vein-to-vein policies, current KATH practices and 
discrepancies with the two and will detail how the findings influenced the next phase of the 
study. 
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3.2 Vein-to-vein policies in Africa 
 
3.2.1 Identifying and generating a list of generic vein-to-vein policies in 
Africa 
This review focused on the WHO’s African Region (WHO/AFRO). In total, 15/48 African 
national blood policies were obtained. Five countries, where neither English nor French are 
one of the official languages, were excluded for linguistic reasons1. A web search, using the 
search engine Google, was conducted in French and in English for each country using the 
following key search terms along with each country’s name (for example, ‘Malawi national 
blood policy): 
 
• ‘blood transfusion policy’ AND [country name] 
• ‘national blood policy’ AND [country name] 
• ‘politique nationale transfusion’ AND [country name] 
• ‘politique nationale sanguine’ AND [country name] 
• ‘blood services’ AND [country name]  
 
Google was chosen as the search engine over other databases such as PubMed as I wanted to 
ensure I covered the relevant grey literature, which would not be easily identified in a 
database such as PubMed, which favours peer-reviewed studies. National policy documents, 
therefore, are rarely identified in a PubMed of MEDLINE search. It also allowed us to cast a 
wider net to ensure no other relevant sources of information went amiss. 
 
The first one hundred results for each search were reviewed. Any national blood policy 
documents and national blood transfusion related recommendations or guidelines were 
included in the review. Where possible, national blood service websites, found while 
searching ‘[country name] blood services’, were also searched for available policies. Personal 
requests for national policies were sent by email to known blood bank directors. The initial 
                                                           
1 Countries excluded for linguistic reasons: Angola, Cape Verde, Guinea-Bissau, Mozambique and Sao Tome and Principe 
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request was sent to a contact in Cameroon who then kindly forwarded a list of further 
contacts in blood services departments in 13 different African countries. In a couple of cases, 
blood service departments were contacted via the email on their website. Emails were sent 
to all relevant contacts to determine whether their country currently had a national blood 
policy. If so, they were requested to provide a copy. Follow up emails were sent within the 
next few months. In March 2014, a final request letter was sent to all those who had not 
responded.  
 
In total, nine countries responded, each with their own national policy document. One, 
however, was a draft version and was excluded from the study as I would be unable to share 
its contents. One policy sent had also been identified via the Google search.  An additional 7 
policies were identified through the Google search. A summary of the national blood policy 
search strategy and results is presented in Figure 3.1  
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Figure 3.1 – A summary of the search strategy and results for African national blood policies 
Google search (see 
section 3.2.1 for 
search terms and 
further details)
Contacted 14 
African blood 
service 
departments
 8 national blood 
policies identiﬁed 
via google search
Received 7 national 
policy documents via 
email; 1 country 
responded saying 
they had no national 
policy in place
Follow up emails 
were sent to those 
who did not 
respond
A further 2 national 
policy documents 
were received via 
email
A total of 9 national 
policies identiﬁed 
by emailing 
contacts
1 document 
excluded as it was 
a draft version
One duplicate 
identiﬁed (received 
via email and 
identiﬁed in the 
google search)
15 national blood 
policy documents 
identiﬁed and 
reviewed
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Three WHO policy documents were also reviewed2, as they informed many of the current 
national blood policies in SSA. These policies were found on the WHO website. Below is a list 
of countries included in the WHO/AFRO region, the national blood policies collected and 
reviewed and the WHO documents reviewed: 
 
WHO/AFRO countries  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
                                                           
2 World Health Organization, (2001). Developing a National Policy and Guidelines on the Clinical Use of Blood. 
[online] Available at:  http://www.who.int/bloodsafety/clinical_use/en/who_bct_bts_01_3.pdf [Accessed 15 
Aug, 2012] 
-World Health Organization. (2009). Screening Donated Blood for Transfusion Transmissible Infections 
Recommendations. [online] Available at: http://www.who.int/bloodsafety/ScreeningTTI.pdf  [Accessed 15 
Aug. 2012]. 
-World Health Organization, (2001). The Clinical Use of Blood. [online] Available at: 
http://www.who.int/bloodsafety/clinical_use/en/Handbook_EN.pdf [Accessed 18 Aug, 2012] 
• Angola 
• Benin 
• Botswana 
• Burkina Faso 
• Burundi 
• Cameroon 
• Cape Verde 
• Central African Republic 
• Chad 
• Comoros 
• Cote d’Ivoire 
• Democratic Republic of Congo 
• Djibouti 
• Equatorial Guinea 
• Eritrea 
• Ethiopia 
• Gabon 
• Gambia, The 
• Ghana 
• Guinea 
• Guinea-Bissau 
• Kenya 
• Lesotho 
• Liberia 
• Madagascar 
• Malawi 
• Mali 
• Mauritania 
• Mauritius 
• Mozambique 
  
 
• Namibia 
• Niger 
• Nigeria 
• Republic of the Congo 
• Rwanda 
• Sao Tome and Principe  
• Senegal 
• Seychelles  
• Sierra-Leone 
• Somalia 
• South Africa 
• South Sudan 
• Sudan 
• Swaziland 
• Tanzania 
• Togo 
• Uganda 
• Zambia 
• Zimbabwe 
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 National SSA Blood Policies Collected and Reviewed 
 
• Algeria 
• Benin 
• Cameroun 
• Ghana 
• Lesotho 
• Madagascar 
• Malawi 
• Namibia 
• Nigeria 
• Senegal 
• South Africa 
• Tanzania 
• Togo 
• Uganda 
• Zimbabwe 
 
 
WHO Documents Reviewed  
 
• Screening Donated Blood for Transfusion Transmissible Infections Recommendations (2009) 
• The Clinical Use of Blood (2001)  
• Developing a National Policy and Guidelines on the Clinical Use of Blood (2001) 
 
3.2.1.1 Reviewing Policies 
 
All national blood policy and blood transfusion clinical guideline documents were reviewed, 
however only information pertaining to the vein-to-vein process (i.e. from blood donation to 
blood transfusion) of blood supply was included in this study. Details regarding clinical 
guidelines and organisational structures were excluded since that was not the focus of this 
study. Policies were made anonymous for analyses purposes, as the aim was to generally 
assess blood transfusion policies in Africa and we wanted to avoid highlighting strengths and 
weaknesses for individual countries in an effort to maintain good relations with the national 
blood services.  
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During the review, all policies pertaining to the vein-to-vein process of blood supply were 
initially grouped under the following themes: blood stock, blood donation, blood storage, 
blood grouping, blood requests, withdrawing blood for sampling, processing blood requests 
and blood transfusion. These themes were pre-determined, based on previous knowledge 
acquired via the literature review (see section 2.3). Some policies, however, did not fit with 
any of the themes but were still relevant to the review. Thus, three more themes were added: 
blood bank facility requirements, preparation of blood components and collection of whole 
blood and blood components. It became clear that some of the themes were too broad, 
therefore policies were further organised into sub-themes.  
 
Policies common to 50%≥ of national blood policy documents and discrepancies between 
policies were identified and compared with existing evidence. A literature review was 
conducted for each of the common policies via PubMed to determine what evidence, if any, 
there was concerning the given policy. As with the previous literature view (see section 2.3), 
the first 100 results were reviewed. The key search terms used for each policy are noted 
below in section 3.2.1.2 underneath each policy listed. 
 
3.2.1.2 Blood policy categories and sub-categories generated through policy 
review 
 
• Blood Stock 
• Blood Donation 
o Donor Recruitment  
o Location 
o Pre-Donation Counselling 
o Collecting Blood from the Donor 
o Blood Screening 
o Adverse Reactions 
o Post Donation 
o Donor Records 
• Blood Bank Facility Requirements 
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o Location 
o Laboratory Records 
• Blood Storage 
• Blood Grouping 
• Preparation of Blood Components 
• Blood Requests 
• Withdrawing Blood for Sampling 
• Process Blood Requests 
o Receiving Blood Samples 
o Cross-matching for compatibility 
• Collection of whole blood and blood components from the blood bank 
• Blood Transfusion 
• Transfusion Monitoring 
• Blood Disposal 
 
3.2.2 Common vein-to-vein policies present in the majority of African 
national blood policies 
 
Below is a list of common vein-to-vein policies present in more than 50% (8+/15) of the 
national blood policies reviewed. Those with an asterisk also appeared in the WHO 
literature. It was important to maintain anonymity when presenting these results so as not 
to discourage countries from sharing their policies in the future. Thus, the summary table at 
the end of this section (Table 3.1) is organised by region and each national policy is assigned 
a random letter from A-O in no particular order, with the exception for Ghana which is clearly 
identified. Looking at this table, there are no clear regional patterns in terms of common 
policies included. The common vein-to-vein policies do vary between countries, but there is 
no case where a single one of these policies is only present or missing from a given region. 
However, it is interesting to note that I was unable to obtain any policy documents from East 
Africa, with the exception of the document that was still in its draft version and excluded 
from the study. 
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Blood Donation 
1. Donors should be selected using rigorous criteria (13/15) * 
a. Key search terms: “Blood donation criteria”; “Donor recruitment”; “Donor selection”  
2. Blood should be collected from volunteer non-remunerated donors (14/15) * 
a. Key search terms: “Volunteer blood donors”; “VNRD”; “Blood safety” AND “Volunteer 
donors” 
3. Paid donors are prohibited (13/15) * 
a. Key search terms: “Paid donors”; “Paid blood donors”; “Remunerated donors”; “Paid 
donors” AND “Blood safety” 
4. Donor confidentiality must be maintained (11/15) * 
a. Key search terms: “Blood donation confidentiality”; “Donor confidentiality” 
5. Pre-Donation counselling for all donors (9/15) 
a. Key search term: “Blood donor counselling” 
6. Donors should be informed about the risks of donating blood prior to donation (9/15) 
a. Key search terms: “Blood donation risks”; “Blood donor information”; “Blood donation 
protocol” 
 
Screening Blood 
 
7. All blood should be traceable (9/15) 
a. Key search term: “Blood traceability” 
8. All blood should be screened for transfusion-transmitted infections (12/15) * 
b. Key search terms: “Blood screening”; “Blood donor screening”; “Blood testing”; 
“Transfusion transmitted infections”;  
 
Blood Grouping 
 
9. All blood should be grouped for ABO and Rh and labelled (12/15) * 
a. Key search term: “Blood grouping” 
 
Blood Components 
 
10. Preparation and Availability of blood components (9/15) * 
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a. Key search terms: “Blood components”; “Blood component production”; “Blood 
component usage” 
 
Clinical Use of Blood 
 
11. Doctors are accountable for appropriate clinical use of blood and alternatives to transfusions 
(12/15) * 
a. Key search term: “Blood transfusion prescription”; 
 
Blood Requests 
 
12. Blood request forms must be completed prior to transfusion. The minimum criteria across all 
policies are patient identity and quantity requested (9/15) 
a. Key search terms: “Transfusion errors”; “Blood request forms” 
 
* policies that were also recommended by the WHO 
 
Note: the number in parentheses represents the number of national blood policy documents where the 
given policy was recommended.  
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Region Country 1 2 3 4 5 6 7 8 9 10 11 12 
West 
Africa 
A X X X X X   X X  X  
B X X X X  X X X X  X X 
C X X  X  X X  X  X X 
D  X X  X X   X X X   
E  X X X X   X  X   
F X X X  X X X X X  X X 
 Ghana X X X X   X X X X X X 
Southern 
Africa 
H X X X X  X     X X 
I X X X X  X X X X X X X 
J X X X X X X X X X X X  
K X X X X X X X X X X X X 
L X X X  X X X X X X X X 
M X X X  X X X X X X X X 
N  X X     X X X   
O X  X X X      X  
 
Table 3.1 – Summary of common vein-to-vein policies found in the African national blood policies reviewed 
(the policy numbers in the top row correspond to those presented above) 
 
3.3 Methods used to identify current practices at KATH 
 
In 2013, a pilot study was conducted over a period of six weeks to identify current vein-to-
vein transfusion practices at KATH. The pilot study was included in the initial submission to 
both the LSTM and CHRPE ethics committees. The methods used are presented in this 
section. 
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3.3.1 Blood donation and screening 
 
Information about current blood donation practices was obtained using the following 
methods: 
• Direct Observation 
• Semi-structured interview with donor clinic head nurse (see Appendix 12 for a rough 
guide) 
• Semi-structured interviews with donors (see Appendix 8 for a rough guide) 
• Reviewing hospital documents/forms 
 
The pilot study began with my supervisor Dr. Owusu-Ofori giving me an overview and tour 
of KATH and its departments. Next, we met with the director of blood services who 
introduced me to the blood bank staff members which included the laboratory staff, who 
were responsible for screening, grouping, cross-matching and general day to day functions 
of the blood bank, as well as the administrative staff in charge of handling blood requests 
and record keeping. Next, my supervisor introduced me to the donor clinic’s head nurse and 
the donor recruitment team lead. Together these two introduced me to the other donor clinic 
and transfusion recruitment team staff members. In each of the introductions, I explained 
who I was, where I was from, the aim of my research project and the overarching plan for 
my fieldwork. I emphasised that I would value their opinions and wanted the research to be 
relevant and useful to their work and would therefore interview some of them during the 
pilot to help guide my study. They were all incredibly kind and helpful and with their help I 
arranged to spend time in the donor clinic and attend a blood drive, known as a mobile 
session, in order to pilot my questions with donors.  
 
Through Dr. Owusu-Ofori, I was also introduced to Maxwell Owusu, a scientist in one 
laboratories in the hospital, who would also voluntarily aid me in translating interviews from 
Twi to English. Maxwell and I went through the semi-structured interview guides together 
which gave him an idea of the aim of the interviews and the opportunity to clarify any points. 
I suggested he translate my questions and the participants’ responses as we conducted the 
 60 
interview. While this can disrupt the flow of the interview, it allowed me to immediately 
follow up on some of the points made by the participants, which was important given that it 
was unlikely we’d be able to make contact with the participant again.  
 
To begin, an interview with the donor clinic’s head nurse was conducted to determine the 
general structure of the donation process both at the donor clinic and at mobile sessions. The 
aim was to learn more about the current practice. The interview consisted mainly of broad 
and open-ended questions, with more specific follow-up questions posed when needed. 
Donor clinic record books (where basic donor information such as name, age, sex, pre-
screening results, and where applicable, date donated and the corresponding ID number on 
the blood bag were recorded) and donor clinical forms were reviewed.  
 
Direct observation was used to develop a detailed outline of the donation process starting 
with when the donor first arrived at the clinic to when the donor left the clinic. The same 
method of direct observation was used at the mobile sessions. The direct observation took 
place over the course of two weeks to ensure that no steps in the process went amiss. During 
this period, I also spent some time in the pre-screening area to learn about current screening 
practices. Following this, 10 semi-structured interviews were conducted with donors 
attending either the donor clinic or mobile session (see Appendix 8). Eight of the donors 
were from mobile sessions and two from the donor clinic.  Seven of the donors interviewed 
were female. The reason for this high proportion is due to the fact that the mobile session I 
attended during the pilot study was at a nursing college, where the vast majority of students 
were female.  
 
The aim was to identify areas of the process that may not have been previously captured and 
to obtain a better idea of current strengths and weaknesses of the donation process. The 
questionnaire included in Appendix 9 was also piloted and but at the beginning of the pilot 
study I realised a large proportion of the donors could not read or write and therefore the 
questionnaire had to be administered orally. Thus, the questionnaire became incorporated 
into the semi-structured interviews.  
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3.3.2 Blood storage and grouping  
 
Blood storage, grouping and processing practices were identified through direct observation 
and through two semi-structured interviews conducted with laboratory staff at the blood 
bank (see Appendix 13). Staff members walked me through the process on how blood is 
stored, for how long and how it is grouped.  
 
3.3.3 Prescribing blood transfusions  
 
I conducted 3 semi-structured interviews with doctors in the Child Health and Medicine 
units to learn more about how physicians make blood requests for their patients, what they 
must consider prior to transfusion, the challenges they face in obtaining blood and the 
improvements they have seen in blood services at KATH.  
 
3.3.4 Handling blood requests and cross-matching 
 
The blood bank staff members guided me through current practices on how incoming blood 
requests are processed, prioritised and cross-matched. I also spent 2 days independently 
observing the process to limit any bias from staff members. Additionally, I looked through 
the blood request forms submitted to the hospital to identify the parts of the form that were 
consistently filled out and those that were often left blank. I later approached blood bank and 
laboratory staff members to determine how forms with blank fields were processed. 
 
3.3.5 Transfusing and monitoring patients 
 
To gain a better understanding of how blood is transfused to patients in the ward, I spent 
two weeks in the Medicine and Child Health hospital specialities where I informally spoke 
with five nursing staff to learn the steps they take before, during and post transfusion. One 
limitation was that many nurses were unwilling to provide written consent or be audio-
recorded as they feared it could result in negative feedback from their superiors. It is due to 
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this, that informal interviews were used to gather data, as nursing staff seemed more willing. 
By informal, I mean information was gathered through multiple short ‘chats’ with ward staff 
members involved in blood transfusions, sometimes over the course of multiple days. These 
were not audio-recorded. Signed consent forms, however, were still required, but they were 
left with staff members for a few days and collected two or three at a time so it was unclear 
which form belonged to whom. Additionally, I spent time observing transfusions to identify 
which aspects were consistent and which were not with the information obtained through 
the semi-structured interviews. 
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3.3.6 Summary of methods used in pilot study 
 Direct Observation Semi-Structured 
Interview 
Reviewing hospital forms 
and documents 
Informal communication 
Blood donation and 
Screening 
Yes – I visited the donor clinic 
and observed donors coming 
in, undergoing the health and 
risk assessment, donating 
blood and waiting 15 minutes 
post-donation in case they 
encountered side effects. I also 
visited the screening room 
where prior to donation, a 
sample of donors’ blood is 
tested for HIV, hepatitis B and 
hepatitis C. 
Yes - I interviewed 10 
donors and the donor 
clinic’s head nurse. A 
questionnaire was 
piloted (see Appendix 9), 
but due to the literacy 
issues was administered 
orally and was then 
incorporated into the 
semi-structured 
interview 
Yes – I looked at the 
health and risk 
assessment 
questionnaire, the blood 
bag labels, the donor 
clinical forms and the 
donor clinic record books 
During slower periods at the 
donor clinic I often chatted with 
the health care assistants and 
nurses who would sometimes 
discuss aspects of how blood 
services works at KATH. This 
was not in a structured setting, 
but they provided useful 
background information which 
helped with my understanding 
of the donation process. 
Blood storage and 
grouping 
Yes – I spent time in the blood 
bank with a member of staff 
guiding me on how blood is 
stored, at what temperature 
the various components are 
stored and how donated blood 
is grouped. 
Yes, two semi structured 
interviews were 
conducted with 
laboratory staff at the 
blood bank 
No No 
Prescription of blood 
transfusions 
No Yes - I conducted 3 
interviews with doctors 
prescribing blood 
transfusions in the Child 
Health and Medicine 
units  
No No 
Handling of blood 
requests and cross-
matching 
Yes – while spending time in 
the blood bank I observed how 
blood requests are handled 
and processed, the cross-
matching process and how 
blood is transported to the 
patient. 
Yes, two semi structured 
interviews were 
conducted with 
laboratory staff at the 
blood bank 
Yes – I looked at the 
blood request forms, 
specifically looking at 
what fields were left 
blank 
No 
Transfusion and 
monitoring patients 
Yes, I returned to the ward 
with health care assistants 
picking up units of blood at the 
blood bank and observed how 
the patient was identified and 
transfused. 
No Yes, I had a look at the 
transfusion monitoring 
form and how it was 
completed 
Yes – I spoke with 5 nurses on 
the wards 
Table 3.2 – Summary of methods used in pilot study 
 
In total, ten semi-structured interviews with donors were conducted, one with the donor 
clinic head nurse, three with blood transfusion prescribing doctors and two with blood bank 
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staff members. An additional five informal ‘chats’ were held with nurses as they were less 
receptive to the idea of a semi-structured interview with signed consent forms and audio-
recording.  
 
 
3.4 Current Blood Services Practice at KATH 
 
Figure 3.2: Summary of Transfusion Services at KATH 
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3.4.1 Blood Collection at KATH 
 
Blood is collected from donors at the hospital’s donor walk-in clinic, at mobile sites and 
public drives. Both volunteer and replacement donors visit the walk-in clinic, which is open 
twenty-four hours a day, seven days a week. Donors at the mobile sites and public drives, 
however, are volunteers, some of whom are repeat donors. Two teams of staff at the blood 
bank organise the mobile site visits. Each team is responsible for a given geographical area. 
Examples of mobile sites include schools, churches and mosques. Both teams work together 
to organise public drives, which are usually sponsored by FM stations and corporations. 
 
3.4.2 The Blood Donation Process 
 
3.4.2.1 Initial Screening/Health Assessment 
 
To donate blood, prospective donors must undergo an initial screening/health assessment 
and pre-screening. During the health assessment, donors are asked a series of questions by 
a nurse, health assistant or phlebotomist regarding personal information, health and lifestyle 
(see Appendix 7). In addition, their weight and blood pressure are measured. Using this 
information, a clinical record from is completed on behalf of the donor (see Appendix 4). 
Only prospective donors who satisfy the criteria listed below are sent for pre-screening. 
Anyone who meets one or more of the disqualification criteria is prohibited from ever 
donating blood. Those who meet one or more of the exclusion criteria listed below are 
deferred. 
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Initial screening donor criteria: 
 
Inclusion Criteria 
 
• Must weigh a minimum of 50kg 
• Must have ‘normal’ blood pressure. While there are no explicit guidelines defining ‘normal blood 
pressure’, interviews with staff members suggest that this means a systolic pressure of 100 - <140 
mmHg and a diastolic pressure of 60-90 mmHg. 
 
 
Exclusion Criteria 
 
• Anyone who has had acupuncture, ear or nose piercing in the last six months 
• Those on antibiotics or who have taken antibiotics in the last one week 
• Anyone having received blood transfusion or blood components within the last six months 
• Anyone who has had chicken pox or shingles in the last three months 
• Anyone with a dirty sore or boil 
• Anyone who has shared facilities or nursed somebody with jaundice (hepatitis) or AIDS 
• Those who have been hospitalised in the last six months 
• Anyone who in the last year has had an injection in a place which is not a hospital or clinic or who 
has had skin scarring or cutting by a traditional healer. 
• Anyone who has had a major surgical operation in the last year 
• Anyone who has had a tooth extraction in the last three days 
• Anyone who immediately after donation will be driving a crane, bus, heavy machinery, or go up a 
scaffolding or swimming 
• Anyone who has been inoculated in the last three weeks for yellow fever, tetanus, rubella, rabies, 
polio, typhoid or diphtheria 
• Anyone who has a fever, chest or throat infection, or feels unwell 
• Those who are pregnant or who have had a child or miscarriage in the last six months 
• Anyone whose work entails being away from home for more than three months in a year 
• Anyone who has had sex with someone who is not their wife (spouse) or regular partner, or 
someone they are unsure about 
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• Females who are breastfeeding or menstruating **(Note: This is not listed in the pamphlet but 
according to the donor staff this is part of the exclusion criteria. I have seen one donor deferred 
because she was breastfeeding) 
 
 
Disqualification Criteria 
 
• Taking drugs for high blood pressure or heart failure 
• Anyone who has ever tested positive for AIDS 
• Anyone who has had jaundice, liver disease, hepatitis or a positive blood test for hepatitis 
• Those with epilepsy, diabetes, duodenal or gastric ulcer and hypertension 
• Drug addicts or anyone who has ever taken self-injected drugs 
• Anyone with sickle cell anaemia (e.g. SS, SC, SBthal) 
• Anyone with asthma 
• Prostitutes 
• Homosexuals 
 
3.4.2.2 Pre-Screening 
 
If the prospective donor passes the initial screening, he/she is sent with his/her clinical 
record form for pre-screening. To donate blood, the potential donor must pass the pre-
screening tests. This means they must meet the following criteria: 
 
• The donor’s Hb level must be at least 12g/dl (for females) or 13g/dl (for males).  
• The donor must test negative for HBV, HCV and HIV 
 
Roughly 3ml of blood is drawn from the donor for the pre-screening tests and placed in a 
test tube, which is labelled with an identification number. Copper (II) sulphate is used to test 
whether the prospective donor’s Hb level is sufficient. The specific gravity for the copper (II) 
sulphate solution for men is 1.053 and for women 1.052.  
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Donors with low Hb - If the donor’s Hb level is found to be too low the pre-screening team 
records the result along with the prospective donor’s name in their record book as well as 
on the donor’s clinical record form. The donor is then sent back to where he/she was initially 
screened, is informed that he/she cannot donate on that day and is provided with counselling 
as to how they may increase their Hb through diet. The donor clinic staff records the date, 
the deferred donor’s name and sex in a record book titled “Low Hb”.  
 
Pre-screening for HBV, HCV and HIV- If the prospective donor’s Hb level is sufficient, their 
blood is tested for HBV, HCV and HIV using rapid tests. The hospital will soon start screening 
for syphilis. The staff must wait 15 minutes before interpreting the results. The results of the 
test are recorded on the clinical record form and in the pre-screening books along with the 
date, the prospective donor’s name, sex and the test tube identification number. The 
potential donor must then provide the donor clinic staff with their clinical record form.  
 
If one of the prospective donor’s tests is positive, the pre-screening team keeps the 
remaining blood in the test tube aside for confirmation testing by ELISA. The donor clinic 
staff informs the potential donor that he/she may not donate and the donor is asked to make 
an appointment for the following week. The prospective donor is not informed about the test 
results. The following week, based on the results from the ELISA, the deferred donor is 
advised about their results and referred to an appropriate doctor or clinic within the 
hospital. 
 
3.4.2.3 Donation 
 
If the donor successfully completes the pre-screening tests, he/she proceeds to donate. A 
blood bag containing 63ml of citrate phosphate dextrose adenine solution as the 
anticoagulant is used for collection. The blood bag is labelled with a batch number, donation 
date and expiry date (35 days after donation). A phlebotomist locates the donor’s vein and 
collects the blood with the patient in a supine position. During this time, the donor is asked 
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to repeatedly make a fist until a maximum of 450 mls of blood has been obtained. In rare 
cases, if the phlebotomist cannot find the vein within two tries, he/she requests another staff 
member to try and locate the vein. If they are still unable to find the vein, the donor is asked 
to come back on a different day.  
 
3.4.2.4 Post-Donation 
 
Immediately after blood collection, the phlebotomist, nurse or health care assistant transfers 
an aliquot of blood (~3ml) into a test tube labelled with the batch number and set aside for 
grouping. After donation the donor is asked to relax for 15 minutes and is provided with a 
soft drink and crackers. During the donation period the donor is provided with “post-
counselling”, where he/she is advised to rest, drink fluids etc. In addition, the staff members 
use this time to enquire about the donor’s experience and encourage them to become repeat 
donors. 
 
3.4.2.5 Adverse Reactions 
 
Donors who experience adverse events during or after transfusion are attended to and 
managed according to the presentation. Examples of adverse events include but are not 
limited to headache, nausea, sweating, weakness and syncope. In case of adverse reaction 
during or after donation the donor is asked to lie down and rest for an additional 15-30 
minutes. His/her blood pressure may be taken during this time. In rare cases, the donor may 
be transported to the emergency unit.  
 
3.4.3 Blood Grouping and Storage 
 
Following donation, blood is stored in a coolbox  until it is transported to the blood bank. At 
the donor clinic, blood bags remain in the coolbox up to two hours. However, at mobile sites, 
the blood remains in the coolbox till the end of the mobile session, after which it is brought 
to the blood bank. This coolbox is not temperature monitored. It is unclear if and how this is 
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having an impacting on the units transfused into patients. 
 
At the blood bank, the blood is stored in a 4°C refrigerator labelled “ungrouped blood”.  The 
refrigerators are all temperature monitored. An alarm goes off if the temperature is outside 
its set range. Generators are in place to ensure the refrigerators remain working even when 
the electricity is out, as can be frequently the case in Ghana. Using the blood from the test 
tubes, lab technicians at the blood bank group blood for ABO and Rh. They record this 
information, label the blood bags appropriately and sort them into the appropriate fridges 
(there are four fridges for O, A, B and AB blood). The grouping results are sent to the donor 
clinic where they record each donor’s blood group. As mentioned above, blood is stored for 
a maximum of 35 days after donation.  
 
The blood bank also stores blood in a refrigerator in the lab. This fridge holds blood that has 
already been cross-matched and is waiting to be collected, blood bags that are not full and a 
few bags of whole blood from each blood type. The latter is done to save time.  
 
3.4.4 Blood Components 
 
During mobile sessions, a proportion of the blood bags are ‘double bags’. Blood collected in 
these bags are separated into components. Commonly prepared components include packed 
red cells and fresh frozen plasma. Platelets and cryoprecipitate may be prepared upon 
request. There is no specific policy as to how often this should be done. See Chapter 7 for 
more information on component production, prescription and usage at KATH.  
 
3.4.5 Blood Requests 
 
Only doctors can make requests for whole blood or blood components. To request blood, a 
‘Transfusion Request Form” must be completed (see Appendix 5) and sent to the blood bank 
along with a test tube with ~3ml of the patient’s blood. This sample is valid for up to seven 
days. Any additional requests after the seven-day period is over, must include a new sample 
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from the patient. Note that often, many of the fields are left blank on the request form and 
the request is still processed. Most commonly, the amount of blood requested and the blood 
component required are not mentioned. If the amount of blood is not provided, the blood 
bank assumes the doctor is requesting one unit. Similarly, if the type of blood is not indicated, 
it is assumed that the request is for whole blood. However, request forms that do not indicate 
the patient’s name or ward will not be processed. 
 
For scheduled surgeries, there is a blood ordering schedule where blood bank group and 
cross-match the patient’s blood and put aside the requested number of units. This, however, 
depends on blood stock levels and whether the given blood component for that blood group 
is available. 
 
3.4.6 Cross-matching 
 
A health care assistant, doctor, nurse, national service year student or even a family member 
may bring the transfusion request form along with the patient’s blood and a coolbox to the 
blood bank. Note that it is unusual for family members to transport blood and is against 
policy, but has occasionally been observed. In urgent cases, doctors will remain at the blood 
bank until they have collected the blood. The blood bank records the patient’s name, ward 
and request time in a book. The patient’s blood and transfusion request form are given to the 
lab technicians who then group and cross match the blood. In urgent situations (as marked 
on the transfusion request form), where blood is needed within the hour, the cells are not 
washed for cross-match. If blood is needed immediately, it is not cross-matched. The test 
tube containing the patient’s blood is then stored for 7 days so that a) if an adverse reaction 
occurs the blood bank staff can verify their work and b) the blood can be used for any 
additional cross-matching that must be done in the next week. 
 
Once cross-matched, a compatibility report is placed on the blood bag. This report includes 
the patient’s name and lists the blood’s grouping results as well as the patient’s blood group. 
If the blood is to be collected at a later time, it is stored in the lab fridge. The blood is then 
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given to a staff member at the front desk who passes it on to the person collecting the blood. 
If the person is a health professional, he/she must verify that the information on the cross-
match sheet (i.e. the lower half of the request form) and the compatibility report match and 
then sign his/her name and write the time of collection in one of the record keeping books. 
The blood is then placed in the coolbox and brought to the ward. In cases where FFP is 
requested, the blood bank staff thaws it for 30 minutes, but the staff in the wards must ensure 
it reaches room temperature prior to transfusion. The blood bank also provides the ward 
with a transfusion monitoring form (see Appendix 6). 
 
3.4.7 Blood Transfusion 
 
Once the blood reaches the ward, it is either a nurse or phlebotomist who transfuses the 
patient. If conscious, the patient is asked to confirm his/her identity by repeating his full 
name and date of birth. If the patient is unconscious, then his/her name in the notes is 
compared to that printed on the blood bag. Note, unlike in many higher income countries, 
patients do not have a hospital bracelet with a unique number, thus the process of patient 
confirmation may still leave room for human error. The risk of error may be even higher in 
Kumasi, where people’s names often correspond to the day of the week they were born, thus 
many people have the same given name.  
 
The nurse or phelbotomist must also verify that the compatibility report and cross-match 
form match. It is important for them to keep the cross-match form so if more blood is 
required, it may be sent back with the patient’s blood group information. Since the blood 
bank stores the patient’s blood for 7 days, there is no need to retake their blood if the 
following transfusion is within that time period. 
 
3.4.8 Transfusion Monitoring 
 
Although a structured monitoring form exists, it is often not completed, and according to 
doctors, some transfusions may go unmonitored for long periods of time. It has been 
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suggested that this may be due to lack of time or in the interest of avoiding duplicate work 
(some details regarding transfusion must also be entered in the patients’ charts). This 
suggests that the monitoring form may need to be simplified or reworked in such a way that 
more staff members will complete it. However, further qualitative research is necessary to 
better understand the culture behind completing monitoring forms and how it can be 
optimised. 
 
3.4.9 Adverse Reactions 
 
The transfusion monitoring form provided by the blood bank also lists signs of adverse 
reactions due to transfusion. If an adverse reaction occurs, the nurse or doctor in the ward 
must complete an “Adverse Reaction Investigation Form”. The blood bank will then 
investigate to see whether the reaction was due to an error on their end or due to some other 
complication or factor out of their control (e.g. patient allergic reaction). It is unclear whether 
this form is always completed.  
 
3.5 Identifying discrepancies between policy and practice 
 
The list of common, generic vein-to-vein polices derived from the review of national blood 
policies and WHO documents were directly compared to practice in Kumasi. First, I looked 
at whether each policy was in some way being practiced at KATH, and if so, what were the 
common aspects and what were the differences between the policies and practice. 
 
3.5.1 Policies not practiced 
 
The main policies that were not practiced or consistently enforced at KATH, but were 
common to most national blood policies are: 
 
1. Blood should be collected from volunteer non-remunerated donors (14) * 
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2. Donors should be informed about the risks of donating blood prior to donation (9) 
 
At the time of this study, there were periods of time where the hospital was struggling to 
meet blood needs even when receiving donations from both volunteers and replacement. It 
was, therefore, not sustainable or practical to rely solely on VNRD. 
 
Semi-structured interviews with donors along with results obtained from direct observation 
during the pilot study showed that not all donors were made aware of the risks of donating. 
Examples of risks for blood donors include adverse events such as nausea, headache and 
syncope. However, there is much debate globally as to what information should be given to 
patients to obtain their consent (which can apply to donors), and how to determine what 
information will be important to whom. For example, a study in the Netherlands with 37 
doctors found that “Doctors have doubts about disclosing or withholding information on 
complication risk, especially in a risk range of 1 in 200 to 1 in 10 000” (Palmboon et al., 2007). 
The main reasons for this were that doctors felt disclosing rare risks served no purpose and 
that patients were more likely to remember that one piece of information and forget the rest 
(ibid). There is some evidence for this from a study in the USA, which found that donors 
understood 73.5% of the donor eligibility and risk information provided to them (Alaishuski 
et al., 2008). In the United Kingdom (UK), the General Medical Council (GMC) suggests that 
side effects and complications of an intervention be discussed with the patient, but that “the 
amount of information about risk that you should share with patients will depend on the 
individual patient and what they want or need to know. Your discussions with patients 
should focus on their individual situation and the risk to them” (GMC, 2017). Thus, one 
approach to addressing this may be to assess each donor’s understanding of the blood 
donation process and determine what concerns he/she may have about giving blood. 
 
While the donor clinic’s policy at KATH was to prohibit paid donors, it is not always possible 
to identify paid donors, and thus some paid donation may still occur. In this study, it was 
apparent that a couple of donors received some type of compensation, though as mentioned 
earlier, paid donation is a grey area and it is difficult to assess whether the compensation can 
be seen as an incentive or not. To KATH’s credit, by ensuring that at most times patients in 
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desperate need of blood receive it regardless of whether they are able to find a replacement 
donor, the hospital has limited the demand for paid donors. 
 
3.5.2 Common aspects and differences between policy and practice 
 
Below is a summary of the similarities and differences between the common generic vein-
to-vein policies and how they are practiced at KATH. 
 
Blood Donation 
1. Donors should be selected using rigorous criteria  
 
a. Donors are clearly selected using a specific set of criteria. These criteria do, 
however, vary by country. It is unclear why this variation exists, but it is likely 
due to meet the local population’s needs.  
 
For example, the minimum age for donation varied between policies from 16 
to 18 years (in Ghana it is 16 years). Recommended frequency of blood 
donation varied from 2 to 4 times a year, whereas in Ghana men are 
recommended to donate no more than 4 times a year and women 3 times a 
year. The minimum weight for donors varied considerably between policies. 
In Ghana, donors must weigh at least 50kg. However, one national policy 
suggested donors weighing less than 50kg should be permitted to donate 
between 60-80ml per kg of body weight. Another policy document 
recommended that donors weigh at least 42kg and that only 250ml be 
collected from donors weighing 42-44kg and 450ml from donors 45+kg.  The 
minimum blood pressure set by various African national blood policies ranged 
between 90/50 mmHg-100/60mmHg. High blood pressure deferral was 
ranged from 140-180mmHg systolic. At KATH the minimum blood pressure 
requirement was 100/60mmHg and hypertension was considered to be a 
systolic pressure of 140mmHg OR a diastolic pressure of 100mmHg. 
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2. Donor confidentiality must be maintained  
 
a. Confidentiality is maintained throughout at KATH 
 
3. Pre-Donation counselling for all donors  
 
a. Pre-Donation counselling is practiced at KATH, but much of it revolves around 
obtaining the relevant health and risk assessment information from the donor. 
Post donation, donors are educated about post-donation care. In the Ghana 
policy, counselling is recommended for those donors testing positive for a 
transfusion transmitted infection (TTI).  
 
There is, however, no standardised outline of what information should be 
provided to donors pre and post donation. Counselling may also include 
information about the donation process, more information on how blood is 
grouped and cross-matched or discussing any concerns or fears a donor may 
have. There is no information in the literature outlining any minimum criteria 
for donor counselling. It is important to remember that a donor may have very 
little face time with staff members and that this may be the only opportunity 
staff have to ensure a positive experience which might encourage the donor to 
return. It is therefore important to develop and test various counselling tools 
(pre and post) to determine which donors find the most favourable, how it 
impacts their donation experience and whether it affects their likelihood to 
return. 
 
Counselling may also be a useful opportunity to outline the donation process 
and illustrate that the blood transfused to patients is safe. One donor 
interviewed at a mobile site stated: 
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“Particularly the pre-screening to rule out hepatitis B, hepatitis C and HIV, and 
they make sure that if you are reactive to any of those tests that you are taken 
out and not allowed to give blood in the first place. There is some assurance that 
the blood donated is good for transfusion.” (VNRD, Nursing student, female, 
unknown age).  
This donor was a nursing student and therefore understood the pre-screening 
process and the implication of safe blood. However, this may not be true for 
everyone. At the same time, we must be careful not to prevent those who are 
scared of finding out their HIV status from donating. Thus, counselling needs 
to be tailored to the individual needs of the donor 
 
Screening Blood 
1. All blood should be traceable  
 
a. All blood is traceable at KATH. Each blood bag is assigned a unique ID number, 
which is recorded on the donor’s health and risk assessment forms. As 
everything is handwritten, human error is possible, but based on direct 
observations, rarely occurs. Later, the blood group is also written on the blood 
bag. Once a patient’s blood transfusion begins, the unique ID number of the 
blood bag is written in that patient’s notes. This ensures that the blood is 
traceable from donor to patient transfused. 
 
2. All blood should be screened for transfusion-transmitted infections  
 
a. Different policy documents recommend different infections for which blood 
should be screened. All recommend HIV and Hepatitis B while some others 
recommend screening for malaria, syphilis and Hepatitis C. At the time of the 
pilot study, KATH screened for HIV, Hepatitis B and Hepatitis C. However, 
towards the end of 2013, the hospital began screening for syphilis as well. 
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Blood Grouping 
1. All blood should be grouped for ABO and Rh and labelled  
 
a. All blood is grouped for ABO and Rh and organised in the fridge by blood 
group.  
 
Blood Components 
1. Preparation and Availability of blood components  
 
a. Blood components are prepared and available at KATH. However, there is no 
clear policy or practice regarding what proportion of blood collected should 
be prepared into components. Additionally, doctors may not be aware of all 
the components available. Greater communication between blood prescribing 
clinicians and blood services is needed. 
 
Clinical Use of Blood 
 
1. Doctors are accountable for appropriate clinical use of blood and alternatives to 
transfusions  
 
Blood Requests 
 
1. Blood request forms must be completed prior to transfusion. The minimum criteria 
across all policies is patient identity and quantity requested  
 
a. This policy is well practiced at KATH. Additional information that is sometimes 
not included is the volume of blood required, whether whole blood or a 
component is specifically required and how urgently the blood is needed. If 
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the volume and type of blood required is not listed, the blood bank assumes 
the doctor requires one unit of whole blood.  
 
3.6 Conclusion 
 
The identified discrepancies between the common vein-to-vein policies and practice at 
KATH formed the basis of the following objectives of this study. Many of the discrepancies 
are due to limited local evidence to inform how some of the general policies should be 
implemented. This guided me as to what aspects of the blood services require more evidence 
in order to develop and implement policies that meet the hospital’s needs.  
 
The common vein-to-vein policies lacking sufficient evidence or presented in a manner that 
was too vague to be implemented properly were prioritised and formed the basis of sub-
objectives 1-3. My aim was to try and collect more data for these policies, with the hope that 
the information would aid in implementing them in a more systematic way.  I looked at all 
12 policies and based on my review of the national blood policies and the literature reviews 
I conducted for each of the 12 policies, I found that donor criteria, donor counselling and 
blood component production were heavily emphasised in the literature, but that there were 
no details or gold standard on how to implement these policies effectively. In addition, I felt 
that my data collecting tools (semi-structured interviews, donor and hospital records and 
direct observation) would permit me to obtain rich data that would address the paucity of 
evidence in the above noted areas. These three themes, therefore, informed sub-objectives 
1-3. 
 
Sub-objective 4 was created based on my observation of a complete lack of information 
regarding the patient’s experience in obtaining a blood transfusion and their experiences in 
finding replacement donors. To my mind, securing a replacement donor while ill and in 
hospital sounded like it could pose a significant burden and I was interested in learning more 
about this to see if this in fact was the case or not. 
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Chapter 4 – Study methodology 
 
4.1 Introduction 
 
Phase 2 of this study consisted of eleven months of fieldwork where Objective 3 (and its 
corresponding four sub-objectives) were addressed. Due to wide ranging topics covered in 
this study, a mixed methods approach was used.  
 
Objective 3: Identify the areas of blood transfusion policy in Kumasi that require further 
research and generate local evidence to improve policy implementation and better address 
local population needs. 
 
Areas Identified: 
 Sub-objective 1: Identify the most common reason(s) for donor deferrals and 
determine if current donor criteria should be re-evaluated to maximise blood 
supply. 
 Sub-objective 2: Determine what information donors are interested in 
receiving during pre and post-donation counselling to improve donor 
satisfaction and potentially increase blood supply. 
 Sub-objective 3: Quantify component usage and demand, understand its 
influencing factors and determine whether the appropriate amount of 
resources is being utilised. 
 Sub-objective 4: Understand the patient experience in obtaining a blood 
transfusion and securing a replacement donor. 
 
4.2 Philosophical and methodological considerations 
 
One of the novel components of this study was examining blood transfusion services from a 
holistic point of view. This allowed me to identify bottlenecks in the system and explore 
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aspects of blood services that have not been researched. There are, however, complexities 
associated with this type of comprehensive research. From donation to transfusion, 
transfusion services consist of a series of steps, each with a unique purpose. To evaluate 
these services it was important to examine each individual step in-depth as well as to step 
back and study the process as a whole. Moreover, data had to be collected from the various 
groups of people involved to ensure that all the necessary information was gathered and that 
all viewpoints were included. This required a multidisciplinary approach where different 
information, methods and perspectives can be integrated (CFIR, 2009). I, therefore, relied on 
mixed methods to address the central questions of this study. 
 
4.3 Research Design 
 
The purpose of the mixed methods approach is to compensate for the limitations of 
quantitative and qualitative research (Creswell, 2009). In this case, the aim of the study could 
not be addressed by relying solely on quantitative or qualitative data. Collecting quantitative 
data provided a broad overview of the observed trends (Cresswell, 2009) and allowed me to 
identify general strengths and weaknesses of the services. One of the advantages of 
quantitative research is that the researcher can manipulate the analyses and determine the 
statistical impact of each independent value as well as identify possible confounding factors. 
However, quantitative analyses provide insufficient information about the reason for the 
observed results. The quantitative data was therefore useful in identifying the areas that 
required further research and was supplemented with qualitative data to better understand 
the quantitative results as well as to gain insight into other issues not captured through 
quantitative research.  
 
The aim of the qualitative portion of the study was to identify the various pathways used by 
patients to access the services as well as to understand staff members’ experiences in 
providing them. Thus, the qualitative part of this study was grounded in the 
phenomenological approach, which aims is to explore how an individual experiences a given 
event or phenomenon (Creswell 2003).  
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4.4 Study Population and Sampling 
 
To fully understand the strengths and weaknesses of blood transfusion services at the Komfo 
Anokye Teaching Hospital (KATH), it is important to gain insight from multiple perspectives. 
Transfusion services are provided and accessed by a multitude of people, each with a unique 
perception of the transfusion process based on his/her experiences, values and beliefs. All 
these viewpoints must be documented to limit bias and provide a complete description of 
blood services at KATH. Providing efficient blood transfusion services is challenging and 
depends on multiple departments and their ability to work together as a team. Due to the 
multiple steps in the transfusion process, it can be difficult to isolate the bottlenecks in the 
system. In some cases, staff members may be unaware that delays are occurring in their 
department.  I, therefore, collected information from the different groups of staff members 
involved in transfusion services (i.e. laboratory and clinical staff) from different hospital 
units. Blood donors were recruited, as they are an essential component of blood services.  
Additionally, it is important to explore how easily transfusions are accessed by patients, as 
this allows us to evaluate transfusion services from an alternative perspective. Thus, patients 
requiring a blood transfusion and their family members/caregivers were invited to 
participate in the study and share their experience in obtaining a transfusion.  
 
Given the study’s phenomenological approach, purposeful sampling was used to identify 
participants. To ensure that multiple perspectives were considered and to limit bias, a 
multiple variation sampling strategy, a form of purposeful sampling, was employed (Palinkas 
et al., 2015). In other words, individuals with different roles in transfusion services were 
recruited from multiple units within the hospital. To ensure an even spread of patient 
participants across the wards, patients who had received and completed a transfusion within 
the past 24 hours were identified via transfusion records.  Donor participants were identified 
and approached in the donor clinic and mobile sessions, and were interviewed post-
donation. Staff members at the donor clinic and in the laboratory were identified with the 
help of the head of transfusion services. Transfusion prescribing doctors were identified and 
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approached in the wards. Below is a list of the inclusion and exclusion criteria for participant 
sampling.  
 
4.4.1. Sampling Criteria 
 
Inclusion 
 
-Patients who required a blood transfusion 
-Family members or caregivers of patients requiring transfusion. 
-Staff members involved in transfusion services 
-Staff members involved in collecting blood, testing blood or grouping blood. 
-Blood donors 
 
Exclusion  
 
-Those who fit the inclusion criteria but do not wish to participate in the study 
-Anyone below the age of 16 
-Anyone who was unable to answer questions (e.g. impaired consciousness) 
-Those who could not speak English, French or Twi 
 
4.5 Quantitative methods 
 
Quantitative data were primarily collected to address sub-objective 3: 
 
‘Quantify component usage and demand, understand its influencing factors and determine 
whether the appropriate amount of resources is being utilised.’ 
 
The aim of the quantitative data collection was to record trends in transfusion services and 
identify the strengths and weakness. To achieve this, a ‘descriptive study’ approach where 
“no attempt is made to change behaviour or conditions” was used (Hopkins, 1998). This 
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allowed me to report on multiple variables. The quantitative data collected also shed light 
on issues that needed to be further explored using qualitative methods.   
 
4.6 Quantitative Outcomes 
 
The aim of the quantitative data collection was to describe transfusion services at KATH as 
well as determine the rate of mortality among patients requiring a blood transfusion. To 
obtain a basic understanding of transfusion services in the different units at KATH 
quantitative data pertaining to clinical care, transfusion human resources and transfusion 
access were recorded. Additionally, data regarding blood donation and testing were also 
recorded to better understand issues of blood supply. Below is a list of the outcomes 
explored: 
 
Blood Donation 
 
ï Number of potential donors 
ï Number of actual donors following screening 
ï Ratio of volunteer and replacement donors 
ï Number of units of blood collected 
 
Blood Testing 
 
ï Time required to test and group blood 
 
Clinical Care (per Unit) 
 
ï Number of units requested (for each blood component) 
ï Number of units issued (for each blood component) 
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Patient Profile 
 
ï Average age of patients 
ï Sex ratio 
ï Number of transfusions received in the past 
 
4.7 Quantitative Data Collection 
 
To address the outcomes listed above, the following forms of data collection were used to 
obtain quantitative data: 
 
ï Hospital Records 
ï Donor Health and Risk Assessment prepared by the Blood Bank (see Appendix 7) 
 
Additionally, previous in-hospital studies, presentations and reports were reviewed for 
quantitative data that were useful for this study.  
 
Hospital Records 
 
Blood bank records were reviewed to obtain the following information of patients 
interviewed 
 
a) Sex 
b) Date of Birth 
c) Blood component requested for patient 
e) Unit/Ward 
f) Date/time of first request 
g) Date(s) and time(s) blood component(s) issued 
h) Patient blood group 
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The benefits of collecting these data from hospital records were that a) data were more 
objective and b) the patient questionnaire’s length was reduced. Collecting data regarding 
the sex and age of the patient was important for socio-demographic analysis and 
standardising data. Data pertaining to admission, diagnosis and transfusion put the patient’s 
experience in perspective and was one way of evaluating possible delays in services. 
 
4.8 Qualitative Data Collection 
 
The aim of pursuing qualitative data collection was to allow participants to provide detailed 
descriptions of their experiences providing or accessing blood transfusions at KATH. This 
approach permitted me to uncover information that may not be revealed through 
quantitative data collection. It also allowed for greater flexibility as I was able to draw on the 
participants’ responses and redirect the focus of the qualitative data collection. 
 
Qualitative data was collected using the following methods: 
 
ï Direct observation 
ï  Semi-structured Interviews 
ï Focus Groups 
 
While some qualitative data was collected through the questionnaires, the bulk of it was 
obtained from individual semi-structured interviews, focus groups and through direct 
observation. 
 
Direct observation 
 
To develop a better understanding of the various donation and transfusion process in blood 
services at the KATH, I relied on direct observation. As I, the researcher, was not actively 
involved in the process, I was able to observe the process in a less biased manner than a 
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participant. As a direct observer, the aim was to be as unobtrusive as possible. By acting as a 
direct observer, I was able to record aspects or events that may otherwise have gone 
unreported by participants. My observations were, however, supplemented by qualitative 
data obtained through semi-structured interviews.  
 
Semi-structured Interviews 
 
To gain a deep understanding of the underlying issues regarding accessing and providing 
transfusion services, patients, family members, caregivers, donors and clinical staff were 
interviewed. The interviews provided respondents with a confidential space where they 
could discuss the positives and negatives of their experience. It also allowed me to further 
probe areas of interest that may not have been adequately captured by the questionnaires. 
The interviews took place following the completion of the questionnaires so that I could 
review the questionnaire responses and obtain a better idea of which topics to pursue in the 
interview.  
 
The qualitative results obtained from the semi-structured interviews are presented in the 
following manner. Each sub-heading represents responses that were common amongst the 
majority of participants and are ordered from most common to least common. Additional 
topics arising from the data that were mentioned by fewer participants are listed under 
“Other”.  
 
Interviews were conducted in English when possible. If not, as I do not speak the local 
language Twi, the interviews were conducted in Twi with the help of an interpreter, Maxwell 
Owusu, who worked in the hospital’s laboratory department. Maxwell translated my 
questions and the participants’ responses on the spot, which allowed me to ask follow up 
questions based on their responses. Prior to conducting the interviews, Maxwell and I had 
gone over the brief structure of the semi-structured interview guide so it was clear what 
information we were looking to elicit. 
 
The interview templates provided me with a guide to follow. Refer to Appendices 8, 11, 12, 
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13 and 14 to view interview templates. Below is a brief description of the general topics 
covered in the various interviews.  
 
Patient interviews 
 
The purpose of these interviews was to obtain information about the patient’s journey in 
accessing blood transfusions. Thus, patients were asked to recount their experiences in 
accessing care following the appearance of initial symptoms. In addition, during the 
interview I tried to investigate whether receiving a blood transfusion had influenced the 
participant’s attitudes towards blood donation and whether he/she would consider 
donating blood in the future. 
 
Family/caregiver interviews 
 
Interviews with family members and caregivers were conducted to obtain a better 
understanding of the difficulties faced by caregivers ensuring the patient has access to blood 
transfusion; as well as to verify the data provided by patients regarding transfusion access 
so as to increase the validity of the data (a method known as triangulation). 
 
Blood donors 
 
Interviews with blood donors were conducted to follow-up on donors’ experiences when 
donating blood and whether their experience had influenced their willingness to donate 
blood in the future. The interviews also aimed to determine how many donors would be 
willing to or were acting as paid donors, but this was difficult given its taboo nature.  
 
Clinical staff 
 
The purpose of the clinical staff interviews was to gain a better understanding of their role 
in providing blood transfusion services, blood component usage on the wards, as well as to 
obtain their thoughts on current transfusion guidelines and how transfusion services could 
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be improved. 
 
Focus groups 
 
Donors were invited to participate in focus groups to better understand donor expectations 
and priorities. Focus groups were designed based on the results from donor semi-structured 
interviews. 
 
4.9 Data Entry and Management 
 
Quantitative data were initially collected using an iPad and entering the data into Microsoft’s 
Excel. The data were then transferred to a computer. Numerical values were assigned to 
different responses for each question and the transformed data were moved to IBM SPSS 
(International Business Machines Corporation’s Statistical Package for the Social Sciences). 
Interviews and focus groups were audio recorded and saved as Audio Interchange Files 
(AIF). Qualitative data were translated (when necessary), transcribed, coded and grouped 
into categories Throughout this process new categories and themes emerged and potential 
relationships between the categories were identified.  
 
Participants’ confidentiality was maintained by ensuring that all data files were password 
protected. Consent forms and questionnaires were kept in a locked filing cabinet at KATH 
and will be destroyed in five years. To prevent loss of data, all data were stored on my 
computer’s hard drive, an external hard drive and the University of Liverpool server. Data 
will remain available to my supervisors and me for up to seven years following the study’s 
completion.  
 
4.9.1 Ethical Considerations 
 
Ethical approval was obtained from the LSTM Ethics Committee as well as the Committee on 
Human Research Publication and Ethic (CHRPE) in Kumasi (see Appendices 1 and 2).  
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4.9.2 Consent 
 
All study participants were asked to read an information leaflet outlining the study and the 
risks and benefits to participants (see Appendix 3). Informed, written consent was obtained 
from participants. The information leaflet and consent form was available in English and 
verbally translated to Twi when necessary. In cases where the participant was not literate, 
the information was provided orally and the participant’s thumbprint was used in place of a 
signature. If the participant was a minor (i.e. below 18 years of age), a parent was also 
required to provide consent.  
 
In cases where the participant was incapable of providing consent, a relative was asked to 
act as a proxy and provide consent on their behalf. If during the course of the study the 
participant was in a position to provide consent, informed written consent was sought. 
 
4.9.3 Risk of Participation 
 
There were no known physical risks of participation. From a psychological standpoint, some 
of the questions could have made participants uncomfortable. However, participants were 
not compelled to answer any of the questions and were free to withdraw from the study at 
any point. 
 
4.9.4 Confidentiality 
 
All participant information was kept confidential. Participants were provided with unique 
project identification numbers to avoid the use of names. In addition, data were stored in 
password protected files and were only available to myself and my supervisors. 
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Chapter 5 - Blood donation counselling and donor 
experiences 
 
5.1 Introduction 
 
The majority of blood policy documents reviewed recommend donor counselling, but there 
are few details regarding what it should entail. Few policies differentiate between pre-
donation and post-donation counselling. For the purpose of this study and based on the 
counselling process at KATH, donor counselling includes pre-donation counselling, deferral 
counselling and post-donation counselling. The following working definitions of pre-
donation, post-donation and deferral counselling were used: 
 
Pre-donation counselling: Period during which donor clinic staff members perform a 
health and risk assessment of the donor (and based on the responses, may provide 
appropriate health and lifestyle advice) and provide information about the donation 
process. 
 
Post-donation counselling: This includes counselling given to donors regarding post-
donation care (e.g. liquid intake, food intake, limited physical activity etc.) and 
appealing to donors to return and encourage their friends to donate. At KATH, this type 
of counselling takes place during and post-donation. 
 
Deferral counselling: Counselling given to temporary or permanently deferred donors  
 
The above definitions were formulated around current practices at KATH observed during 
the pilot study and information relevant to the donor (based on donor response in the pilot 
study). For example, the health and risk assessment is always conducted prior to donation 
at KATH and is required to determine whether the donor is a suitable candidate. Information 
about post-donation care and speaking to donors about returning or encouraging friends or 
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family to donate is done during or after donation. As it may vary whether this is done during 
or post-donation based on how busy the clinic is these two time periods were grouped 
together and termed ‘post-donation counselling’. More information about the donation 
process was a point raised by donors during the pilot study and then again during phase 2. 
As this information is most useful at the start of the donation process it was included in the 
‘pre-donation counselling’ definition.  
 
A positive donation experience is important to help retain donors, and counselling can help 
improve the experience. This chapter presents the results from five semi-structured 
interviews with donor clinic staff, thirty semi-structured donor interviews and two donor 
focus groups, focusing on donor experiences and with the aim of developing a framework for 
donor counselling at KATH to meet donor needs and improve the donation experience. The 
interviews were transcribed, and a list of responses for each question was generated. 
Responses were grouped into common themes. The transcripts were re-reviewed and 
quotes that could be used to illustrate specific examples were highlighted.   
 
5.2 Current donation counselling practice based on direct 
observations and according to donor clinic staff 
 
While donor counselling is recommended, there are currently no existing donor counselling 
guidelines in Ghana. As mentioned in Chapter 3, this is the case in many other African and 
WHO blood transfusion policy documents. Though no formal policy document regarding 
donor counselling exists at KATH, donor clinic staff are trained to assess donors’ health and 
risk of infection and to counsel donors appropriately. Below is a description of current 
counselling practice based on direct observations and the results obtained from semi-
structured interviews with five donor clinic staff members. Donor clinic staff was defined as 
anyone who worked in the donor clinic, was involved in blood donation and had direct 
contact with donors donating blood. 
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5.2.1 Pre-Donation Counselling 
 
Potential donors are posed a series of health and risk assessment questions (see Appendix 
 7) prior to donating, usually by a phlebotomist or nurse. All pre-donation counselling is 
given orally. In mobile sessions, particular those in post-secondary institutions, donors may 
be asked to complete the questionnaires themselves. Note that the time spent on pre-
donation counselling varies and is influenced by the donors’ needs and the time and human 
resources available.   
 
At the time of my study the assessment questionnaire was being piloted and donors were 
allowed to proceed to pre-screening* regardless of their responses. However, in the future, 
certain responses may result in temporary or permanent donor deferrals. Currently, donors 
exhibiting high risk behaviours are counselled by staff on how to limit the risks. For example, 
potential donors who admit to engaging in sexual activities with multiple partners are 
counselled on the risks of acquiring sexually transmitted infections (STIs) and the 
prophylactic measures available. 
 
* Note, pre-screening in this study refers to the rapid testing of prospective donors for HIV, Hepatitis B, 
Hepatitis C and Syphilis. 
 
5.2.2 Deferral Counselling 
 
Potential donors deferred due to low haemoglobin level are counselled on diet (e.g. to 
incorporate iron-rich foods) and advised to have their haemoglobin level tested after a few 
months of incorporating the dietary changes. Donors deferred due to a positive HIV, hepatitis 
or syphilis test are told they are unable to donate that day and requested to return the 
following Monday. Meanwhile, tests are run to confirm the diagnosis. Upon return, donors 
are informed about their pre-screening results and counselled at the donor clinic. They are 
also provided with referrals to other counselling services and medical care.  
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5.2.3 Counselling during and post-donation  
 
During donation, donor clinic staff (usually a nurse or phlebotomist, sometimes a health care 
assistant) engage donors in conversation and informally educate donors on the benefits of 
blood donation and encourage them to become regular donors, donating every four months, 
and make their friends, family and colleagues aware. Post-donation, donors are given advice 
on how to care for themselves through diet and fluid intake and advised to take ‘adequate 
rest’. 
 
5.2.4 Results from donor clinic staff interviews 
 
Eight donor clinic staff members were approached to participate in this study and ultimately 
five donor clinic staff members were interviewed during the work day: The head of the donor 
care unit (a trained nurse), two phlebotomists and two nurses. The three staff members who 
did not wish to participate were health care assistants (HCAs). 4/5 of the participants were 
female. Length of time working at the donor clinic at KATH varied between 3-8 years. Though 
interviews were conducted in a separate area of the donor clinic, due to limited space, other 
staff members were present at times. 
 
Participants described the donation process and this was in line with direct observations.  
All donor clinic staff members received counselling training from the head of the blood bank. 
According to staff members, donors are counselled based on their responses to the health 
and risk assessment questionnaire and their pre-screening results and are also provided 
with post-donation care advice, such as “Don’t do hard work” or “Abstain from drinking 
alcohol today”. Donors are encouraged to increase their fluid intake (ideally water). There is 
no specific information staff are prohibited from sharing with donors. 
 
Prior to donation, donors are told not to be fearful and reassured that the procedure will not 
be very painful. Donors with high blood pressure are advised to consult a doctor and are 
temporarily deferred. Those with low haemoglobin level are provided with dietary advice 
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and advised to return after ‘some time’. Very rarely are donors under 50kg (see section 
5.3.1.1). There is no maximum weight criteria and overweight donors are not counselled 
about diet or exercise. 
 
During donation, staff members explained they emphasise the simplicity of the donation 
process and encourage donors to return in four months and bring their friends. This is 
incorporated into friendly conversation with the donor, thus making it seem less like a 
formal request or demand. 
 
When asked what additional information donors should be provided with, most staff were 
satisfied that the information provided was accurate and complete. They felt that they had 
received adequate training on donor counselling and felt that they were able to provide 
thorough counselling to donors. One staff member suggested that donors be educated on and 
encouraged to obtain a Hepatitis B vaccination.  
 
5.3 Donor Experiences: Results from Donor Interviews 
 
5.3.1 Donor Participant Profile 
 
Thirty donor interviews were successfully completed. The semi-structured interview 
template was based on the one piloted with some slight modifications (see the text in red in 
Appendix 8). As these were semi-structured, parts of the interview varied between donors 
depending on their responses.  
 
Eleven interviews were conducted in the hospital’s donor clinic and nineteen at two mobile 
sessions. One mobile session took place at the local university, the Kwame Nkrumah 
University of Science and Technology, and the other at the Kumasi Polytechnic. Three 
potential participants were excluded: one could not speak either English, French or Twi (the 
local language), one did not have time to complete the interview and one was excluded 
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because there were no translators available. The average participant age was 25.4 years, 
with donors ranging in age from 19 to 45 years. Of the thirty participants, 83.3% (25/30) 
were male, 70% (21/30) were voluntary non-remunerated donors, and 53.3.% (16/30) 
were first time donors. Among repeat donors, total number of donations in lifetime ranged 
from 2-6 with an average number of donations of 3.36. 7/9 of replacement donors donated 
blood for an immediate family member (i.e. parent, sibling, spouse or child). One 
replacement donor donated for his neighbour and another for his manager’s son. 
 
5.3.2 Factors that Motivate Donors 
 
In countries where blood donations are low, blood donor motivations are of particular 
interest as they provide greater insight into donor perceptions and may be helpful in 
designing and implementing schemes aimed at recruiting and retaining donors. 
 
While this study was not designed with the aim of exploring donor motivations in depth, the 
topic was included in the interviews to better understand the donor participants and provide 
contextual background. Donor counselling can be used to encourage donors to return and a 
good understanding of donor motivations would be helpful in developing and implementing 
retention strategies.  
 
In the individual semi-structured interviews, donors were asked “Why did you come to 
donate today?”. Every donor had at least one reason; some had multiple. All responses were 
collated into one document. Donor interview transcripts were reviewed in case other 
motivating factors were mentioned at some other point in the interview. The responses 
collated were reviewed and grouped into common themes. Factors not common to the 
majority of donors are listed under ‘Other factors’. Transcripts were re-reviewed to find 
appropriate quotes that supported the different themes. Data were stratified based on 
VNRD/RD, gender and first time/repeat. Clear differences in motivations were seen between 
voluntary and replacement donors, whereas there were no observed differences due to 
gender or between first time and repeat donors. The results are presented below. 
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5.3.2.1 Factors that Motivate VNRD Donors 
 
“To save lives” 
 
Among volunteer donors, both in mobile sessions and in the donor clinic, the primary 
motivations for donating blood were ‘to save lives’ and ‘to help people’. This was commonly 
coupled by donors expressing their knowledge about the need for blood in nearby hospitals. 
Both first time and repeat VNRD made the connection between the need for blood and their 
willingness to donate. For example, one donor stated “Many people need blood. At times 
blood is not available, so I have to donate blood to save lives”.  Another donor responded  
 
 “Actually I heard people in the hospital need blood, and most people die not  
 because of anything but blood, so I just came to donate to save lives at the   
 hospital. That is my reason for donating.”. 
 
Information regarding limited blood supply appears to come from a variety of sources 
including, school, families, friends and media announcements (some of which are posted in 
schools). 
 
 
Community Influences 
 
At mobile sessions in post-secondary institutions (e.g. polytechnics and universities), some 
students donated as part of a group or social activity. The mobile sessions were organised 
by smaller groups within the school (ex: the choir), and thus donating blood was seen as a 
social event with peers or as a new experience. For example one university student stated:  
 
 “I [donated blood] because the university choir, we are donating blood and I  
 haven’t done so before, this is my first time”.  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Note the respondent said ‘we’, further emphasising the social experience tied to blood 
donation. However, when volunteer donors were asked whether they felt pressured by their 
peers to donate, they unanimously answered “No”. 
 
Other Factors 
 
“Because I feel like it”   
Three donors donated because they “felt like it”. When probed further, one donor explained 
that he had not previously donated because “I didn’t feel like it”. He further elaborated by 
explaining how he had lacked knowledge about blood donation and had not heard much 
about it.  
 
“I have blood to donate” 
According to two volunteers, they donated because they have the available blood and other 
people may not. One donor explained:     
 
 “I feel that there are a lot of people at the hospital that need blood and if I’m strong  
 and healthy and I’m having blood in my body and I can donate and it’s safe why  
 shouldn’t I go?”.  
 
To these participants, it made sense to share something they had if it resulted in improved 
outcomes for others. 
 
Personal Gratification 
One volunteer donor highlighted the personal gratification he felt as motivation to donate. 
The donor stated”    
 
“I feel like if I’m donating…somehow I feel like I’m trying to save lives somehow. It 
 makes me feel OK. I feel happy when I do that”.  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This donor was a repeat donor, having previously donated twice, once as a volunteer and 
once as a replacement donor, and had therefore experienced donation under different 
circumstances. 
 
5.3.2.2 Factors that Motivate Replacement Donors 
 
Donating for a known person 
 
The most common motivating factor among replacement donors was to donate blood for 
someone else, whether it be for a family member, friend or colleague. One donor donated 
blood for his manger’s son and was asked whether he felt any pressure as it was his 
employer’s request, to which he responded no. For most replacement donors, donating for 
someone else was the sole motivating factor. In fact, some replacement donors openly stated 
they would not consider donating blood for an unknown person. One donor, when asked 
whether he would consider donating blood again, responded:     
 
“If it’s not a close relative I don’t see the need for it. I’ll only donate to a relative if the 
person is in need”. 
 
 
Gifts and Compensation 
 
None of the replacement donors interviewed claimed to receive any form of compensation 
whether in monetary or gift form and among this study’s participants it did not appear to be 
a motivating factor. This may be true in most cases, but patient interviews did indicate that 
some replacement donors are provided with a monetary incentive. It is possible that some 
did not feel comfortable disclosing this information as paid donation is prohibited, meaning 
that if donor clinic staff discover that a donor is receiving monetary compensation for 
donating, he/she will not be permitted to donate blood. One donor, however, who was 
donating for his manager’s son thought his manager may provide him with a gift as a thank 
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you, though he could not speculate as to what it might include. 
 
When asked whether they knew anyone who had received gifts or compensation for 
donating blood, a couple of donors admitted to knowing people who had received gifts for 
donating blood such as mobile phones, textbooks or clothes, thus indicating that some form 
of compensation for replacement donors still exists in some cases. Nearly every donor 
interviewed, however, said that they would not accept money for donation, with the most 
common reason being that ‘blood should not be sold, it should be donated freely’. Two donors, 
however, said they would consider it, depending on the amount offered, though they were 
unsure what the threshold would be. 
 
Interestingly, when patients were asked whether their family members who donated blood 
received any gifts or compensation, many referred to the refreshments provided by the 
donor clinic. The key factor, however, is whether these are seen as motivating factors, for 
which there is no supporting evidence based on the results from the donor interviews.  
 
5.3.2.3 Repeat donors vs. first time donors 
 
Repeat donors appear to donate for the same reasons as first time donors - to save lives or 
to replace blood for someone they know. This leads to the question, why do some donors 
return, while others do not and is addressed in section 5.3.6. 
 
5.3.3 Donor Expectations 
 
Expectations prior to an event may shape post-event experiences. For example, in a study on 
childbirth experiences, women with low expectations were less likely to find the experience 
fulfilling (Green, Coupland and Kitzinger, 1990). It is therefore important to better 
understand donors’ expectations so that they can be met and the donation experience 
improved. While a satisfactory or pleasant donation experience may result in the donor 
returning, an unpleasant experience will contribute to a donor not returning. As mentioned 
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earlier, repeat donors are seen as the safest donor type, and it is therefore important to find 
ways to increase a donor’s willingness to return and promote donor retention.  
 
5.3.3.1 First Time Donors’ Expectations 
 
Donation Associated Pain 
 
Many donors, when first asked about their expectations of the donation process, stated that 
they had not had any expectations. When further probed, however, the most common donor 
expectation for first time donors was that blood donation would be painful. One donor even 
voiced his concerns prior to donation, asking one of the donor clinic staff members whether 
donation would be painful. However, all donors who expressed this expectation also stated 
that the donation, was in fact, not as painful as they had predicted. According to one donor:    
  
 “I thought it would be painful, but after the first prick everything seems normal”.  
 
Another donor stated:    
 
“When they were putting the needle in the starting I was feeling pain, but after the 
 needle enter my body I felt nothing”. 
 
 
Other expectations 
 
Blood grouping 
 
A couple of replacement donors expected to learn their blood group during that donation 
visit, one of whom wanted to ensure it was compatible with the patient they were replacing 
for. One donor said: 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 “[…] but for the first time I was thinking the blood group – were they going to be the 
 same? That is what I was thinking about. Because I don’t know my blood group”.  
 
Another donor was under the impression that the patient for whom he was replacing for 
would be receiving his blood and stated:     
 
“I was thinking that when you get here they just check it and after that they have to 
 communicate your blood group and the person’s blood group but I didn’t get such 
 information – whether my blood group is the same as [the patient’s], I didn’t get  
 that information”. 
 
Refreshments 
 
Some donors expected to receive food prior to donation, particularly since donors were 
asked whether they had eaten prior to donation as part of the initial donor screening process 
(If a donor has not eaten within the last two hours they are asked to have a meal and return). 
Currently, donors are provided with crackers and a malt drink post donation. 
 
A first-time volunteer donor at a mobile session at the local university stated:    
 
 “Actually, I was thinking, they would give us something to take in. Maybe we didn’t  
 eat before coming and I thought they would give food before we go for donation”.  
 
The same donor further commented:  
 
 “And I expect them to give some milo after donation […] to regain my energy”.  
 
Milo is a malt and chocolate Nestle beverage. One donor specifically mentioned having to go 
out and obtain food before donating. A first time replacement donor, when asked whether 
he would attend a mobile session, stated:  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 “Yes […], but I will see to it that they give me something that will recover me from  
 my donation. You know all those things – food, vegetables, drinks. You cannot  
 release my blood without giving me a little milk and those things”.  
 
In this case, refreshments were not only expected by the donor, but seen as something that 
was necessary to recover from blood donation. It did not appear that it was seen as a form 
of compensation, but rather was ‘required’ medically to aid in their recovery.  
 
Difficult or Long Process 
 
One replacement donor expected the process to be more complicated, but was pleasantly 
surprised that this was untrue and post-donation said:  
 
 “Actually, I was very anxious. I thought it was a very huge process but it was very  
 simple”.  
 
A second replacement donor responded:  
  
 “Because I have not donated before, I thought it would be difficult”.  
 
On the other hand, a volunteer attending the donor clinic was disappointed with the length 
of the process saying:    
 
 “I thought it would be a little bit quicker, but it was slow”.  
 
Adverse Events 
 
There was one donor, a female first-time VNRD at a mobile session, who expected a possible 
adverse reaction and stated: 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 “Ok well, maybe I expected to be a little dizzy but I feel ok. I don’t feel terrible”. 
 
At this particular mobile session, there was a female student who collapsed post-donation 
which may have contributed to the respondent’s expectations. 
 
No expectations stated 
 
A couple donors did not mention any expectations, even when probed. According to one 
replacement donor:  
 
“Everything was normal. No different than expectations”.  
 
Another replacement donor further explained their lack of expectations by saying: 
 
 “This is my first time, so I didn’t even know what the whole process was about it”. 
 
5.3.3.2 Repeat Donors’ Expectations 
 
Expectations derived from past experiences 
 
Similar to the first-time donors, there were repeat donors who did not express any 
expectations regarding the donation process. However, the reason for this differed 
compared to those mentioned by first-time donors. Repeat donors claimed to already know 
what the process would be like, with one volunteer, who was donating at the donor clinic 
and had previously donated blood five times (twice at KATH), saying:    
 
 “I’ve gone through the process so many times so I’m used to it. I know the general  
 process”.  
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Thus, though these donors did not describe any expectations, their responses suggest that 
their expectations are based on their past donation experiences. 
 
Other Expectations 
 
Time required to donate blood 
 
A student volunteer at a mobile session had expectations concerning the time necessary to 
donate blood. According to the student:  “ 
 
At times it will take 3 or 4 hours before you are able to donate. I think if it could take a 
shorter time…Today I’ve spent almost 2 hours so it was shorter than last time I came”. 
   
 
Again, the donor’s expectations were based on his past experiences. 
 
5.3.4 Donor Experiences 
 
5.3.4.1 Positive aspects 
 
Most donors were keen to express their appreciation towards the donor clinic staff for their 
friendly demeanour. Repeat donors who had donated elsewhere stated that the staff at KATH 
were particularly friendly compared with other hospitals. The fact that most donors 
mentioned this when asked about the positive aspects of the donation process illustrates 
that the donor clinic staff are consistently friendly and make an effort to make donors feel 
welcome. It also shows how important donors perceive staff behaviour when reflecting on 
their donation experience, suggesting it could play a significant role in their decision to 
return. 
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5.3.4.2 Negative aspects 
 
Few negative issues were raised by donors.  
 
Of the items mentioned, the most common was the length of time the donation process took. 
Based on direct observations there was considerable variation in process times during these 
interviews (approximately 30 minutes to 150 minutes). Longer times were due to increased 
number of donors, thus more blood to pre-screen, and limited staff to withdraw blood. In 
support of this, longer wait times were usually mentioned when there was a big influx of 
donors and the donor staff were busier than usual.  
 
 
5.3.4.5 Donors’ experience with the Health and Risk Assessment Questionnaire 
 
As the donor health and risk assessment questionnaire was being trialled, it was important 
to explore donors’ views on the new screening tool. The responses varied between donors. 
Only a few donors thought the questions were long and a couple thought they were a little 
difficult to answer and would have liked more explanation with the questions. For example, 
when asked if any of the questions were difficult to answer, one donor responded: 
 
 “No - One question about taking painkillers – at times if you don’t educate the  
 person maybe what a painkiller and malaria is, at times they might find it difficult to  
 answer such questions. At times you will be attacked by malaria and you will not  
 even be aware”.  
 
 
One donor said:  
 
 “[The questionnaire is] okay, it actually captures the – how do I put it? They want to 
 ensure that the person donating is in good health, in sound health”.  
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Some donors found some of the questions uncomfortable to answer, particularly those 
relating to sexual behaviours, with one donor answering:   
 
 “Yes [some questions made me uncomfortable]. They asked me I’m a married  
 person. I said no. I’m not married. Then you have to have someone dating you and 
 I said yes”.  
 
Another donor, however responded:   
 
 “When you are with a medical practitioner you shouldn’t feel uncomfortable when  
 they ask you certain questions”. 
 
Overall, however, donors felt that this was a ‘normal’ part of the process and some donors 
even expressed appreciation for the questionnaire, noting their importance as the nurses 
and phlebotomists posed health related questions. For example, according to one donor:     
 
 “For the questions, I think it’s perfect. Because it’s blood, they should – maybe you 
 have some problem in your blood, so once they are asking you the questions that  
 one will necessitate them to get the right information”.  
 
In two cases, according to donors, they did not have to respond to any health or risk 
assessment questionnaires. These were donors attending mobile sessions and donated at 
peak hours. It is possible, that to process all the donors in time, little to no time may have 
been spent on the questionnaires. 
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5.3.5 Information blood donors recall receiving  
from donor clinic staff 
 
As mentioned in section 5.2, current donor counselling focuses on counselling those with 
potential risky lifestyle behaviours on how to minimise these risks and providing donors 
with post-donation care such as dietary and fluid intake information and what type of 
activities to engage in the next 24 hours.  This section, however, will focus on the information 
donors recall receiving. Note that donor interviews were conducted approximately 2-10 
minutes post-donation. The data below were collected during the semi-structured 
interviews. Donors may or may not have been given additional information, but any points 
omitted mean that they did not mention it in the interviews and illustrates what information 
donors recall. 
 
5.3.5.1 Personal Health 
 
Most of the information or questions donors recalled hearing were associated with their 
personal health. Donors most commonly remembered donor clinic staff ensuring they had 
eaten prior to donating. For many donors this was the only information they recalled 
receiving. A first time replacement (female) donor stated:  
 
 “They asked me whether I have eaten and that I should eat before, but I had eaten 
 before coming.”.  
 
A repeat volunteer donor further explained why this was important, saying:   
 
“The first advice they give you is ‘have you eaten’ because if you have not eaten you will 
faint or collapse”.  
 
Donor clinic staff ensuring donors had eaten seemed to provide donors with reassurance 
that the staff prioritised their health and well-being.  
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Donors remembered receiving post donation care advice such as to rest and ensure they 
drank adequate fluid throughout the day. A repeat volunteer donor remembered: 
 
   “[…] after [donation] I should rest, not do anything stressful”. 
 
Another volunteer, first time donor, was told:  
 
 “To take enough fluid and take enough rest,”, but was not told specifically how  
 much fluid to take in or what was considered “enough rest”. 
 
Some donors discussed points raised in the health and risk assessment questionnaires, all of 
which concerned personal health and well-being. One first time replacement donor 
recalled:  
 
 “ […] they also asked me some health related issues – whether I have some  
 problem, maybe I drank something and other issues”.  
 
Other donors discussed learning about donation frequency, which reflects staff members’ 
efforts aimed at encouraging donors to return. 
 
5.3.5.2 Lack of information 
 
According to some donors, they did not receive any information about blood donation prior 
to or post donation. One donor expressed his dissatisfaction with the limited information 
provided, noting “it is a problem”, suggesting that donors may appreciate added counselling. 
Donors may not have felt any the information received was pertinent to recollect or share, 
or in some cases this may be an accurate reflection as through personal observation at one 
of the mobile events, I noticed staff were busy and unable to spend long with donors. 
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5.3.6 Additional information blood donors would have liked to receive 
 
When probed about wanting to receive additional information, nearly all donors replied yes. 
Few stated that they were satisfied with the information received and did not require any 
additional information. Interestingly, the majority of donors said they did not ask staff 
members any questions and when further probed as to why donors responded that they did 
not have any questions. 
 
5.3.6.1 Providing information prior to the donation process 
 
At the mobile sessions, one donor suggested that it should advertised in advance that donors 
should consume some food prior to donation, so that they do not faint or collapse. 
 
5.3.6.2 Donation Process 
 
Many donors felt that it was important to reassure donors prior to donation that the process 
is simple. According to one donor:    
 
 “when I went I was discussing about [blood donation] with those first donors and  
 people were thinking, those who haven’t donated before, were thinking it’s very  
 serious so you need to inform the person that it’s not anything – it’s a normal  
 thing”.  
 
Another donor stated:     
 
 “Before donating [donor clinic staff] should encourage the people what they are  
 going to do is risk free and that they are helping others”. 
 
Donors also wanted additional details about the donation process. For example, the time it 
would take, the different steps involved, and how the blood donated would help save lives. 
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Time was particularly important as donors had other commitments such as work or school 
later in the day. One repeat student volunteer came to the donor clinic during a break 
between classes and discussed how he had limited time to spare, thus if the process took too 
long he would have to leave. 
 
5.3.6.3 Blood Screening Results 
 
ABO Rh Grouping 
 
Some donors expressed interest in learning their blood group during their donation visit. 
Blood, however, is grouped post donation at the blood bank - though not all donors are aware 
of this. Donors requesting their blood group information, according to them, were given the 
telephone number at the blood bank as well as the batch number associated with their blood 
bag and asked to call at a later date. This was deemed a satisfactory response by participants. 
 
Pre-Screening Results 
 
Another request for additional information was to learn the results of the pre-screening 
tests. One donor responded:  
“I think after [donors] donate [staff] should let [donors] have a look at their test. Whether 
[donors] have certain diseases or they don’t have them. [Staff] should let [donors] check 
their status”. 
 
Not disclosing pre-screening results immediately, however, intentional on the part of the 
blood bank at KATH, so as not to stigmatise those who do test positive and to confirm test 
results. 
 
5.3.6.4 Post-Donation Care 
 
Post-donation care advice was a common request from donors, particularly relating to diet 
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and activity. As stated in the previous section, this information is usually provided to donors 
by donor clinic staff. However, donors may either have forgotten receiving this information, 
or during busier times, staff may not have had the time to counsel donors appropriately on 
post-donation care. One specific issue raised by multiple donors was to learn the number of 
days it would require them to ‘regain their blood’. Although this will vary between people, 
donors can be provided with an estimated time frame. It is possible, however, that the time 
period may seem lengthy to some and may deter some donors 
 
5.3.6.5 Donation Risks 
 
One donor mentioned the importance of educating donors about the risks involved in blood 
donation:    
  
“Yes, time and the risks involved. Maybe the donor like I just feel like donating but they don’t 
know the consequences of it. They should be educating us – maybe  these are the risks 
involved in donation but there’s nothing like that”. 
 
5.3.7 Donors’ willingness to return 
Donors were asked about their willingness to return. Also, donors were asked under what 
circumstances they would return (ex: as a volunteer, for a family member or friend, in 
response to a television or radio advert or as a paid donor). Every donor interviewed was 
willing to return. Yet many donors do not return. This may be explained by some of the added 
stipulations made by donors. For example, donors stated the would return:    
 
 ‘[…]if [they] have the opportunity”, or if they have the money for transport or  
 adequate time. 
 
Overall, most donors said they would return as a volunteer and all said they would if a family 
or friend required blood. Some were only willing to come as a replacement donor, which 
highlights the importance of the close family and community relationships within the 
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country. Many also said they would return if they heard a call for blood, but some added that 
it would depend on whether they had the time and money for transport. These issues also 
arose when discussing whether donors would return to the KATH donor clinic as ‘walk in’ 
VNRD. One donor, unwilling to donate at media related events, explained: 
 
 “[I’m] not sure where blood is going. Are they going to sell my blood?”. 
 
5.4 Counselling information priorities - donors’ responses 
 
The decision to introduce focus groups was made following a brief analysis of the results 
from the semi-structured interviews with donors. These interviews revealed a number of 
points donors considered important to donor counselling, but it was unclear, if given the 
choice, which of these points were greater priorities. This was deemed important as in some 
cases, as mentioned above, the staff to donor ratio is low and staff members may not have 
adequate time to provide in-depth counselling,  
 
The aim of the focus groups was to generate a discussion regarding donor priorities 
regarding information given during donor counselling. Using the results from the semi-
structured interviews, the three main types of information donors seek information about 
blood donation and the process, information about their blood and blood status, and post 
donation care advice. 
 
5.4.1 Participant Profiles 
 
Two focus groups were conducted. One took place at a secondary school and consisted of ten 
students aged 17-19. Three were female and two had donated before. The second focus 
group took place at a mobile session at a mosque, however there were limited donors that 
attended that day (total of 13) and 6 did not want to participate in the focus group. Two 
smaller discussions (one with 4 people and one with 3 people) were held instead. All were 
men, aged 17 to 50 years and three had previously donated blood. 
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Participants were asked “Of the following three, which information is the most important for 
you to receive as a donor?” and further probed for specific issues, such as risks and benefits 
of blood donation, STD status and dietary advice (see Appendix 10 for a complete list).  
 
5.4.1.1 Student Focus Group Discussions 
 
The participants were enthusiastic and eager to partake in the discussions. As classmates, 
they interacted easily with one another. This was beneficial as it led to a livelier discussion, 
but also affected students’ responses. Students sometimes changed their responses after 
hearing those of their peers. It appeared that this generally occurred because a peer had 
raised a point the student had previously not thought of, but may have also been partially 
driven by peer pressure. 
 
None of the students discussed post-donation care advice as a priority, and were evenly 
divided as to whether information about blood and the donation process or information 
about their health and blood status were of higher priority. Those who felt that information 
about blood donation and the process was the most important to receive highlighted risks 
and benefits, donation process steps and time required and the maximum blood one could 
donate as specific pieces of information they would like provided during counselling. Donors 
who were keen to receive more information about their blood and health status were looking 
for more details as to whether their blood was “healthy” and if their general health was good.  
 
5.4.1.2 Focus Group Discussions held in Mosque 
 
Compared with the student focus group, there was less discussion among respondents at the 
focus groups held at the mosque. 6/7 respondents were most interested in receiving more 
information regarding their general health and blood status. The donors discussed the 
importance of receiving advice on how they could contract various diseases and how they 
could maintain their health. One donor felt that post-donation care tips was of higher priority 
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than information regarding his general health. None of the participants prioritised 
information regarding the blood donation process over health and post-donation care 
advice. 
 
5.5 Discussion 
 
5.5.1 Recruiting Donors 
 
5.5.1.1 The link between knowledge and motivation 
 
Knowledge and attitudes regarding blood and blood donation play a defining role in 
motivations and many studies exploring donor motivations have also examined knowledge 
and attitudes. In a study looking at 542 blood donors in Lagos, Nigeria, 196 donors (36.1%) 
had a university degree and 284 (52.4%) of blood donors believed they could contract HIV 
or hepatitis C by donating blood (Olaiya et al., 2003). Such a misconception may prevent 
many from coming forward to donate. A study in Iran found that 432/1394 (31.2%) of study 
participants in the urban population of Yazd were unaware of the location where they could 
donate blood (Shahshahani et al., 2006), which suggests that there is limited knowledge 
regarding the basic logistics of blood donation amongst the population. In Saudi Arabia, only 
49% of study participants were aware that blood is screened for HIV, hepatitis B and 
hepatitis C (Baig et al., 2013). All of these misconceptions can deter people from donating 
blood and  highlights the importance of knowledge and education in donor recruitment.  
 
The results from the semi-structured interviews with donors illustrated the importance of 
knowledge and donor motivation. Similar results have been documented in Dakar, Senegal 
where 43% of participants in a study stated ‘altruism’ as the main motivation for blood 
donation and 20.33% ‘awareness of blood shortage’ (Duboz, Macia and Cuneo, 2010).  24.1 
% of donor participants from a tertiary educational institution in Nigeria were found to not 
donate blood due to limited knowledge about the donation process and 'the importance of 
blood donation’ (Salaudeen and Odeh, 2011). This suggests that an important factor in 
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motivating volunteers to donate blood is their knowledge regarding limited blood supply 
and that one of the possible reasons others do not donate blood is because they are unaware 
of the need for it. 
 
Since 2002, the KATH blood bank has made considerable efforts in community education on 
blood donation, primarily through motivational speeches (Owusu-Ofori, S. et al., 2009). The 
results from the interviews with volunteers reflects these efforts as knowledge was an 
important motivating factor among this group of donors. 
 
 
5.5.1.2 Social Inclusion 
 
Donating as part of a group or club was one of the motivating factors for VNRD participants 
at mobile sessions. Watching their peers donate blood influenced their decision, but none 
felt pressured by anyone to donate. This suggests that social inclusion, without peer 
pressure, can be an important factor in motivating blood donors. This is supported by 
research in Australia that found that African migrants were more likely to become blood 
donors if they felt “included in their […] host society” (Polonsky, Brijnath and Renzaho, 
2011). This is similar to the response seen at FM radio hosted mobile sessions in Kumasi, 
which led to an increase in repeat volunteer donors by creating an atmosphere that was 
socially acceptable for blood donation (Allain et al., 2008).  
 
5.5.1.3 Donating for a known person 
 
One of the most common motivating factors among replacement donors was donating for a 
known person, with one donor admitting he would only donate for a close relative. This 
sentiment is not unique to Ghana. In a study in Lagos, Nigeria, 93% of donors stated personal 
or family benefits as their motivation for donating blood (Olaiya et al., 2004). Similar results 
have also been seen in China, Chile and Trinidad (Lownik et al., 2012). 47.2% of donors in a 
study in India said the first time they donated was for a friend or family member (yet 99.2% 
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stated VNRD was the best form of donation compared to other forms) (Uma, Arun and 
Arumugam, 2013). This is an important finding as it illustrates the importance of 
replacement donors, explains why they continue to play a significant role in blood collection 
in Africa and supports similar reasoning by other authors that it 'fits well with the African 
culture of extended family support’ (Tagny et al., 2010).  
 
WHO policy documents and the majority of African national blood policies reviewed 
recommend that blood should be collected from voluntary donors. However, there are 
seasons when the KATH struggles to meet the demand for blood even with a constant flow 
of replacement donors.  This is often during the school holidays when malaria related 
anaemia cases are at their peak and student volunteers are limited. However, replacing blood 
for someone you know is a powerful motivator for some, and should not be dismissed as a 
donor recruitment tool if the blood obtained is safe and the supply is limited.  
 
Some responses from donors suggested that they were under the impression their blood 
would be directly transfused into the patient they were donating for. This was echoed by a 
patient who said: 
 
“Yes. I have B+ and their blood is not B+. If they had B+ I could take their blood.” (Male, 
50 years, A&E, Primary) 
 
The blood bank, however, avoids transfusing patients with blood from their relatives to 
prevent transfusion associated graft vs. host disease. It is unclear whether this belief 
contributes to donor motivation and whether some donors would refuse to donate if they 
learned that their blood would be given to a stranger. In KATH, ideally patients are asked to 
find replacement donors after they have received blood, thus preventing the belief that the 
patient will receive the donor’s blood. However, patients who require multiple transfusions 
are generally transfused until stable and asked to secure replacement donors prior to being 
transfused again. Also, at times there is insufficient blood in the blood bank and patients 
requiring transfusions are urged to find replacement donors even before they receive their 
transfusion.  
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Further research in this area is required in Ghana. Studies in other countries in the region 
suggest that donating blood that will be transfused into a family member might be a 
motivating factor. Focus group discussions in a study in Sierra Leone revealed that many 
donors were not comfortable with receiving blood from a stranger, but were willing to 
receive blood from relatives (Sengeh et al., 1997). Similar results were seen in Cameroon 
(Koster and Hassall, 2011). If this is a strong motivating factor among replacement donors, 
it poses an ethical dilemma on how much information donors should receive. It can be argued 
that donors are entitled to be fully aware of the donation process and transfusion process 
and guidelines, however, if this results in a considerable decrease in replacement donors and 
increased morbidity and mortality among patients, it may be argued that it is more 
important to focus on patient outcomes. 
 
5.5.1.4 Gifts and Compensation 
 
Some donors admitted to knowing other replacement donors who had received gifts from 
family for donating blood. Further research in Ghana is needed to determine whether this 
type of compensation is seen as a motivating factor or as a gesture of gratitude. For example, 
in Cameroon, replacement donors expected some form of compensation from family (ex: 
food, transport money, traditional remedies), but donors still saw themselves as ’voluntary' 
donors (Koster and Hassall, 2011).  These results vary between populations. 92.33% of 
participants in a study in Lome (where only 95/277 were donors), believed that blood 
‘should be donated without remuneration’. (Agbovi et al., 2006), whereas 11.5 % of 
respondents in a study in Nigeria said they would be motivated by monetary compensation 
to donate blood (Salaudeen and Odeh, 2011).  
 
While nearly every donor said they would not donate for money and felt strongly that their 
blood should not be sold, a couple of donors, however, said it would depend on the amount 
of money offered. This suggests that paid donation may be socially unacceptable to some, but 
that for others it is influenced by the size of the incentive and their financial circumstances. 
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Further research is required in this area to determine: a) if this is felt by a larger proportion 
or donors or a very minute minority and b) among those who would consider donating for 
money, at what threshold an incentive’s value must cross before donors consider donating 
for money. 
 
5.5.2 Importance of donor counselling 
 
Nearly all the donors interviewed stated they would have liked to have received additional 
information at the donor clinic. This included topics like process times, more information 
about their pre-screening results and post-donation care advice. This implies that there are 
gaps in donor counselling that need to be addressed. Few, however, were willing to obtain 
this information by asking staff members, claiming they had no questions to ask. This 
highlights the importance of providing donors with thorough counselling given that donors 
are looking for information, though they may not pro-actively search for it. It is also 
necessary to understand and address why donors are unwilling to ask staff members 
questions as even the most thorough donor counselling may not satisfy a donor's needs.  
 
5.5.2.1 Blood donation counselling priorities according to donors 
 
Donation Process 
 
Results from the semi-structured interviews and focus groups showed that donors were 
interested in learning about the steps involved in the donation process and would like to be 
provided with an estimated time frame for how long the process will last. Note that some of 
the responses regarding process times came from participants attending a mobile session 
where set-up was delayed or there was difficulty obtaining fuel (for the van that transports 
the mobile session staff and supplies) and some of the prompter donors were forced to wait 
for staff to arrive and organise the session. This suggests that the actual process is not long 
for donors unless wait times are increased. 
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Process times varied considerably (approximately 30 minutes to 2.5 hours) and as 
uncovered by the interviews, repeat donors based their expectations on their previous 
donation experiences. Thus, repeat donors may under or overestimate the time required to 
donate blood, potentially interfering with their work or school schedules. Despite donors 
commenting on the time donation took, with some saying the process was quick and others 
saying it was long, few donors left once they had started the donation process. In a one-
month period, February-March 2014, only 5/302 donors who visited the clinic left after 
undergoing the initial clinical screening. Thus, while donors seek shorter donation visits, 
once they have commenced the donation process, they are unlikely to leave.  
 
Nevertheless, the responses from donors illustrates the importance of staff being 
transparent with donors regarding the donation process. Donors should be made aware of 
what the process entails and also provided with an estimated time frame. During known 
busy periods (e.g. when there is limited blood available and more replacement donors are 
asked to come), increased staff numbers may help, however, logistics may remain an issue 
as there are currently six donation beds available. Further research is required to determine 
whether increasing the number of staff and hospital beds (i.e. increasing the donor clinic’s 
capacity to attend to more donors at a given moment of time. In the time being, simply 
keeping donors up to date about the process and wait times and encouraging them to be 
patient may help improve the donor experience.  
 
Personal Health 
 
The majority of the information that donors would like to receive is related to their personal 
health. The most important aspect of donor counselling that donors recalled was being asked 
whether they had eaten. Also, donors were interested in learning about the ‘status of their 
blood’ (i.e. is it safe or not?) and showed appreciation for the post-donation advice given 
regarding nutrition and exercise.  
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Adverse reactions 
 
One donor participant discussed the importance of advising donors on the risks involved in 
donating blood. Currently, there are no guidelines regarding informing donors of the risks of 
donation. In fact, one donor stated that clinic staff should encourage donors “that what they 
are about to do is risk free”, suggesting that some donors are unaware of the risks involved. 
During the pilot study one donor was asked whether he/she would donate again if they 
experienced an adverse event and they responded, “No, I would be afraid the same thing 
would happen next time”, Others discussed fear or possibility of fainting and collapsing 
suggesting that these are the most common risks perceived by donors, possibly due to the 
fact that they most often occur shortly after donation and are witnessed by other donors. 
While this was only mentioned once, some people may expect or fear averse post-donation 
reactions and this may be what deters other potential donors from donating. This is 
important to keep in mind when looking at ways to improve donor recruitment. 
 
A study in neighbouring Togo showed that risk aversion (e.g. fear of health problems related 
to blood donation) was one of the main factors deterring potential donors (Alinon et al., 
2013). This represents an ethical dilemma. So long as sterile equipment is used, the risks of 
donating blood are low for donors meeting the donor requirements (MayoClinic, 2016) and 
mentioning risks may scare donors and prevent them from donating. From a Kant 
perspective, one should not use others as a ‘means to an end’ and donors should therefore 
be made aware of the risks. However, from a utilitarian point of view, the aim should be to 
maximise benefits for the general population and in a region where blood stock levels and 
donation rates are low, while blood demand is high, too much information about risks could 
potentially deter people from donating and results in lower blood stocks and greater 
mortality. However, a study at Ohio University found people were more likely to volunteer 
to donate blood following information regarding the risks and coping mechanisms to 
prevent vasovagal reactions (France et al., 2010). 
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STI status 
 
Some donors, all of whom donated blood that day, suggested that they would like to be made 
aware of the ‘status of their blood’ (i.e. is it safe? Are they healthy?) or HIV status. This 
suggests that some donors may not have had a clear understanding of the pre-screening 
process, and were unaware that the fact that they were able to donate means they were 
tested negative for HIV, hepatitis B, hepatitis C and syphilis. This is not true for everyone, as 
other donors mentioned knowing their blood was free from disease was a benefit of blood 
donation, suggesting that information about pre-screening results may be communicated 
with donors, but not consistently. Since staff members did not mention making donors aware 
that they tested negative for HIV, hepatitis and syphilis as part of the information given to 
donors, it is likely not part of their counselling routine. This may be intentional to limit the 
stigma associated with testing positive. By sharing negative results with donors, they may 
suspect that those deferred post pre-screening are deferred due to a positive test (in reality 
they may also have been deferred for a low haemoglobin level). Unlike with ABO and Rh 
grouping, pre-screening results are considered too sensitive to deliver over the telephone, 
thus, limiting the ways donor can learn their results. A possible solution is to invite donors 
to learn their test results post donation.  
 
Post-donation care 
 
Results from the donor interviews and focus groups reveal that donors would appreciate 
advice on post-donation care, such as dietary, fluid intake and rest recommendations. 
According to donor clinic staff this information is consistently provided to donors. Indeed, 
some donors recalled receiving post-donation care advice, but others did not, suggesting that 
this information may be not consistently included in donor counselling. Additionally, based 
on the responses from donors and staff members, the advice is unspecific. For example, 
donors are to take in ‘sufficient fluid, preferable water’, yet there is no indication as to what 
constitutes sufficient. Similarly, donors are recommended to get ‘adequate' rest, with no 
further details.  
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Donors are concerned for their health and efforts should be directed at consistently 
counselling them with detailed post-donation care advice to aid in their post-donation 
recovery and improve their satisfaction with the donor counselling received. 
 
Following donation, donors are normally provided with a malt drink and crackers, but some 
of the donor interview responses suggest that donors associated certain refreshments (e.g. 
Milo) with being more effective at regaining their strength post-donation. Greater education 
on post-donation can help dispel such myths. Since donors look to the post-donation snack 
as an opportunity to recover from donating blood, a beverage or snack high in iron may be a 
suitable alternative, with an explanation to donors as to how this may help them recover. 
 
5.5.3 Encouraging donors to return 
 
Most donors were willing to return to donate blood and donors genuinely seemed interested 
in returning and many expressed their surprise that their fear of pain was not validated. This 
is an important finding as an estimated 55% (292/530) of study participants in Tamil Nadu, 
India stated that fear of pain was the main reason why people hesitated to become donors 
(S., Uma, et al., 2013). Word of mouth and reassuring words from staff members and other 
blood donors is therefore important in providing potential donors with a more accurate 
expectation of pain levels and to minimise their fears. Donors also stressed the lack of 
opportunity to donate, financial resources and transport as preventative factors. These are 
common problems worldwide. It is worth noting, however, that it is possible that 
participants feel compelled to provide certain responses to please the interviewer, but in this 
case it is unlikely given the enthusiasm expressed by donors.  
 
A study in India also revealed that opportunity to donate was major motivating factor (S., 
Uma, et al., 2013). Similarly, 45.5% of donor participants from a tertiary educational 
institution in Nigeria stated ‘lack of opportunity’ as one of the main reasons they did not 
donate blood (Salaudeen and Odeh, 2011). The main reason for not donating among 
participants in a study in Dakar, Senegal was not having been contacted directly to donate 
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blood (Duboz, Macia and Cuneo, 2010). The results from these studies and the data from 
respondents at KATH indicate that blood donation needs to be made more easily accessible. 
As the donor clinic is open 24 hours a day, 7 days a week, the main issue is travelling to a 
donation site. Mobile sessions hosted and advertised by FM radio stations have been 
successful in recruiting large numbers of volunteer donors. Additional sessions held near 
prominent junctions may also improve accessibility. 
 
One donor was hesitant to donate at a mobile session hosted by a media related organisation 
and he was concerned that his blood may be sold. A similar concern was voiced in Togo 
where volunteer donors suggested that others may not be donating due to “concern about 
the use of blood” (Alinon et al., 2013). The hospital should ensure, when advertising or 
encouraging blood donation, that donors are reassured that their blood will not be sold and 
explained how their blood will be used in the hospital.  
 
5.5.4 Suggested recommendations for future donor counselling 
 
Below is a list of suggested guidelines for donor counselling. To ensure consistency, staff 
members may be provided with a checklist to ensure all necessary points are discussed. 
 
-Provide donors with information prior to their donation visit. For donors donating at 
mobile sessions this is partially in place as motivational speeches are given in schools, 
mosques and churches prior to mobile sessions. Additional information on how to prepare 
for donation (e.g. informing potential donors to eat before donating) should be provided.  
 
-Explain the donation process. Donors should be explained the donation process, the 
different steps involved, the reasons for each step and the estimated time required. 
 
-Reassure donors. Donor should be encouraged that the donation process is safe and 
reassured that the process is not as painful as one might expect. At the same time, donors 
should be made aware of the potential adverse effects. 
 125 
 
-Encourage donors to ask questions. Staff members should encourage donors to ask 
questions or share any fears or concerns. They should also make it a point to ask donors if 
there is any additional information regarding the donation process donors would like to 
receive. 
 
-Inform donors how they can access their blood grouping information. First time 
donors should be explained why they are unable to receive their blood group information 
the same day and informed on whom to call and when to access this information. They should 
also be reassured that this information will be included in their blood donor booklet, which 
they will receive a few weeks post-donation.  
 
-Provide donors with detailed health and post-donation care advice. Donor should 
continue to be given personal health related information (such as food intake prior to and 
post donation, fluid intake post-donation and rest post donation). However, counselling 
sessions may benefit from slightly greater detail - ex: amount of fluid, what type of fluid, 
definition of rest etc. Information on how to regenerate blood quicker through diet should 
be provided, a concern mentioned by participants, with specific nutrition suggestions. 
Deferred donors should continue to receive tailored counselling on how to improve their 
health or minimise health related lifestyle risks. In spite being eligible to donate, donors 
considered overweight should also be counselled on diet and exercise, and the health risks 
associated with obesity. 
 
-Continue to encourage donors to return. Donor clinic staff should continue to make use 
of counselling sessions to encourage first time donors to become repeat donors and should 
take into account the responses from this study when implementing retaining strategies. For 
example, the need for blood in the community should be impressed upon and the impact 
blood transfusions have on patient morbidity and mortality rates should be emphasised.  
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5.5.5 Implementing suggested recommendations and potential 
challenges 
 
The motivational speeches given in schools and religious institutions prior to mobile 
sessions are a good tool through which future donors can be educated on the donation 
process. Posters and pamphlets with information on how to prepare for donation (e.g. 
recommend that donors eat prior to donating) and frequently asked donor questions and 
concerns can be distributed prior to mobile sessions. These can also be provided to 
replacement donors prior to their donation visit. However, given that nearly 30% of the 
Ghanaian population is not literate (UNICEF, 2013), this method of delivering information 
may not be appropriate for everyone. An alternative would be to provide patients, when 
possible, with the necessary information and request them to pass it on to any replacement 
donors they secure, though this is not ideal given the burden it places on patients.  
Additionally, a video, in Twi, on the blood donation process could be played on the TV in the 
donor clinic on loop, which would provide donors with information while they wait without 
adding to staff workload.  
 
Special efforts should be directed at minimising donor fears (e.g. fear of pain), particularly 
for first time donors. Staff should ask donors prior to pre-screening whether there is any 
additional information they would like to be given and donors should be reminded and 
encouraged throughout the process to ask questions. 
 
Pamphlets, with explanatory illustrations (to address the needs of the non-literate 
population) on the donation process and post-donation care should be distributed to donors. 
Pamphlets should be specific and include details regarding each step of the donation process, 
information on how the blood is processed, which foods donors should consume, what types 
of liquids and what amount, the amount of rest required post-donation, potential signs of an 
adverse event and where to seek care should they experience any symptoms. These 
pamphlets could serve dual purpose as they provide donors with information and may also 
aid in donor recruitment as current donors may share the pamphlets with friends, colleagues 
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and family which may motivate non-donors to donate blood. 
 
When appropriate, successful and deferred donors should be given personal written advice 
regarding their personal health and lifestyle habits, reassuring donors that their health is 
staff’s primary concern.  
 
5.5.5.1 Potential challenges 
 
There may be insufficient human resources to consistently provide donors with such 
detailed information, particularly during peak donation periods. Pamphlets may help reduce 
staff workload, but may also prove costly. However, it important to maintain donor 
satisfaction and efforts should be made to secure the necessary resources to ensure donors 
receive adequate counselling and their needs are met.  
 
5.6 Limitations 
 
During the study period, there were few mobile sessions in religious institutions (e.g. church 
and mosque), thus I was unable to conduct interviews there and have a limited perspective 
from those donating at a faith based event (except for a focus group at mosque), and may not 
have a complete list of factors that motivate donors. 
 
Lack of HCA participants 
 
In some cases, there were logistical issues and donors were interviewed in close proximity 
with donor clinic staff - this may have had an impact on the results as donors may have been 
unable to speak freely. It is also possible that some information was lost or misinterpreted 
in translation - follow up questions, however, were useful in detecting this and limiting such 
problems.  
 
A major limitation was the implementation of focus groups. Two attempts were made to hold 
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a focus group with replacement donors, with refreshments as a motivator. The aim was to 
hold discussions with 5-10 replacement donors. After attempting to recruit fifteen 
participants, only one returned. This was likely due to the fact that it is difficult for many 
donors to find time off work to attend and there is the added financial cost of transport. In 
fact, some of the participants approached declined stating work or school commitments. 
Weekends were considered, however, Ghanaians generally have many engagements during 
the weekends (e.g. funerals, church, family visits) and according to local staff would not be 
convenient.  
 
The student focus group was much more dynamic than the discussions held in mosque, 
largely I believe because the students knew each other and had a comfortable rapport with 
one another, something that was lacking in the focus groups held at mosque, where despite 
attending the same mosque, it did not appear as if everyone knew each other. This limited 
the discussions between participants. 
 
 
5.7 Conclusion 
 
Donor counselling is a commonly recommended policy, but there are limited details on how 
it should be implemented. Increased research at local levels is required to better understand 
donor needs so that donor counselling can be appropriately tailored to the donor population 
and improve donors’ experiences. Based on the qualitative data collected in this study, 
donors are overall satisfied with their donation experience and most are willing to return 
again under any circumstance provided they have the time and resources. However, quicker 
processing times and more information, particularly relating to donors’ health, are still 
desired. Donor counselling can be used to provide donors with this information, and perhaps 
a better understanding of the donation process will help donors appreciate longer 
processing times.  
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Chapter 6 – Donor Deferrals 
 
6.1 Introduction 
 
Donors are deferred for many reasons and can be temporarily or permanently deferred. At 
KATH, donors who test positive for HIV, Hepatitis B and Hepatitis C during pre-donation 
screening are permanently deferred. In Ghana, the infections for which donors are screened 
for may vary between regions. Temporary deferrals occur when the donor’s bio-
measurements (e.g. weight, blood pressure and haemoglobin (Hb) level) do not meet the 
criteria - the KATH’s criteria are presented in Chapter 3 (these criteria are in line with 
Ghana’s national blood policy). As highlighted in the review of national blood policies (see 
Chapter 3), these criteria vary between countries and as a result increase or decrease the 
potential donor population size. This chapter presents the results of donor deferrals at the 
donor clinic in KATH and aims to estimate whether changes in bio-measurement criteria 
could have a worthwhile impact on reducing donor deferrals. 
 
Information from all prospective donors attending the donor clinic from March-April 2014 
was recorded. This included socio-economic information (e.g. age, gender, occupation and 
residence), donor type (e.g. volunteer, replacement or autologous), bio-measurements 
(weight, blood pressure and Hb screening results) and when applicable donors’ pre-
donation screening results. If one or more bio-measurements did not meet the criteria, 
donors were not sent for pre-screening - i.e. donors were deferred prior to their 
haemoglobin level being assessed and prior to undergoing screening for HIV, Hepatitis B, 
Hepatitis C and syphilis. The data were initially recorded in Microsoft Excel and then 
transferred to SPSS for descriptive statistical analyses to better understand donor deferral 
patterns at KATH and to investigate whether small changes in donor bio-measurement 
criteria will have an impact on the number of successful donations. The results and 
discussion are presented in this chapter. 
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6.2 Types of Donor Deferrals 
 
6.2.1 Permanent Deferrals 
 
A permanent deferral is defined as a donor who is deferred from donating blood for his/her 
entire life. Donors were permanently deferred at KATH if they tested positive for one or more 
of the following infectious diseases during pre-donation screening: HIV, Hepatitis B or 
Hepatitis C.  Donors were not initially permanently deferred. Instead, they were told they 
could not donate that day and asked to return the following Monday. During this time, the 
laboratory staff at the blood bank would do confirmatory tests and if and when the donor 
returned, he/she would be informed of the tests results’ and offered counselling regarding 
the medical care they might consider. Though these donors were told they were permanently 
deferred, as donor records were not yet electronically stored, permanent deferrals may have 
tried and returned or donated elsewhere where screening may not have been as stringent.  
 
Donors were also screened for syphilis. The donated blood was then tested by Rapid Plasma 
Reagent (RPR). If the rapid tests were positive, they were still permitted to donate.. A 
positive RPR test implies an active infection and blood determined to have active infections 
were discarded. At the time of this study, syphilis testing had newly been introduced and 
there was no specific process in place for informing donors about their infection.  
 
6.2.2 Temporary Deferrals 
 
Temporary deferrals refer to donors who are deferred from giving blood for a period of time. 
This may be a set period of time or may be contingent on meeting a specific criterion. The 
list of reasons for temporary deferrals is presented in Chapter 3, though many of these 
deferrals are not recorded at the donor clinic. For example, breastfeeding mothers may be 
told they cannot donate prior to them completing a donor health and risk assessment. 
Donors who fail to meet the bio-measurement criteria can return once the criteria are met. 
 131 
For example, a prospective donor weighing under 50kg would be temporarily deferred, but 
would qualify once his/her weight reached 50kg. During their visit to the donor clinic, 
donors were encouraged to re-visit the clinic and re-attempt donation in 3-4 months. 
However, unless the donor was a regular donor, there was no follow up to recall the donors 
and it is unclear what effect deferring donors has on their willingness to return.  
 
6.3 Donor Deferrals at the Donor Clinic at KATH  
 
6.3.1 Introduction 
 
To determine the common reasons for donor deferrals at the Donor Clinic at KATH, data from 
all donor records from the donor clinic over the course of two months were recorded and 
analysed. The focus was on the donor clinic as both volunteer and replacement donors attend 
the clinic, compared to only volunteers at the mobile sessions  
 
The following donor information was recorded and used in the analyses in this chapter: sex, 
age, marital status, religion, donor type (VNRD or RD), weight, blood pressure, Hb pass/fail 
test results, pre-screening results for syphilis, HIV, hepatitis B and hepatitis C and whether 
the donation was completed and retained (i.e. was not discarded due to syphilis RPR test 
results). For replacement donors, information about which hospital the patient for whom the 
donor was donating for was also recorded. As mentioned earlier, the KATH supplies blood 
to other hospitals in the region and at times replacement donors may be requested to attend 
the KATH donor clinic. For RD donating on behalf of KATH patients, the hospital unit in which 
the patients were admitted was recorded. 
 
6.3.2 Sample size  
 
Sample size was determined based on a confidence level of 95%, a standard deviation of 0.5 
and a confidence interval of +/- 5%. Based on these figures and using the below formula, the 
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estimated sample size was 385. In this study, the actual sample size was 392 as we wanted 
to include all donors who attended the clinic on the last day of sampling to limit any bias 
associated with time required for donation or deferral. Thus, data from all 392 donor visits 
during the two-month period at the donor clinic were analysed. Note, this two-month period 
occurred between March and April. During March, school was still in session, when donation 
rates tend to be higher, whereas in April, school holidays occur resulting in fewer donations 
(as many of the mobile sessions occur in secondary schools) and the rainy season begins, 
meaning there tend to be higher malaria related anaemia cases and therefore increased 
demand for blood. 
 
Sample size = (Z-score) 2 X Standard Deviation (1-Standard Deviation) 
      (Margin of Error)2 
 
6.3.3 Donor profile – Descriptive Statistics 
 
Table 6.1, see below, provides basic descriptive statistics on the sampled donor population, 
where the total percent for each section is equal to 100%. At the donor clinic, the vast 
majority of donors were replacement donors (87.8%), male (87.0%) and Christian (79.1%). 
There was a fairly even representation of married and single donors. 
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Table 6.1 – Descriptive statistics on the donor population at the donor clinic  (n=392) 
 
6.3.4 Temporary Deferrals 
 
Temporary deferrals were defined as those deferred for reasons associated with bio-
measurements such as weight, blood pressure and haemoglobin (Hb) level. Though the 
hospital does have a more extensive list of deferral criteria, in the data collected bio-
measurement criteria were the only reasons recorded for temporary deferral.  
 
Low Weight 
 
Of the 392 entries recorded, two (0.5%) donors were deferred due to low weight. However, 
of those 392 entries, three prospective donors’ weights are not specified, and one was not 
measured as his blood pressure did not meet the required criteria and was therefore 
temporarily deferred before his weight was measured. This does not significantly alter the 
percentage of donors deferred due to low weight, and it remains 0.5%.  
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A summary of these donors’ profiles is presented in Tables 6.2. The two who did not meet 
the weight criteria were students, female, aged 16 and 22 years and weighed 44kg each.  
 
 
 
Table 6.2 – Profiles of donors temporarily deferred due to low bodyweight (<50kg) 
 
Blood Pressure 
 
At KATH, donors with a systolic blood pressure of 140 mmHg or higher or a diastolic 
pressure of 100 mmHg or higher were temporarily deferred. Similarly, donors with a systolic 
blood pressure of below 100 mmHg or a diastolic pressure below 60 mmHg were also 
temporarily deferred. In both cases, these deferred donors would receive some type of 
counselling and may be encouraged to visit their doctor. 
 
Five prospective donors (1.3%) of the 390 donors whose blood pressure were measured 
were deferred due to high blood pressure and 0 due to low blood pressure. Of those with 
high blood pressure, none of these donors presented with a blood pressure slightly over the 
cut off. All had a reading of at least 20 mmHg over either the systolic or diastolic upper limit, 
or both.  All five potential donors who presented with high blood pressure were male 
replacement donors, ranging from 34-57 years old. Their professions included driver, 
farmer, sales worker, teacher and electrician.  
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Table 6.3 – Profiles of donors temporarily deferred due to high blood pressure (> 140/100mmHg) 
 
Haemoglobin Level 
 
As mentioned in Chapter 3, female donors must have a haemoglobin level of at least 12g/dl 
and males 13g/dl. This is assessed using the specific gravity of copper (II) sulphate. Of the 
392 entries recorded, 8 prospective donors’ haemoglobin levels were not measured. Seven 
of these were due to the donor being underweight or having a high blood pressure (thus 
these donors were temporarily deferred prior to haemoglobin testing) and one donor left 
before his haemoglobin level could be measured.  
 
Of the 384 donors’ whose haemoglobin levels were tested, 11 (2.9%) presented with a 
haemoglobin level below the requirement. The majority of these donors were 30 years old 
or younger (72.7%), female (54.5%), single (81.8%) and replacement donors (90.9%). Most 
worked in the trades or were unemployed. A summary of these donors’ profiles is presented 
in Table 6.4. 
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*As patient is to donor 
Table 6.4 – Profiles of donors temporarily deferred due to low haemoglobin level (< 12.0g/dl for females and 
13.0g/dl for males) 
 
6.3.5 Permanent Deferrals 
 
Donors were permanently deferred if they tested positive for HIV, HBV or HCV during pre-
donation screening. These results were confirmed by ELISA prior to informing the donor of 
his/her infection and deferral status. In some cases, donors may be infected with more than 
one virus. Also, note that donors temporarily deferred due to low weight, high blood 
pressure, during the health and risk assessment or due to low Hb were excluded from pre-
screening of the above-mentioned viruses. Donors, however, screened for HIV, HBV and HCV 
were also simultaneously screened for syphilis, something that had been newly 
implemented at KATH during the course of this study. 
 
One donor left the donation process prior to undergoing pre-screening. An additional 5 
donors left the process following pre-screening, 
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Of the 392 donors who presented to the donor clinic for donation, 19 did not undergo pre-
screening. One donor left the process prior to pre-donation screening, 5 were temporarily 
deferred due to low blood pressure, 2 due to low weight and 11 due to their low haemoglobin 
level. Of the 373 donors who were pre-screened, 40 (10.7%) were permanently deferred. A 
further breakdown of these permanent deferrals is presented below. 
 
HIV 
 
5/373 (1.3%) of donors undergoing pre-screening tested positive for HIV. A summary of 
these donors’ profiles is presented in Table 6.5. All were replacement donors, three were 
married males and two were single females. The average age was ~40 years old. Only one 
was donating blood for a patient in a hospital other than KATH. A summary of these donors’ 
profiles is presented in Table 6.5.  
 
Table 6.5 – Profiles of donors permanently deferred due to an HIV positive test 
 
HBV 
 
28/373 (7.4%) of donors screened for infectious diseases tested positive for HBV. All were 
male, the majority were single and worked in the trades, one was a volunteer donor and 
another was donating for a patient outside of KATH. A summary of these donors’ profiles is 
presented in Table 6.6. 
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Table 6.6 – Profiles of donors permanently deferred due to  HBV positive test 
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HCV 
 
7/373 (2.4%) screened for infectious diseases tested positive for HCV. Note, however, upon 
a more detailed look at the donor data, it was discovered that donors 1, 2 and 3 are the same 
person who visited the donor clinic three times within four days, and was deferred all three 
times. All 392 donor visits were included for analyses and thus this donor’s information was 
included all three times. Of the 7 potential donors deferred for HCV, all were male 
replacement donors; two were married, most worked in the trades and their ages ranged 
from 25-49 years. A summary of these donors’ profiles is presented in Table 6.7. 
 
 
** Same as Donor 1 
Table 6.7 – Profiles of donors permanently deferred due to a HCV positive test 
 
Syphilis testing 
 
Syphilis testing had newly begun when these data were collected, and at the time, donors 
testing positive for syphilis were still permitted to donate (provided they tested negative for 
HIV, HBV and HCV), but the donated blood was then additionally tested for syphilis through 
RPR. If the syphilis infection was deemed active the donated blood was discarded. 15/328 
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(4.0%) donated units were discarded due to syphilis.  
 
6.3.6 Summary statistics for donor deferrals 
 
392 donor visits were recorded and analysed. Overall, 56 donors were deferred, 15 units 
were discarded due to syphilis and 313 units passed all screening levels and were made 
available for blood transfusion.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 6.1 – Flow chart summarising the donor deferrals at KATH between March-April 2014. 
392 donors visits at the KATH’s donor 
clinic were recorded and analysed. 
2/392 donors were temporarily deferred 
due to ‘low weight’ (i.e. under 50kg) 
5/390 donors were temporarily deferred 
due to high blood pressure 
1 donor voluntarily left the 
process at this point 
11/384 donors were temporarily deferred 
due to their low heaemoglobin level. 
40/373 donors were permanently deferred 
– 5 for HIV, 28 for HBV and 7 for HCV
328 donors donated blood at the donor 
clinic at KATH 
313 units of successfully screened blood 
provided by donor clinic to the blood bank 
5 donors voluntarily left 
the process at this point 
15 units of blood discarded 
due to the presence of 
infectious syphilis 
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6.4 Discussion  
 
Based on the results presented above, an estimated 1/5 donors are lost. 50% of those lost 
are permanently deferred due to HIV, HBV or HCV positive tests. This illustrates the 
challenge Kumasi faces with regards to securing safe donors and preventing TTIs, given that 
in total, ~10% of blood donors are infected with at least one of the three viruses. The 
remaining 50% are temporarily deferred, left before donating or tested positive for active 
syphilis infection, but can donate once they are no longer actively infected. In spite of it being 
a small number, the most avoidable loss in donors are those who leave without completing 
the donation process and thus more efforts should be made to understand why they do not 
complete the process and based on these results implement strategies to prevent or limit 
this in the future. 
 
The aims of analysing donor deferral data were to a) explore any existing trends and patterns 
in current deferrals and b) determine whether modifying any of the existing criteria relating 
to bio-measurements would significantly impact the number of successful donations (and 
thus amount of blood collected). Identifying trends in deferrals and potential high-risk 
donors is useful primarily in donor recruitment, as efforts can be better focused at low risk 
groups.  
 
As identified in the policy review, there are slight variations in bio-measurement criteria for 
blood donors across Africa and there is no evidence indicating that these criteria are unsafe. 
Adjusting these criteria without compromising the safety of donors could mean an increased 
available donor population size and an increase in units of blood donated.  
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6.4.1 Trends in donor deferrals at KATH 
 
6.4.1.1 Temporary Deferrals 
 
Low weight deferrals 
 
The two donors deferred for low weight were both 44kg, female student replacement 
donors. The low number of deferrals for low weight makes it difficult to draw conclusions 
regarding patterns of deferral among those temporarily deferred for low weight. However, 
it suggests that young females are more likely to be under 50kg. It can be argued that this is 
due to the fact that men tend to be larger than women, but an exploratory study in Accra 
found that the prevalence of overweight students between the ages of 15-19 was higher for 
females (15.6%) compared to males (4.5%) (Nyawornota et al., 2013). In general, while 
many children remain malnourished, according to the World Food Programme (WFP, 2016) 
5% of Ghanaians lack ‘adequate access to food’, where food access was defined by the World 
Food Summit in 1996 as “having sufficient resources to obtain appropriate foods for a 
nutritious diet” (Lal and Stewart, 2012). These data along with results from this study 
suggest that low weight is not a major limiting factor when it comes to blood donation in 
Ghana. 
 
The reason why crude weight is used as a measurement, rather than BMI, is due to the fact 
that according to the American Association of Blood Banks (AABB) and Pan American Health 
Organization (PAHO) no more than 10.5 ml of blood per kg of body weight should be 
collected (PAHO, 2009). However, it is important to keep in mind that other body 
measurements such as height and BMI are not recorded, thus it may be that the donors 
deferred were of ‘normal’ BMI. In Ghana, 8.6% of females between the ages of 15-49 are 
considered underweight (i.e. have a BMI below 18.5), while in Ashanti this figure is 9.6% 
(WHO, 2008) 
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High blood pressure deferral trends 
 
All those deferred due to their high blood pressure were male replacement donors aged 
between 34-57 years. All five were employed and among them covered a range of sectors 
such as agriculture, trades, education and business. There is, however, no evidence 
suggesting a negative link between hypertension and blood donation. In 1999, Trouern-
Trend et al. found no significant association between pre-donation blood pressure and 
vasovagal reactions. In fact, the American Red Cross (2016) cites broader criteria for donors' 
blood pressure, recommending that it be below 180/100 mmHg. Had these criteria been in 
place at the time of this study, an additional two units of could have potentially been 
collected. Widening the criteria for donors' blood pressure could have considerable impact 
on the donor population size given that a review of population based studies in Ghana from 
1970-2009 found the prevalence of hypertension (i.e. >140/90 mmHg) to vary between 
19.3%-54.6% (Addo et al., 2012). This range dropped to 4.5%-16.2% when considering the 
prevalence of those with blood pressure >160/95mmHg (ibid). Based on these data, an 
additional 14.8%-38.4% people who may normally be temporarily deferred, could 
potentially donate blood successfully, provided they meet the remaining criteria.  
 
 
Low haemoglobin deferral trends 
 
Of the 11 deferred, 10/11 were replacement donors; 6 were females and 5 were males aged 
between 19-42 years. This is contrary to evidence from other studies, which indicates 
considerably higher rates of low haemoglobin deferrals among women. Studies in Turkey 
and India have found the most common reason for donor deferral among females to be low 
haemoglobin level (Arslan, 2007; Bahadur et al., 2009) One study in the neighbouring 
country of Cote d’Ivoire recorded a total of 2618/24643 (10.8%) donors deferred for low 
haemoglobin, the majority of whom were women (Kouao et al., 2012). In this study the 
minimum haemoglobin level required to donate was 11 g/dl for both women and men - this 
is lower than the minimum level set at KATH, where the minimum is 12.5 g/dl for women 
and 13.5 g/dl for men.  
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The results in this study may be due to a bias whereby only females with a certain nutritional 
status attend the donor clinic. For example, only women who consider themselves ‘well-
nourished' and ‘healthy' may choose to donate blood. It may also occur as a result of the 
lower threshold set for haemoglobin level for women, which was not the case in the study in 
Cote d'Ivoire (Kouao et al., 2012).  
 
A major discussion point has been whether haemoglobin reference values should be 
ethnicity specific, as not doing so may be contributing to a greater number of deferrals for 
certain ethnic groups. In the United States, it has been found that African-Americans have on 
average a significantly lower haemoglobin level than Caucasians, in spite of higher serum 
ferritin levels (Beutler and West, 2005). The average haemoglobin level for African-
American women was 12.70 +/- 0.04 g/dl compared to 13.49 +/- 0.01 in Caucasian women. 
Similarly, the average haemoglobin level in African-American men was 14.45 +/- 0.04 g/dl 
compared to 14.93 +/- 0.01 g/dl in Caucasian males (ibid). The reason for this is unclear, but 
was not explained by educational differences and has been hypothesised to be genetic (ibid). 
This suggests that current reference ranges for ‘normal' haemoglobin levels may only be 
relevant to the Caucasian population and may result in a higher proportion of temporary 
deferrals due to low Hb levels in Africa, where donated blood is scarce. However, ensuring 
donor safety is of utmost importance, and further research looking at the impact of lower 
reference ranges on adverse donation related events is necessary before any changes to 
donor criteria are made.  
 
Counselling and retaining temporary deferrals 
 
Currently, temporarily deferred donors are counselled on how to, for example, lower their 
blood pressure or increase their haemoglobin level through diet, medications etc. They may 
also be advised to make an appointment with a doctor. Donors are also encouraged during 
counselling to return in 3-4 months and attempt donation again. Generally, for all return 
donors, a 3 month interval is suggested for males and 4 months for females – the lower 
suggested donation frequency for women is based on the assumption that they have a lower 
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baseline haemoglobin levels than men and that blood loss during menstruation will mean it 
takes longer for them to return to their baseline levels.  However, temporarily deferred 
donors are not actively followed up to limit loss of donors. This can impact donation rates, 
with the extent of the impact dependent on temporary deferral rates. Past studies have 
shown that temporary deferrals are unlikely to return within the next 1-4 years (Custer et 
al., 2007; Custer et al., 2011; Zou et al., 2008). Low return rates were higher for different 
deferral reasons - something that may vary culturally (Custer et al., 2011). It is not well 
understood why these donors do not return, and thus more research is needed in this field 
to limit this challenge in the future and to determine the effect, if any, follow up will have on 
these temporarily deferred donors.  
 
As a general principle in resource limited countries, effort should be put in where returns 
will be maximal. Follow up efforts in my view should be maximised in successful donors 
rather than in following up temporarily deferred donors. When one succeeds in getting 
donors to become repeat donors then those strategies can be used to bring back temporarily 
deferred donors. 
 
6.4.1.2 Permanent Deferrals 
 
HIV deferrals patterns 
 
There were no clear trends among those deferred for HIV. All were replacement donors. 3 
were males and married and 2 were females and single. They ranged in age between 28-47 
years. The HIV prevalence among donors screened for HIV (1.3%) was similar to the national 
prevalence rate published by the of HIV in Ghana in 2013 (1.47%) (Ghana AIDS Commission, 
2014). 
 
HBV deferrals trends 
 
All 28 were males ranging in age from 19-37 years. 27/28 were replacement donors and one 
was a volunteer. 16 were single, 7 married and 5 did not specify their relationship status. 
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Hepatitis B rates are generally higher in Africa and it is estimated that 8% are chronically 
infected (Bloch et al., 2012). Currently, Ghana has implemented a vaccination programme 
against hepatitis B for children, which will hopeful curb the rates in the future.  
 
HCV deferrals trends 
 
The prevalence of hepatitis C in Ghana is not well quantified. In 2012, the WHO submitted an 
initial baseline survey to member states globally aimed at assessing prevention and control 
strategies of viral hepatitis, but many countries did not respond, including Ghana (WHO, 
2013). A review of studies found only one from Ghana regarding HCV prevalence (Messina, 
et al., 2015). The study, conducted in a district hospital in the Ashanti region, found the 
prevalence of HCV, based on a sample size of 2773 blood donors, to be 9.4% (Nkrumah et al., 
2011).  All 7 ‘donors’ deferred due to testing positive for HCV were males and replacement 
donors. 5 were young unmarried men ranging from 25-28 years of age. The other two were 
married men aged 48 and 49 years old. Of the men whose employment information was 
available, all were involved in a specific trade. However, when looking carefully at the donor 
data, it appears that the same donor re-visited the donor clinic two additional times within 
one week. Since the donor clinic staff on duty changes during different shifts and there are 
no electronic records, it would be easy to miss. Thus, in reality, while there were 7 deferrals 
due to HCV in the two-month period, only 5 actual donors were deferred, with one being 
deferred three times.  
 
 
6.4.2 Effects of modifying bio-measurement criteria  
 
It is important to note that due to the limited number of deferrals in some areas (e.g. weight), 
it is difficult to conclude the impact changes in bio-measurement criteria may have on the 
number of units donated. In the future, sample size should be calculated keeping in mind the 
low deferral rate - this would likely require a much longer study.  
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6.4.2.1 Modifying weight criteria 
 
Currently at KATH, the minimum weight requirement for a donor is 50kg. In some hospitals, 
those below a certain weight (e.g. 45kg) are able to donate a smaller amount, but this is not 
the case at KATH. This may be due to the increased cost associated with smaller blood bags, 
which does not make them a cost effective option. However, weight requirements vary 
between countries in Africa. Given that there is limited evidence at exactly what weight 
adverse events are more highly associated with blood transfusions, these broader criteria 
may be useful in countries with low blood stocks and/or low weight populations, provided 
there is no increase in adverse events. There is no current evidence examining the impact of 
these broader criteria on adverse events. Thus, these should not be altered dramatically 
given the insufficient evidence in this area.  
 
In this analysis, we looked at what would occur if we used the broadest criteria identified in 
African policies at KATH (see Chapter 3). In this case, that would mean deferring anyone with 
a bodyweight of under 45kg. Since both low weight deferrals weighed 44kg, this would not 
change the outcome of successful donations, and the deferral rate for low weight would 
remain at 2/393. Thus, based on the data collected, there would be no statistical difference 
if the weight criteria were broadened.  
 
6.4.2.2 Modifying blood pressure criteria 
 
At the time this study was conducted, a donor would be deferred due to high blood pressure 
if either a) their systolic blood pressure was 140+ mmHg or b) their diastolic blood pressure 
was 100+ mmHg. Based on discussion with the donor clinic staff, the minimum blood 
pressure at KATH was considered to be 100/60 mmHg. The minimum blood pressure set by 
various African national blood policies ranged between 90/50 mmHg-100/60mmHg. High 
blood pressure deferral was ranged from 140-180mmHg systolic (with less information 
provided about the diastolic threshold). In the data analysed, no donors were deferred due 
to low blood pressure,  
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Assuming the KATH changed its systolic, maximum blood pressure cut-off to the highest 
referenced in an African national blood policy, 180 mmHg, none of the 5 donors would be 
deferred, thus resulting in an overall decreased deferral rate prior to screening for infectious 
diseases of 1.2% and potentially adding 5 units of blood to the blood bank. Moreover, as 
mentioned earlier in this chapter, up to half the Ghanaian population has hypertension and 
thus modifying this criterion could increase the available donor population pool 
considerably. It is unclear, however, given the high prevalence of hypertension in Ghana why 
only 5 donors were deferred for this reason in this study. One possible explanation for this 
may be selection bias, where mostly ‘healthy' or young donors present for donation. Only 
donors between the ages of 16-65 are eligible to donate and in this study the average age 
was 30.69 years, with only 7/393 donors aged over 50 years.  
 
6.4.2.3 Modifying haemoglobin criteria 
 
There are varying thresholds across Africa for minimum haemoglobin levels for blood 
donors. One of the lowest thresholds documented is in Cote d'Ivoire, where the minimum Hb 
level required was 11.0 g/dl.  It was, however, difficult to assess how these lower thresholds 
could have impacted deferral rate at KATH as donors’ haemoglobin level is tested on a 
‘pass/fail’ scale rather than a precise measurement being obtained. However, the evidence 
from the United States showing the lower haemoglobin levels in African-Americans 
compared to Caucasians even when adjusted for education suggest that further research is 
required to determine what the 'normal' ranges of Hb levels are in the African population 
and that future criteria in terms of blood donation should take this into account.  
 
6.4.3 Implications of donor deferral patterns 
 
Given the limited evidence regarding donor safety at higher blood pressure levels and given 
that many countries have a higher maximum systolic blood pressure cut off point (ranging 
from 160mmHg in the Americas to 180mmHg in Africa), modifying the blood pressure 
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criteria for donors may be a simple way to decrease the number of donor deferrals and 
increase blood stocks. 
 
The results from this study suggest that further research should be done to determine 
whether donor criteria ought to be modified to increase blood stock, while maintaining blood 
safety. It is difficult to ascertain whether changing the minimum haemoglobin requirements 
will have any impact on donor deferral rates as haemoglobin level is currently assessed on a 
pass/fail basis. If most donors are considerably below the minimum threshold, altering these 
criteria may have no effect, but if many are near the threshold, it is important to re-evaluate 
a safe haemoglobin level for donation and re-evaluate the criteria.  
 
 
6.4.4 The case of repeat visits from a deferred donor 
 
As highlighted earlier in this chapter, one donor who tested positive for Hepatitis C returned 
to the donor clinic and attempted to donate blood two additional times within a period of 
one week. Generally, if donors tested positive for one or more of the viruses tested for they 
were told they were unable to donate that day and asked to return the following week. 
During that time, the hospital would confirm the results through ELISA and if and when the 
donor returned he/she would be told their infectious status and counselled appropriately.  
 
As a result of the above practice, it may have been unclear to the donor that he was unable 
to donate and he may have assumed that he would be able to donate the following day. 
Moreover, staff members change throughout the day and it would be easy to go unnoticed 
that the same donor was returning. Lack of electronic records makes it additionally difficult 
to identify returning donors, unless donors themselves admit to returning.  
 
It is understandable why the donor clinic waits for confirmation before disclosing the 
donor’s positive test result to them and it limits the stigma a donor might feel when receiving 
this information as the counselling is done is more private area. However, donors returning 
before they are recommended to results in increased usage of resources such as donor clinic 
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staff time, donors’ time (i.e. other donors must wait longer to be seen), laboratory staff time 
and materials required for testing. This would be minimised by an electronic system – 
something the hospital is in the midst of designing and implementing.  
 
6.5 Limitations 
 
The study focused on donors attending the donor clinic at KATH, which mostly receives 
replacement donations. Data from mobile sessions were not included due to time constraints 
and the sheer volume of paper records for each potential donor. Moreover, it would not have 
been possible to randomly sample these data as the donor records are organized in file 
folders based on their deferral status. The results presented in this chapter, therefore, are 
more reflective of the replacement donor population despite the fact that some volunteers 
do attend the donor clinic.  
 
Additionally, when attaching the strips from the rapid tests for HIV, HBV and HCV onto the 
donor’s clinical record form, plasters are often used instead of transparent tape. As a result, 
some of the data are covered by the plaster. For example, 21/393 ‘donor to patient 
relationship’ could not be recorded as I was unable to make out the information. In some 
cases, I was able to gently peel the plaster back to record the data, but in other cases I was 
not as it risked damaging the form. Thus, this limited the amount of information I was able 
to record. 
 
Finally, as all the data are currently handwritten, there were at times difficulties making out 
certain figures or words. However, when this occurred, the script in question was verified 
with at least two members of the donor clinic before recording it electronically.  
 
6.6 Conclusion 
 
Overall, the results from this study suggest that though temporary donor deferral rates due 
to bio-measurements is relatively low, re-evaluating and modifying current criteria may lead 
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to a decrease in temporary deferrals, and thus increase in blood donated, without 
compromising donor and patient safety. Though further research is needed in this area to 
confirm this. In some cases, larger studies with finer quantitative measurements may be 
needed as part of the re-evaluation. In other cases, such as blood pressure, looking at 
temporary deferral evidence in other countries whose criteria are broader may be sufficient 
to pilot a change in criteria. Of course, any change in criteria should be followed up carefully 
to ensure that donor safety is not compromised. 
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Chapter 7 - Blood component production, demand 
and usage at KATH 
 
7.1 Introduction 
 
The WHO and many of the African national blood policy documents reviewed (see Chapter 
3) recommend the use of blood components. The process of separating blood into its 
components was first developed in 1960, allowing production of packed red blood cells 
(PRBC), fresh frozen plasma (FFP) and platelet concentrates(PC) using a heavy spin 
refrigerated centrifuge (Basu and Kulkarni, 2014). Preparing PRBC and FFP is a one step 
process, however, the preparation of PRBC, FFP and platelets requires a two-step 
centrifugation (ibid).  
 
There has been some debate as to whether components should be produced, particularly in 
resource poor settings, as there are several advantages and disadvantages, outlined in the 
literature review in Chapter 2. In this study, blood component stocks and requests were 
recorded to quantitatively determine the demand of blood components at KATH and if there 
were any blood component shortages. To gain qualitative insight into component usage at 
the hospital, prescribing doctors from different hospital specialties were interviewed. This 
chapter will use this data to explore current component demand and usage at KATH and 
make corresponding recommendations to improve blood services at KATH.  
 
7.2 Blood component production at KATH 
 
In 2014, according to the blood bank staff, the aim was to convert 30% of collected blood 
units to components. When asked how this number was calculated, a staff member explained 
that currently, the blood bank’s goal is to slowly increase the proportion of blood units 
converted to components year by year, as there is demand for them, but they do not want to 
risk overproducing and they must also consider the cost of production. I further probed for 
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the calculation details and the staff member attempted to locate the minutes of the meeting 
at which this was discussed, but to no avail.  
 
The main components produced were PRBC and FFP, though other components such as PC 
and cyroprecipitate were also produced on demand.  A double blood bag system was used 
for separation of whole blood into the two main components – an added cost to the blood 
bank. FFP units were stored at -40 degrees Celsius for up to one year and PRBC were stored 
under the same conditions as whole blood – up to 30 days at 4 degrees Celsius. Note, 
production of blood components may be limited by the number of donations and the storage 
space available.  
 
It is clear that the blood bank is moving towards greater component production. The blood 
bank’s aim is to increase the proportion of whole blood units converted into components 
each year, though it is not clear how this figure is calculated. When speaking with blood bank 
staff members, there is a strong belief that component production is advantageous as a single 
blood donation can serve a greater number of patients and that increasing the availability of 
blood components will increase their demand and usage. According to the KATH’s 
transfusion medicine review, in 2013, 16247 units of blood were collected and 2131 units of 
FFP were produced (13.0%).  This is a considerable increase from previous years where FFP 
production was 1622 units in 2012 (10.3%), 1292 units in 2011 (8.2%), 773 units in 2010 
(4.9%) and 540 units in 2009 (4.1%). Evidently, there has been a steady rise in the 
proportion of components produced. 
 
7.3 Weekly blood component stock levels at KATH 
 
Below is a summary of the components available at KATH between August-December 2014. 
This period was chosen as it included school holidays, when donation rates are low 
(December), malaria season, when usage rates are high (September-October) and the dry 
season, when usage rates are lower (November-December).  The data were collected weekly 
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by two blood bank staff members. They counted all blood components available, by blood 
type. The included both cross-matched and non-cross matched units. 
 
Table 7.1 – Weekly stock levels of whole blood units at KATH, by blood type 
 
 O- O+ A- A+ B- B+ AB- AB+ Total 
02/08/2014 2 14 1 29 0 58 1 24 129 
09/08/2014 10 19 1 35 0 90 0 37 192 
16/08/2014 2 55 0 56 0 122 1 52 288 
23/08/2014 0 8 1 47 4 74 3 58 195 
30/08/2014 0 6 0 22 0 54 0 48 130 
06/09/2014 2 9 0 5 1 36 2 48 103 
13/09/2014 3 7 0 6 0 28 0 40 84 
20/09/2014 3 9 3 8 1 13 0 52 89 
27/09/2014 0 8 3 4 1 10 0 48 74 
04/10/2014 0 49 2 17 1 39 35 0 143 
11/10/2014 1 13 3 5 2 31 0 32 87 
18/10/2014 6 19 5 11 3 35 0 39 118 
25/10/2014 10 22 5 20 7 17 0 32 113 
01/11/2014 2 12 8 32 5 32 0 33 124 
08/11/2014 0 7 0 17 1 15 0 11 51 
15/11/2014 0 11 1 3 0 8 0 2 25 
22/11/2014 5 22 3 12 0 12 1 16 71 
29/11/2014 0 80 5 18 1 11 1 15 131 
06/12/2014 3 66 8 22 1 35 1 17 153 
15/12/2014 7 186 7 55 8 59 1 36 359 
20/12/2014 1 132 0 56 1 45 2 40 277 
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Table 7.2 – Weekly stock levels of packed red blood cells units at KATH, by blood type 
 
 O- O+ A- A+ B- B+ AB- AB+ Total 
02/08/2014 0 7 0 2 0 19 0 5 33 
09/08/2014 2 19 0 6 0 12 0 0 39 
16/08/2014 1 15 0 13 0 3 0 0 32 
23/08/2014 0 0 1 5 0 19 0 3 28 
30/08/2014 0 0 0 5 0 8 0 0 13 
06/09/2014 0 0 0 0 0 8 0 0 8 
13/09/2014 0 1 0 0 0 0 0 0 1 
20/09/2014 0 3 0 0 0 0 0 0 3 
27/09/2014 0 2 0 0 0 0 0 3 5 
04/10/2014 0 4 0 6 0 23 0 0 33 
11/10/2014 0 0 0 0 0 8 0 0 8 
18/10/2014 0 13 0 5 0 0 0 0 18 
25/10/2014 3 5 0 7 0 8 0 0 23 
01/11/2014 0 5 0 5 2 8 0 0 20 
08/11/2014 0 0 0 3 0 0 0 8 11 
15/11/2014 0 5 0 0 0 0 0 0 5 
22/11/2014 0 9 2 4 0 0 0 0 15 
29/11/2014 0 10 2 10 0 4 0 0 26 
06/12/2014 0 4 0 2 0 0 0 3 9 
15/12/2014 0 11 0 5 0 15 0 0 31 
20/12/2014 0 35 0 0 0 14 0 0 49 
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Table 7.3 – Weekly stock levels of fresh frozen plasma units at KATH, by blood type 
 
 O- O+ A- A+ B- B+ AB- AB+ Total 
02/08/2014 0 0 0 4 0 0 0 0 4 
09/08/2014 0 6 0 2 0 4 0 0 12 
16/08/2014 0 6 0 0 0 1 0 0 7 
23/08/2014 0 8 0 1 0 3 0 0 12 
30/08/2014 0 2 0 0 0 0 0 0 2 
06/09/2014 0 4 0 2 0 12 0 0 18 
13/09/2014 0 0 0 2 0 0 0 0 2 
20/09/2014 0 8 2 0 0 0 0 0 10 
27/09/2014 0 4 2 6 0 7 0 2 21 
04/10/2014 0 1 0 0 0 0 0 0 1 
11/10/2014 0 0 0 0 0 0 0 0 0 
18/10/2014 1 0 0 0 0 0 0 0 1 
25/10/2014 0 0 0 1 0 2 0 1 4 
01/11/2014 0 4 0 0 0 0 0 0 4 
08/11/2014 0 0 0 0 0 0 0 0 0 
15/11/2014 0 4 0 0 0 0 0 0 4 
22/11/2014 0 3 0 2 0 6 0 0 11 
29/11/2014 0 11 0 0 0 2 0 0 13 
06/12/2014 0 1 0 5 0 2 0 2 10 
15/12/2014 0 4 0 2 0 2 0 0 8 
20/12/2014 0 9 0 3 2 2 0 9 25 
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As seen in Tables 7.1-7.3, there was considerable variability in the number of blood products 
components available. For example, the number of whole blood units available ranged from 
25 units mid-November, to 359 units mid-December. While overall whole blood stock levels 
never dropped to zero, there were several times when there were not O- or AB- units 
available. PRBC and FFP availability also varied from 1 to 49 units and 0-25 units 
respectively. Like with whole blood, there were several instances when certain blood groups 
were completely unavailable.  
 
7.4 Blood component demand 
 
Daily requests for blood components at KATH over a period of nine months (February-
October 2014) were recorded and analysed. This period included both dry and rainy seasons 
(malaria-related anaemia rates are at their highest during the rainy season and demand for 
blood is often higher than during the dry season) as well as school term time and school 
holidays (when donation rates, and thus blood supply, tend to be lower). At KATH, the blood 
bank record all incoming requests by hand. All request, therefore, were entered into MS Excel 
and subsequently analysed.  
 
For each blood request the blood bank received, staff recorded by hand the date, the name 
of the patient, patient’s age and sex, which ward they were admitted to, the type of blood 
component requested and the amount. At times, some of these fields were not completed in 
request form and left blank in the records book.  If the type of component or amount was 
unspecified, it was processed with the assumption that the component was whole blood and 
the amount was one unit. Requests for patients at nearby private hospitals were also 
recorded. Occasionally, if blood bank staff members suspected there was an error with the 
volume requested, they would clarify this with the prescribing doctor.  
 
To maintain anonymity, when entering data from the record books, patients’ names were 
not included. I, however, did enter the date, patient’s sex, age and ward they were admitted 
in as well as the blood component and amount requested.  The data were entered into MS 
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Excel, and SPSS was used to generate descriptive statistics, including number and percentage 
of blood components requested, stratified by month and by hospital speciality. The median 
age of patients requiring transfusions was 32 with the age ranging from 1 day to 107 years. 
In 1.79% of cases the patient’s gender was not recorded. In the remaining cases where it was 
recorded, 43% were male and 57% were female. 
 
One major limitation was that if any subsequent blood requests for a given patient were 
received within seven days of the initial request, the blood bank would not record these in 
the request book and the request would be directly passed on to the laboratory staff who 
would issue the blood, as the patient’s blood sample for grouping and cross-matching was 
deemed viable for up to seven days. Thus, while in total, 17,278 whole blood and blood 
component requests were recorded and analysed, this represents an underestimation of 
their demand at KATH.  
 
Generally, blood components were prescribed by volume (ml) for children and by unit for 
adults. For analyses purposes, the units have been converted to their corresponding volume 
in millilitres, where one unit of whole blood and fresh whole blood were equivalent to 500ml, 
one unit of packed cells is equivalent to 300ml, one unit of fresh frozen plasma is equivalent 
to 300ml, one unit of platelets is equivalent to 50ml and one unit of cyroprecipitate is 
equivalent to 10ml (Fuenfer and Creamer, 2010).  
 
Most blood policies reviewed insist that doctors specify the blood component and volume 
requested when prescribing. The same is true for the blood component request forms at 
KATH. However, in practice, there are times when either the blood component requested, 
the amount or both were not provided. In these cases, the component and amount requested 
were assumed to be whole blood and one unit respectively, as this is what is done in practice. 
Of the 17,278 requests, there were 417 (2.41%) instances where blood volume was not 
specified and 1,282 (7.42%) instances where blood component was not indicated.  
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7.4.1 Demand according to blood requests 
 
Overall, whole blood was prescribed significantly more often than any other component 
and accounted for 74.2% of all blood requests (see Table 7.1). The remaining requests 
were mostly for packed cells. Fresh whole blood, platelets, cyroprecipitate and Autologous 
transfusion requests were rare in comparison (see Table 7.1).  
 
 
 Whole 
Blood 
Packed 
Cells 
Fresh 
Frozen 
Plasma 
Platelets Cyroprecipitate Fresh 
Whole 
Blood 
Autologous 
(Whole 
Blood) 
Total 
February 1175 317 26 12 0 5 0 1535 
March 1552 475 25 3 0 1 0 2056 
April 1433 437 31 15 0 1 0 1917 
May 1503 466 22 5 0 3 0 1999 
June 1520 524 24 5 0 2 0 2075 
July 1418 563 35 9 0 4 0 2029 
August 1380 507 30 1 0 6 0 1924 
September 1385 386 24 8 1 1 1 1806 
October 1454 437 32 10 2 2 0 1937 
         
Total (%) 12820 
(74.2) 
4112 
(23.8) 
249 
(1.4) 
68 (0.4) 3 (0.2) 25 
(0.1) 
1 (0.006) 17278 
 
Table 7.4 – Blood component requests over a period of nine months in 2014, stratified by month 
 
In terms of amount requested, there was a considerably higher demand for whole blood 
(see Table 7.4). On average, the monthly demand for whole blood was 1424 units, though 
monthly demand varied between 1175-1552 units throughout the nine-month period. 
Average monthly demands for PRBC, FFP and PC were 456, 28 and 8 units respectively.  
 
 
 160 
 
Table 7.4 shows how the number and amount of blood components requested varied 
between hospital specialities. Both in terms of number of requests and volume requested, 
the Accident and Emergency (A&E) department was responsible for most of the hospital’s 
blood component demand (N=6552; 37.9%), with Obstetrics and Gynaecology (O&G) 
second (N=3125; 18.1%). This pattern of demand has been validated by the blood bank and 
KATH and is the major reason why the main blood bank is situated in the hospital’s A&E 
unit and why a second ‘mini blood-bank’ has been created in the O&G unit.  
 
Note that while the Child Health unit accounts for over 1/8th of the blood requests at KATH, 
in terms of volume, it accounts for very little in demand due to the nature of paediatric 
transfusions and the limited volume required. 
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Figure 7.1 – All blood component requests by hospital speciality 
 
7.5 Blood component discards 
 
The number of blood components discarded and the reason for the discard were recorded 
to determine whether any of the blood components were being over-produced and 
consequently wasted. Similar to the blood requests, the serial number of the blood 
components discarded, the date they were discarded, the blood group of the component 
discarded and the reason for discard were recorded by the blood bank in a log book. I entered 
the data into Microsoft’s Excel and used SPSS to generate descriptive statistics. Units testing 
positive for syphilis, expired units and underbled units were most commonly discarded. 
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Note, however, when looking through the book recording discards, it was unclear which 
blood component they were. Nevertheless, the data do illustrate a couple of important points 
(see Figure 7.5): 1) There are relatively few discards given the amount of blood issued and 
2) Most of the units that have expired are AB+.  
 
 
 
 
 
 
Figure 7.2 – Reasons for discarding units of blood 
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7.6 Blood component usage according to prescribing doctors 
 
Semi-structured interviews were conducted with fifteen doctors across six different units. 
Initially, I visited the different wards weekly to make contact with doctors and ask if they 
would be willing to participate in the study. However, after the first eight interviews, it 
became clear that it was easier to recruit house officers, particularly from the Medicine and 
Child Health specialities. To obtain a wider spectrum of perspectives, I then focused on 
interviewing doctors from the other specialties and with more clinical experience. I was put 
in contact with three doctors by a visiting doctor and others were approached in the ward. 
Given unpredictability of hospital medicine, it was challenging to recruit participants. On 
eight occasions I was asked to return at a different time to conduct the interview. On three 
of these occasions I managed to conduct the interview. In five instances, the prospective 
participant was unavailable. Generally, I made three attempts to contact a prospective 
participant. If by the third attempt I was still unable to make contact, I moved on to another 
participant. The aim was to ensure I interviewed doctors from each of the hospital’s 
specialties to ensure a variety of clinical perspectives were included in the study.   
 
The interviews explored issues such as patient consent (discussed in Chapter 8), blood usage 
and the positive and negative aspects of blood services at KATH. Further details on the 
methodology are described in Chapter 3. Most interviews were audio-recorded, but in some 
cases the respondent requested that the interview not be recorded. Additionally, there were 
times when the background noise of the hospital setting made it difficult to make out certain 
parts of the interview. However, thorough notes were also taken throughout every interview 
(regardless of whether it was audio-recorded), thus minimising any loss of data. Interviews 
were transcribed within two days. Upon initial review of the transcriptions, responses for 
questions consistently asked were tabulated and compared between the hospital specialities 
Common themes were identified and responses were grouped accordingly. Responses that 
did not fit into a particular theme were also noted.  
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The results from the interviews are presented according to the specialty the doctor was 
working in, as illnesses and disorders commonly seen will vary by specialty and 
consequently so will blood component needs and usage. They are summarised at the end of 
this section.  
 
Results from Interviews in Child Health 
 
Seven doctors were interviewed from the Child Health department. Four house officers, one 
resident, one specialist and one senior specialist were interviewed. Doctors were based in 
different wards within the unit, such as the mother baby unit (MBU), the paediatric 
emergency unit (PEU) and general paediatric wards.  
 
MBU 
 
A specialist and two house officers were interviewed in MBU. The specialist was aware that 
blood components such as whole blood (WB), packed red blood cells (PRBC), platelets and 
fresh frozen plasma (FFP) were available at KATH’s blood bank. According to this physician, 
in MBU, transfusions occur almost daily and WB is the most required and the most ‘readily 
available’ and ‘because of the indications for which we prescribe it’. It is mostly needed for 
severe neo-natal jaundice (NNJ) cases where twice the baby’s blood volume is required. 
PRBC were sometimes necessary to increase the baby’s Hb level and in rarer cases, platelets 
may be given for severe thrombocytopenia. These responses were echoed by a house officer 
participant from MBU. 
 
The above results, however, conflicted slightly with the response from a second house officer 
who was also interviewed in MBU. This participant was aware of the availability of the same 
blood components as the specialist paediatrician and agreed that WB was the most needed 
on the ward for NNJ exchange, but felt that in MBU they prescribed PC more often as it was 
more readily available. When asked which blood components were available at the hospital 
the house officer responded: 
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“Normally we often get packed cells. Sometimes we get FFP. And then sometimes we 
get platelet concentrates and then in on other conditions we also get full – whole 
blood. But, the prevalent one is the packed cells.” (House officer, MBU) 
 
When probed further whether this meant “Prevalent in terms of quantity at the blood bank 
or what you prescribe most often in MBU?”, the house officer replied: 
 
“Availability. The one that is really available is packed cells.” (House officer, MBU). 
 
To clarify, I explicitly asked “Do you request packed cells or whole blood more often 
because there is a greater need or because they are more readily available or both?”, to 
which the house officer responded:  
 
“[Because] Packed cells are readily available”.  
 
According to this house officer, PC was mostly prescribed in MBU for anaemia, platelets for 
bleeding disorders and FFP for patients who had received several PC transfusions. 
 
PEU 
 
A senior specialist in PEU with 18 years of experience in Child Health was interviewed. The 
doctor was aware of blood components being available at KATH and listed WB, PC, FFP and 
platelets as examples. 
 
According to the doctor, 80% of blood transfused in PEU was WB and this was due to the fact 
that it was the most needed and the most readily available. The participant explained that 
WB was largely required for acute blood loss, sickle cell anaemia, severe malaria, bleeding 
disorders and malignancies in PEU. PC were also used for sickle cell anaemia while FFP was 
usually prescribed for nephritic syndrome and haemophilia and platelets for 
thrombocytopenia  
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However, when asked whether blood usage in PEU would change if all blood components 
were available at all times, the senior specialist responded that in that case the use of PC 
would increase and that the proportion of WB transfusions would decrease from 80% to 
55%.  
 
Child Health General Wards 
 
Two house officers and one resident were interviewed in the Child Health wards. All three 
were aware that the blood bank produced WB, PRBC, FFP and platelets. All agreed that PRBC 
were the most needed in the wards, based on the conditions seen most often on the words, 
but most felt that there were times WB was more readily available and thus prescribed more 
often. PRBC were particularly required for treatment of severe malaria related anaemia and 
iron deficiency anaemia (often due to malnutrition) as they raise the haemoglobin level 
quickly and effectively. Platelets were seen to be the most difficult to obtain. According to 
one doctor: 
 
“We prescribe whole blood most often because it is easier to get, but packed cells are needed 
more but packed cells are not as easily available so we make do with whole blood” (House 
officer, Child Health ward) 
 
Another doctor cited delays in obtaining FFP and platelets, but seemed satisfied with the 
availability of WB and PRBC : 
 
“We have fresh frozen plasma…FFP. But sometimes we have challenges with it because 
for that one they need fresh blood. So if they are not getting fresh blood it’s difficult, but 
we do get them when we request. Platelet concentrates, there are also some delays. 
Platelet concentrates and FFP. But for the full blood and packed red cells we usually get 
them” (House officer, Child Health ward) 
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The same doctor went on to elaborate on the usage of WB and PRBC and explain how FFP 
shortages are managed: 
 
“We use more of the full blood and then the packed cells. […] Mostly […] one of the 
commonest ones is severe malaria so they’re usually packed cells. In cases where they’re 
bleeding, for example, haemophilia we give whole blood. And also some of the children 
are suffering from cancers like leukaemia we give whole blood, sometimes packed cells. 
Depending on the blood results…If it’s just the red blood cells or the Hb is down then we 
give packed cells, if there is platelet deficiency alone we give platelets concentrate. […] 
Compared to packed cells, [we give whole blood] because there is a need for it, but when 
you compare it to something like FFP, that one is more difficult to get. Sometimes if you 
don’t get FFP you give whole blood.” (House officer, Child Health ward) 
 
A paediatric resident echoed the houseman’s comments, stressing the difficulty in obtaining 
platelets as well as Factor VIII. In response to my question “Do you have difficulty obtaining 
any of the blood or blood components?”, he/she responded: 
 
“I think only the platelets – it takes time before they prepare it. They ask for relatives to 
come donate. They give some blood and pull the platelets out. Factor VIII too – it’s very 
difficult. At time it gets finished for the haemophiliacs. It comes in season. At times when 
there is no Factor VIII we give them whole blood. If we are lucky we give them Factor 
VII” (Paediatric Resident, Child Health ward) 
 
When probed further as to when platelets may be needed in paediatrics, the resident 
responded: 
 
“For thrombocytopenia. Cases of ITP (idiopathic thrombocytopenic purpura). And even 
for the leukaemias – before they do the bone marrow aspirate they have to build their 
platelets up before they go for the bone marrow.” (Paediatric Resident, Child Health 
ward) 
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Results from Interview in Medicine Unit 
 
A physician specialist was interviewed from the Medicine department. When asked about 
component production at KATH, the doctor responded that he/she was aware that 
components were available and included cryoprecipitate, platelets, whole blood, FFP and 
PRBC. According to the doctor, almost daily he/she requested for blood. PRBC were most 
often prescribed because it was most needed but that it being ‘readily available is one of the 
things’. Generally PRBC were most commonly prescribed for infection, patients with sickle 
cell anaemia and renal failure, whole blood for aplastic anaemia and leukaemia and FFP for 
DIC and liver failure. PRBC was preferred for sickle cell anaemia as it can increase a patient’s 
Hb level, without the volume overload. FFP is often used in those with liver failure and it can 
help improve a patient’s prothrombin time (note, prothrombin is made by the liver, and thus 
in liver failure blood may take longer to clot).The doctor said that platelets were difficult to 
obtain but that ‘we don’t see so many things we require platelets. Maybe chronic liver disease 
with decreased platelet count’.  
 
The specialist was unaware of any official guidelines for component usage and felt that the 
introduction of guidelines could help guide clinicians on component prescribing.   
 
Results from Interviews in Surgery Unit 
 
Two members from the Surgery Unit participated in the study – one was a house officer who 
had spent three months in the unit and the other was a consultant. Both were aware that 
blood components were available at the hospital, and both listed whole blood, PRC, FFP and 
platelet concentrate as examples.  
 
When asked what is prescribed more often, the consultant replied: 
 
“Most often is packed cells. […] Well, if there’s whole blood we take whole blood, but most 
of the time we have packed cells. But if there is whole blood, most of them in surgeries 
have hypovolaemia due to blood loss so we have whole blood. […] You see normally we 
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request for whole blood when we need fresh blood […] but otherwise I think the blood 
bank normally have packed cells, I’m not too sure” (Consultant, Surgery department) 
 
The consultant estimated that 65% of the blood components prescribed [in his/her field] 
were PRBC, 30% whole blood and 5% FFP. According to the doctor anaemia was the most 
common reason for PRC transfusion, whole blood was used to replace blood volume (e.g. 
patient has lost a lot of blood in surgery) and FFP when ‘we’ve done a massive transfusion – 
more than 4 pints, or when platelets are low [and platelets are unavailable]’. 
 
When asked whether PRBC were “prescribed most often because they’re most need, they’re 
more readily available or a combination of the two”, the consultant responded: 
 
“Because they are most readily available”. 
 
When asked how component usage would change if all blood components were equally 
available, he/she said they would prescribe WB more, estimating that 80% of transfusions 
would be WB and 15% PRBC.  
 
In contrast, according to the doctor in the wards 75-80% of the components prescribed were 
whole blood and 15-20% PRC, with platelets and FFP rarely transfused. In the wards, whole 
blood was most often required for loss of blood, anaemia, haemorrhage and shock, while PRC 
was used for severe anaemia. The houseman felt that whole blood was prescribed partially 
because it was most needed but also because it was more readily available and that if all 
components were available, the proportion of whole blood to PRC prescription would 
change to 50:50.  
 
The consultant felt that increased knowledge about components was needed among doctors 
as he felt that the correct component was not always prescribed, though he was not sure 
whether this was due to difficulty procuring certain components, however this sentiment 
was not echoed by the houseman. The consultant gave the following example: 
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“I’ve seen people prescribe fresh frozen plasma when the patient needs platelets. 
Whereas fresh frozen plasma does not contain platelets. So he needs platelets but he 
asks for fresh frozen plasma, which does not contain platelets. So the knowledge impacts 
on the prescription habits.” ((Consultant, Surgery department) 
 
The consultant suggested that increased education through workshops or meetings would 
be useful in improving how blood components are prescribed. The houseman felt that 
greater communication between the blood bank and doctors was needed so that doctors 
were aware of what the blood bank had in stock. He/she also thought that a more detailed 
blood request form would be beneficial to differentiate between urgent cases. Both doctors 
felt that published guidelines on component usage would be useful and were unaware of any 
current guidelines.   
 
The consultant did emphasise that over the years things have improved in terms of blood 
transfusion services. He explained:  
 
“Most of the time they have the blood available. […] [Some of the improvement] now 
they have a dedicated head of unit [who] is a clinician who can understand issues and 
anytime we have problems we can easily fall back upon. Now they have components, 
before it was only whole blood. No you have packed cells, platelets FFP.” 
 
 The main challenges expressed by the consultant were that rare blood groups were 
sometimes not in stock and that it was difficult to obtain large quantities when needed. 
Similar positive aspects were mentioned by the houseman, though he mentioned that when 
it came time to collect the blood he received it quicker if he went in person to collect rather 
than sending a nurse. His hypothesis was that:  
 
“ […} maybe the nurse doesn’t realise the urgency. Senior nurses don’t go. Junior nurses 
may not know as much about the patient’s condition” (House man, Surgery department) 
 
Results from Interviews in Obstetrics and Gynaecology (O&G) Unit 
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Two doctors in O&G were interviewed, one was a houseman who had been based in 
obstetrics for four months and the other a resident who had been there for one year and who 
had worked as GP before that. For these interviews, it is important to keep in mind that the 
unit is served by its own ‘mini blood bank’. This is a room within the O&G department with 
its own refrigerators which are capable of storing whole blood. The main blood bank 
transfers some units to the O&G ‘mini blood bank’ to ensure that blood is delivered more 
quickly, given the high demand and urgency of the cases in this unit. 
 
Both knew that components were available at the hospital and cited whole blood, PRC and 
FFP as examples. The resident also mentioned platelets. Both agreed that whole blood was 
the most of prescribed, largely for post-partum haemorrhage, ectopic pregnancies and pre-
eclampsia. PRBC are used particularly to increase Hb levels in gynaecological malignancies. 
According to the houseman about 60% of blood prescribed was whole blood, 30% FFP and 
10% PRBC. However, when asked if and how those proportions would change if whole blood 
and all blood components were all readily available at all times, the house man responded:   
 
“I think the prescription for packed cells for instance would increase. Because at times 
you request for packed cells and it’s not available so you have to just do your whole blood 
transfusion. […] I think packed cells might increase to about 20-30 percent. Whole blood 
would come down.” (Houseman, O&G) 
 
The houseman also specifically noted that it was nice that in acute situations patients do not 
need to find replacement donors, only if they receive three or more units are they usually 
asked. 
 
Results from Interviews in Accident and Emergency (A&E) Unit 
 
Two first year medical residents were interviewed from the A&E unit. Given the fast paced 
nature of this unit it was difficult to a) find participants from this unit and b) have a lengthy 
discussion with respondents. Both doctors were aware that components were available at 
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KATH and both provided similar responses regarding demand and usage, stating that whole 
blood was most often prescribed in A&E, largely because it was in fact most needed (usually 
for trauma), but both admitted that if all blood components were equally available, they 
would prescribe packed cells more often. According to one of the resident’s: 
 
“Whole blood [is prescribed most often] … 70% whole blood, 20% fresh frozen plasma - 
packed cells is not common… [Whole blood is prescribed] for trauma, haematuria, 
severe anaemia and carcinoma…for packed cells when the kids come in they have 
anaemia we want to give them packed cells…FFP is used when they have DIC 
(disseminated intravascular coagulation)” (1st year resident in A&E) 
 
The same resident was asked whether whole blood was prescribed more often because it 
was more needed, more readily available or a combination of the two, to which he/she 
responded:    
 
“Because it’s readily available, but also needed” 
 
When probed further to determine how the prescribing of blood components in A&E would 
change if all components were readily available, the resident replied: 
 
“Oh definitely we’d go in for the packed cells more […] [we’d prescribe] maybe 50% 
packed cells, FFP would stay the same and the remaining [30%) would be whole blood].” 
 
While one doctor was aware of both national and KATH blood transfusion guidelines, the 
other resident was unsure if KATH had their own guidelines as he/she had only been 
working at KATH for three months at the time of the interview and had not had a chance to 
familiarise his/herself with all the available guidelines and protocols. The two residents, 
however, felt that there was sufficient knowledge among doctors on blood components and 
that this was not impacting prescribing patterns.  
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Results from Interviews in the Oncology/Dialysis Unit 
 
One resident in the dialysis unit was interviewed. He/she had previously been based in the 
Medicine unit for five years. In this unit, ‘close to 100%’ of transfusions were packed cells. 
Generally, the main cause for transfusion in the unit was anaemia for chronic disease. 
According to the doctor: 
 
 “They mostly have anaemia of chronic disease. What you do here is mostly some come to the 
ward, most of the CKD patients. Unlike the other patients who are currently bleeding so we 
want to give the whole components of the blood to correct the anaemia […] but if the problem 
is only with the haemoglobin we try to put it up faster, so the packed cells help […]” 
(Resident in the Dialysis unit) 
 
Whole blood may occasionally be transfused for nephrotic syndrome as could FFP, if a 
patient’s albumin level was low. Platelets, however, were unlikely to be used in the dialysis 
unit. Thus, according to the respondent, PC were prescribed most because they are the most 
needed, and even if all components were widely available, demand from the unit would not 
alter. The participant was unaware of any published guidelines on transfusion policy, and 
while he/she  did feel that doctors had the necessary knowledge regarding blood 
components, he/she felt that additional training and an update on transfusion services 
would be helpful.  
 
Summary of responses by doctors according to unit 
 
Overall, it seems that there is demand for blood components and that they would be 
prescribed more often (compared to whole blood) in some of the wards if all components 
were more readily available. It is, however, important to note that while all the doctors 
interviewed felt that obtaining blood at times could be challenging, they unanimously 
praised the KATH blood bank for the strides they have made over the past few years, 
highlighting the impressive increase in blood component availability. This is a true testament 
to the progress the transfusion team has made. The table below illustrates common blood 
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components used in each of the hospital’s specialties and summarises which specialties 
blood requests’ are influenced by availability and to what extent.  
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7.7 Summary of results 
 Specialty Position Blood 
component 
most 
prescribed 
in the ward  
Does the ward 
ever have to 
prescribe 
alternative 
blood 
components 
because the first 
choice is 
unavailable? 
Would your 
blood 
prescribing 
pattern change 
if all blood 
components 
were readily 
available? If so, 
how? 
Participant 1 Child Health Houseman WB and 
PRBC 
No. “Though FFP 
difficult to 
procure 
sometimes”  
No 
Participant 2 Child Health Resident PRBC Rarely Yes. If factor VIII 
and platelets 
can’t be 
obtained, whole 
blood is 
prescribed 
Participant 3 Child Health Houseman WB Yes Yes. Would 
prescribe PRBC 
more (rather 
than WB) 
Participant 4 Child Health Specialist  WB No No 
Participant 5 Child Health Houseman WB/PRBC Yes Yes. WB needed 
for neo-natal 
jaundice (NNJ), 
but PRBC 
prescribed often 
because it is 
readily available 
Participant 6 Child Health Houseman WB No No 
Participant 7 Medicine Specialist PRBC No No 
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Participant 8 Child Health Senior Specialist WB Yes Yes. WB 
requests would 
drop from 80% 
to 55%. PRBC 
would be 
prescribed more 
often.  
Participant 9 Surgery Consultant PRBC Yes Yes. PRBC would 
be prescribed 
more often than 
WB 
Participant 10 O&G Resident WB Yes Yes. If platelets 
were more 
easily obtained 
more they 
would be 
prescribed 5X 
more. 
Participant 11 O&G Houseman WB Yes Yes. PRBC would 
be prescribed 
more 
frequently. 
Participant 12 A&E Resident WB Yes Yes. PRBC would 
be prescribed 
5X more often. 
Participant 13 A&E Resident WB Yes Yes. PRBC would 
be prescribed 
more. 
Participant 14 Surgery Houseman WB Yes Yes, PRBC would 
be prescribed  
2.5-3X more 
often 
Participant 15 Dialysis Resident PRBC No No 
 
 
Table 7.5 – Most common blood components prescribed on wards according to clinicians interviewed 
and whether infinite blood component availability would result in a change in their prescribing pattern 
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7.8 Discussion 
 
Researchers in South Africa have advocated for the use of component therapy in low and 
middle income countries, arguing that in areas of limited blood supply a single donated unit 
can have a greater effect and benefit more people when separated into components (Erhabor 
and Adias, 2011) – an argument that has been made by many high income countries who rely 
exclusively on components. In fact, the WHO also advocates for all countries to move towards 
component therapy, but there is insufficient evidence to demonstrate how or to what extent 
this will change outcomes in low and middle income countries. To understand this, we need 
to have a better idea of the needs of regional blood banks (for example, what blood 
components their clinicians require most) as well as take into account the cost of component 
therapy and consider how to best manage limited resources, including what services can be 
provided and those that may need to be cut, while maximising the best patient outcomes.   
 
The aim of this part of the study was to address sub-objective 3: 
 
‘Quantify component usage and demand, understand its influencing factors and determine 
whether the appropriate amount of resources is being utilised.’ 
 
Data presented in KATH’s Annual Report (2011) indicates that the number of donors willing 
to donate blood and the number of units of blood collected are both increasing (see section 
2.3.1.2), which explains the increased satisfaction by staff with regards to blood availability. 
Past years’ data and anecdotal evidence from blood bank staff members indicate that the 
blood bank’s aim is to continue to increase the proportion of their blood units converted to 
components. Based on the results from this study, it is evident that there is significant 
demand and use of whole blood across all of the hospital’s specialities. Currently, the demand 
for whole blood far outnumbers the demand for any other blood component. However, there 
is a considerable demand for packed cells, which represented nearly ¼ of the blood 
component requests. Moreover, past data suggest that the demand for components is 
growing. A similar trend has been witnessed in Namibia and has been attributed to the 
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changing health needs of the population (Pitman et al., 2015). For example, HIV/AIDS 
treatment has improved and the prevalence of chronic illnesses, such as malignancies, is 
increasing (consequently, there is increased use of FFP in Namibia, as it is use in patients 
with cancer) (ibid).   
 
As stated earlier, I was unable to obtain the calculations used to estimate component 
production. Several doctors admitted that if all components were equally available the 
amount of whole blood and components prescribed would alter.  However, other doctors 
also highlighted the need and importance for whole blood in situations of trauma and 
extreme blood loss. Thus, 100% component production may be unnecessary at KATH at the 
moment. To better approximate component demand, it would be useful to conduct another 
yearlong study with an added section on the blood request forms which asks ‘what 
component is preferred if all are available?’. It would also be helpful if the doctors could 
justify their preference so it can be determined to what extend in each case the use of a 
different component might alter the patient’s outcome. This would provide a more accurate 
estimation of blood component needs to which the blood bank could work towards.  
 
7.8.1 Demand exceeding supply 
 
Weekly stock levels provide a snapshot view of the number of blood components available 
at a moment in time, while data collected regarding blood component requests indicates that 
on average 47 units of whole blood are requested each day. As mentioned earlier, this figure 
is likely an underestimation as additional requests received within seven days of the initial 
request are not recorded in the requests log book. Given that stock levels for whole blood 
varied from 25-359 units, it is likely there is a high turnover rate of whole blood units and 
there may be days when demand exceeds supply.  
 
There were several instances where WB, PRBC and FFP were available for O- blood type. 
Patients with O- blood can only receive O- blood, meaning that any patients requiring a blood 
transfusion would have to wait until a unit became available. O- blood is referred to as the 
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universal donor and its supply levels are vital for any blood bank as it can also be used in 
emergency settings when there may be no time to group or cross-match a patient’s blood. At 
KATH, the blood bank tries to avoid a situation where a given blood group’s supply is 
depleted, by calling blood donors with the needed blood type to come and donate.  A similar 
approach is taken by the American Red Cross (2016) – when supply is low, the organisation 
calls on eligible donors with O-, A- and B- blood to donate. However, as illustrated by the 
stock levels, this strategy is not providing sufficient results.   
 
In addition, the pattern of blood demand at use at the hospital by each speciality may be 
unique to KATH given that it has the largest A&E in the region and is thus the main trauma 
centre. Given its tertiary regional hospital status, the O&G department may also attract more 
complicated pregnancies and thus the risk of PPH may be higher than in smaller, lower 
hospitals. All of this results in an increased demand of blood from these two specialities. The 
proximities of the blood bank and mini-blood bank to these specialities, however, minimises 
delays in obtaining blood. 
 
 
7.8.2 Discarding blood components 
 
The majority of discards were due to expired units, most of which were AB+. One way to 
minimise this may be to temporarily defer donors with known AB+ blood when stock levels 
are high. However, it is important to consider the impact a temporary deferral may have on 
the donor. As discussed in Chapter 6, temporary deferrals may discourage blood donors from 
returning. An alternative would be to phone nearby hospitals, when KATH’s AB+ blood stock 
levels are high, and determine whether they could use extra units of AB+ units, to prevent 
wastage.  
 
There were also a high number of discards due to syphilis, but by screening blood for active 
infections post-donation, the donor clinic can avoid deferring potentially safe and healthy 
donors. The alternative would result in few successful blood donations and thus a lower 
supply. 
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7.8.3 Blood component demand according to clinicians and how demand 
might change if all blood components were consistently available 
 
Results from the interviews with prescribing doctors indicates that demand for components 
may increase if they were more readily available. However, it should be noted that while 
many doctors felt that certain components (namely packed cells) might be prescribed more 
often if there was a greater supply, they still felt that in many cases whole blood was the 
blood component most needed. This is an important finding, because it suggests that while 
the KATH’s blood bank is on the right track, aiming to slightly increase its component 
production each year, current data suggest that it would not be suitable for the blood bank 
to shift to component production exclusively as this would not necessarily meet the needs of 
the hospital. This is in contrast to blood banks in high income countries, which in most cases 
have done away with whole blood and rely exclusively on components.  
 
It can, however, be argued that the lower demand for blood components may be due to 
insufficient knowledge regarding components and their usage. The responses from 
prescribing doctors varied with regards to this, with some confident that all doctors had 
sufficient knowledge regarding components and that the demand levels reflected need and 
availability, while others felt that increased training on component usage would result in 
increased component prescription from doctors. Indeed, this may change given that 
according to the more junior doctors, component usage and prescription is a part of the 
medical degree curriculum. However, further research should be conducted to better 
understand what training the doctors are seeking, particularly since the blood bank 
organises and provides training in this area.  
 
In addition, regular studies regarding component therapy and doctors’ blood prescribing 
habits should be conducted to correctly identify when the blood bank has achieved the 
perfect balance between whole blood use and component production. As long as there 
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remains a significant demand for whole blood, from a practical and economic standpoint, it 
does not seem necessary to shift to exclusive component therapy.  
 
7.9 Limitations  
 
Below are a list of challenges faced in obtaining the necessary data and any implications they 
may have on the results of this study: 
 
1. Obtaining blood stock levels – To obtain regular, weekly blood stock levels, I had to rely 
on a member of the blood bank team to record the stock levels for me, as I was not 
qualified to deal with blood components could not be responsible if any damages or loss 
occurred. To provide 24/7 access to the blood bank, the employees’ work schedules are 
shift based, meaning the same person is not always working the same day of the week. It, 
therefore, took some time to organise a weekly stock level count and is these data were 
only recorded from August-December. While ideally a longer period of data collection 
would have provided greater validity to the study, the period of time covered included 
both the dry and rainy seasons as well as term time and school holidays – i.e. the times 
when demand and supply vary the most.  
2. Entering blood requests – All the blood requests are handwritten in record books at the 
blood bank. Entering these data daily onto the computer took the better part of the day 
most days. To reduce time consumption, we did consider employing a research assistant, 
but it was difficult to find someone who could devote the necessary time. Given that the 
data were initially handwritten, transcription errors were possible. To minimise this 
possibility, data entered were cross-referenced with the initial handwritten data. 
3. Discards – It was not clear what components were discarded, making it difficult to 
ascertain whether certain blood components are being wasted, and whether any specific 
components are being over produced. However, collecting weekly stock levels provides 
some indication of this, and generally component levels were on the low end. 
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4. Interviews with prescribing doctors – At times, it was difficult to identify senior level 
consultants to provide a wider spread of participants. In addition, it was challenging to 
find sufficient time to conduct some of the interviews given the doctors’ heavy schedules. 
 
7.10 Conclusion 
 
Overall, whole blood is still in high demand at KATH and while doctors do prescribe 
components regularly and would prescribe them more often if they were more readily 
available, many still feel that whole blood is most needed. The KATH blood bank has clearly 
made excellent progress in providing greater accessibility to both whole blood and 
components over the past few years and this has been acknowledged and greatly 
appreciated by all doctors interviewed. However, if clinicians feel that the need for whole 
blood transfusions remains high, it may be necessary to maintain both whole blood and 
component therapy at KATH. Thus, despite the WHO’s recommendation for component 
therapy, further research should be conducted to determine the health outcomes and 
financial impact exclusive component therapy would have at KATH, before determining 
component production targets. 
 
 
 
 
 
 
 
 
 
 183 
Chapter 8 – Blood transfusions in patients 
 
8.1 Introduction 
 
Most policy recommendations regarding blood transfusions relate to blood donors, the vein-
to-vein process and haemovigilance. The most common recommendation concerning 
patients is to obtain informed patient consent prior to transfusion. There is no evidence on 
how often this occurs nor the challenges doctors may face in obtaining consent. Additionally, 
there is limited research on patients’ experiences in receiving blood transfusions and any 
challenges they may face.  For example, replacement donors remain common in sub-Saharan 
Africa and at the Komfo Anokye Teaching Hospital they accounted for 34.3% of blood 
donations in 2013 (KATH, 2014), but there is no data concerning patient experiences in 
securing a replacement donor. This chapter presents results from twenty-four semi-
structured interviews with patients from varying units of the hospital and is complemented 
by data obtained from semi-structured interviews with doctors prescribing blood 
transfusions. Interviews with patients were conducted in English or Twi.  Mr. Maxwell 
Owusu provided translation assistance. Interviews with physicians were conducted in 
English. All interviews were audio recorded and transcribed, and a list of responses for each 
topic was created. Common responses were grouped in themes and the transcripts were 
reviewed to identify helpful quotes. 
 
8.2 Informed Patient Consent 
 
Not all patients were made aware of their transfusion prior to receiving the transfusion, 
and only some were informed about both the risks and benefits. Doctors from different 
units were interviewed to determine how they addressed the issue of informed patient 
consent when transfusing patients with blood and to understand why patients may not be 
given more detailed information about the risks of blood transfusions. 
 
 184 
8.2.1 Clinician Participants Profile 
 
Fifteen physicians of varying levels from all different units and who were involved in 
prescribing blood transfusions were interviewed. Physicians were approached in the 
wards, explained the study and asked if they would be willing to participate. This initially 
led to an overrepresentation of House Officers. Thus, using existing contacts in the hospital 
and contacts made through study participants, individual residents and specialists were 
approached to partake in the study. Below is a brief description of the doctors interviewed 
based on the hospital unit they were working in at the time of interview.  
 
• Two A&E Residents 
• Four Child Health House Officers 
• One Child Health Resident 
• One Child Health Specialist 
• One Child Health Senior Specialist 
• One Medicine Specialist 
• One O&G House Officers 
• One O&G Resident 
• One Dialysis Resident (had previously been based in Medicine) 
• One Surgery House Officer 
• One Consultant in Surgery  
 
8.2.2 Is informed patient consent sought? 
 
Doctors were asked whether informed consent was sought from patients needing blood 
transfusions. The responses were mixed. 
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‘Yes, informed consent is sought’ 
 
The majority of participants said that informed consent was obtained from patients. 
Generally consent was sought orally, though a couple of doctors said there were cases 
where written consent may be documented. For example, according to one doctor, consent 
for blood transfusion is part of the general surgical consent form. In some cases doctors 
admitted that while generally oral consent was obtained, it was not consistently sought. 
For example: 
 
“No written consent required. [Oral consent] is not strictly enforced” [Physician 
specialist In the Medicine Unit] 
 
When informed consent is sought, the current condition of patients and why they require 
blood are explained to them. In addition, the risks and the benefits of the transfusion is 
explained. One doctor also mentioned that the risks of transfusion are explained to the 
patients, while a couple others admitted that the potential risks and complications arising 
from transfusion are not always discussed. 
 
“Limited information on complications is provided … no reason, but more literate 
parents ask questions so it is not practical” [Senior specialist in Child Health] 
 
“[Risks?] Normally we don’t tell them.” [House Officer in O&G] 
 
“[Risks?]  Not so much, but if they ask we do” [Resident in A&E] 
 
“Honestly, we don’t go into much details about the risks.” [Resident in O&G] 
 
The doctor from the dialysis unit, however, stated that patients were told of any expected 
reactions with blood transfusions. According to him: 
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“Patients are told about their blood group, what component is given, why they need 
blood and any expected reactions.” [Resident in the Dialysis Unit] 
 
 
No consent is sought 
 
A resident and a specialist in Child Health both said that no consent was sought for blood 
transfusions. According to a consultant in Surgery, generally verbal consent is sought but: 
 
“If patient is unconscious we hardly tell them afterwards. Some patients may not be 
aware of the transfusion.” [Consultant in Surery].  
 
Unsure 
 
The resident in the Dialysis unit provided information patients are given, but was unclear if 
consent was regularly sought and if so, how. According to this participant, the nurses 
handle this aspect. 
 
 
8.3 Results from patient interviews 
 
8.3.1 Patient Participants Profile 
 
Following two pilot interviews, twenty-four patient interviews were successfully completed 
across six of the seven main hospital units, as identified by the KATH blood bank. They were 
conducted throughout the year, during periods of both high and low blood component 
demand, and high and low supply. Patients were interviewed 24-48 hours after their last 
transfusion. Three patients from A&E were interviewed, seven patients from Child Health, 
four from the Medicine unit, four from the O&G unit, one from Oncology and five from 
Surgery (see Figure 8.1). All interviews in Child Health were conducted with the patients’ 
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mothers. Though multiple attempts were made to recruit participants from the Dialysis unit, 
there were limited numbers of transfusion patients in this unit and nearly all eligible for the 
study left the hospital shortly after transfusion.  
 
Patients’ age ranged from 5 days to 70 years, with the average age being 27.0 years old. 
15/24 patients were male whereas only 10/24 of the participants interviewed were male, as 
five of the participants were the mothers of male children. The education level of participants 
ranged from none to post-secondary, with the majority having completed some form of 
secondary school, either junior high school (JHS) or senior high school (SHS) (16/24). One 
participant had not attended school, two had completed up to primary school level, two had 
not finished primary school, one was enrolled in a post-secondary institution and one had 
completed post-secondary schooling. One participant did not disclose his educational 
background. Household income ranged from 1-200 Ghana Cedis/day with an average income 
of 18.1 cedis/day.  
 
 
Figure 8.1 – Patient participant distribution according to hospital speciality 
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8.3.2 Patient experience in obtaining blood 
 
8.3.2.1 Patient understanding of blood transfusions and their need for blood  
 
Need for transfusion 
 
Nearly every patient or caregiver interviewed was advised about their blood transfusion and 
why it was necessary. Patients were generally spoken to before receiving blood, but in cases 
where the patient was unconscious during transfusion the patient was advised once they 
regained consciousness. One patient, a nineteen-year-old male, was not personally told he 
would receive blood, but according to him his parents were given the information. Based on 
participants’ responses, most patients were provided with similar reasons for transfusion, 
which are presented below. 
 
Anaemia/Low Hb 
 
The most common reason for blood transfusion was anaemia and/or low Hb. Patients who 
were told they were receiving blood for this reason were male and based in the Medicine and 
Child Health units, though there were also individual cases from Surgery, O&G and A&E. 
Among those transfused for anaemia or low Hb, there was no association between 
participants’ education level and the information they received. For example, when asked 
what reason(s) staff gave for his need for blood, the only respondent who had completed 
post-secondary education answered:  
 
 “They said I’m pale.” (Male, 36 years old, Medicine Unit, HND Accountancy) 
 
Another respondent with junior high school education answered: 
 
 “They told me I am anaemic and need blood.” (Male, 45 years old, Medicine Unit, JHS) 
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Insufficient amount of blood 
 
A second popular reason given to patients needing blood transfusions was they had an 
insufficient amount of blood or had lost a considerable amount of blood. Again, there was no 
association between education attainment and information received, as described by 
participants. Only one respondent had completed SHS. Both men and women were 
transfused due to loss/shortage of blood and at the time of interview and these patients were 
admitted in the A&E, Medicine, Surgery and O&G units. ‘Loss of blood’ was the most common 
reason for transfusion by patients in the Surgery unit.  
  
“I was told I would need blood because in the operation I lost a lot of blood and I need 
blood to replace it.” (Male, 38 years, Surgery Unit, SHS). 
 
“They say I don’t have enough blood […] the blood transfusion will help me gain blood” 
(Male, 50 years, A&E, <Primary School) 
 
No reason 
 
According to some respondents, they did not receive any information as to why they were 
being transfused. When probed further as to whether they asked staff questions about the 
transfusion, only one participant sought additional information regarding the need for 
blood. 
 
Other reasons 
 
Jaundice 
 
There was one case of neo-natal jaundice observed. The mother of a baby boy five days old 
was told that her child needed blood because he had jaundice. According to the respondent: 
 
“They said the child needs blood because of jaundice.” (Female, No age, Secondary 
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school, Child Health) 
 
Cancer 
 
A 62 year old female participant in the Oncology unit was told that she was receiving blood 
because she has cancer. The participant, however, had forgotten which type of cancer and 
said her son knew this information.  
 
Information patients received regarding blood transfusions 
 
No information 
 
All participants were asked whether they were made aware of their blood transfusion and 
if so, when they were told and what information they were given. Aside from the reason(s) 
for transfusion, the majority of respondents claimed to have received no information about 
blood transfusions.  When further probed, a few listed some benefits and a couple were 
advised to pay attention to adverse reactions. 
 
Other information 
 
Benefits 
 
Some patients were told that following blood transfusion their condition or symptoms (e.g. 
low Hb) would improve. For example: 
 
“They said if he receives the transfusion the symptoms of jaundice will decrease” 
(Female, No age, Secondary school, Child Health) 
 
“I was told I would need blood because in the operation I lost a lot of blood and I need 
blood to replace it.” (Male, 38 years, Surgery, SHS) 
 
 191 
“I was told I would be strong.” (Male, 26 years, Medicine, SHS –  currently enrolled in 
university) 
 
Potential adverse reactions 
 
Two participants were indirectly made aware that they may experience some adverse 
reactions. According to one respondent: 
 
“I was told if I experienced any difficulty during transfusion to tell staff, but I didn’t have 
any difficulty.” (Female, 22 years, O&G, SHS) 
 
The second participants was more specifically advised: 
 
“[…] if when I get blood it is itching to let them know” (Male, 56 years, Surgery, JHS) 
 
Information patients requested from staff (i.e. nurses or doctors) regarding blood 
transfusions 
 
None 
 
Most of the patients interviewed did not pose staff any questions relating to blood 
transfusions. When probed as to why not, patients said they had nothing to ask: 
 
 “I was told I was pale so I didn’t have any other questions.” 
 
 “I had nothing in mind to ask them” 
 
Towards the end of each interview patients were asked if there were any other blood 
transfusion related issues they would like to discuss. Two participants discussed 
experiencing an adverse reaction during or post transfusion (e.g. itching). These 
respondents were asked whether they have made any of the staff aware of this.  
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According to a pregnant woman in O&G suffering from severe anaemia: 
 
 “I felt dizzy after the blood transfusion” [Female, 24 years, O&G, JHS]. 
 
According to the patient she did not make any staff members aware of this because “It went 
away on its own”. 
 
Another patient responded: 
 
“After blood transfusion my stomach has become big. Itching started last night. There 
was no doctor so I told the nurses and they paid no attention.” [Female, 70 years, O&G, 
JHS]. 
 
Other information 
 
Blood Group 
 
One patient asked the nurse transfusing him what blood group he was receiving. The 
patient was aware of his blood group and wanted to ensure that he was receiving the same 
group. 
 
Purpose of the transfusion 
 
One of the participants asked staff why he needed the transfusion and was told he would 
get better. According to the patient, this was a satisfactory response. 
 
Necessity of transfusion 
 
One patient remained unconvinced regarding the need for transfusion and was at first 
hesitant to consent to transfusion. According to this patient: 
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“[…] I asked them whether it was necessary.[…] That yes it would me because my Hb was 
not high enough. At first I didn’t want the transfusion but after the explanation I 
accepted it.” (Female, 41 years, Surgery, Not provided) 
 
Adverse Reaction 
 
One mother brought to the attention of a doctor a potential adverse reaction the child may 
have suffered as a result of transfusion: 
 
“One day after transfusion there were rashes on his stomach. I told the doctor. I am 
waiting to hear from doctor”. [Patient: Male, 3 years, Child Health, NA; Respondent 
was the child’s mother: Female, unknown, NA, primary school] 
 
 
8.3.3.2 Difficulties associated with the transfusion according to participants 
 
None 
 
The majority of participants responded that they had no difficulties with regards to 
obtaining blood or the transfusion itself. According to these participants, it did not take 
long for them to receive the blood. When further probed as to how long it took, the answers 
varied from “about five minutes” to “the next day”, indicating the time elapsed from when 
the patient first found out they would require a blood transfusion to when the transfusion 
began. One patient responded: 
 
“They went to collect the blood but it wasn’t ready but it didn’t take long […] 2-3 hours” 
(Female, 41 years, Surgery, Not provided)  
 
Another patient similarly responded: 
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“[…] it took about 2 hours […] To me it is not long.” (Female, 35 years, Surgery, JHS) 
 
Time elapsed in obtaining blood for transfusion 
 
While the majority of patients did not express any difficulties with obtaining blood, 
according to three participants it took long to receive the blood, with the time ranging from 
one to three and a half hours. All three patients were admitted in the A&E unit. One patient 
responded: 
 
 “Three and a half hours […] it’s a long time!” (Male, 50 years, A&E, Form 4) 
 
Another patient similarly responded: 
 
 “It took an hour to get blood. It took long.”  (Male, 24 years, A&E, SHS). 
 
Other 
 
Difficulty finding a vein 
 
One participant discussed difficulties staff had with finding her child’s vein. She said: 
 
“They had a difficult time inserting the needle.” (Female (patient’s mother), unknown, 
Child Health, Primary) 
 
Weakness 
 
One mother mentioned that her child was “weak and crying” when probed about any 
difficulties experienced with regards to the blood transfusion. 
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8.3.3.3 Securing replacement donors: Patients’ perspectives 
 
 
Of the twenty-four patients who took part in this study, seventeen were requested by 
hospital staff to find one or more replacement donors, 11/17 of whom were male. 5/17 were 
admitted to the Surgery unit, 4/17 to Medicine, 3/17 to A&E, 3/17 to O&G and 2/17 to Child 
Health (see Figure 8.2). Every patient interviewed in the Surgery unit was asked to find 
replacement donors. Note, in this study, none of the surgical patients were in for elective 
surgery. The number of transfusions these patients had received at the time of interview 
ranged from one to five, with the average being 2.6 blood transfusions. Highest level of 
education achieved by these participants ranged from primary to post-secondary. 
 
 
Figure 8.2. Distribution of participants requested to find one or more replacement donors according to unit 
admitted in 
 
At the time of interview, six patients had not been requested to secure a replacement donor, 
4/6 of who were male. 5/6 of these patients were admitted in the Child Health unit and 1/6 
in O&G. 4/6 of the patients had only received one transfusion while the remaining two 
patients had received two and three transfusions each. The average number of blood 
transfusion patients, who were not approached to find a replacement donor, received was 
2
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1.5. Education level among these participants ranged from nil to JHS. 
 
One female patient from the oncology ward with primary school education and who had 
received five transfusions was unsure as information concerning her transfusion was given 
to her son.  
 
Timing of replacement donors’ blood donation with regards to patients’ blood 
transfusions 
 
Pre-Transfusion 
 
Some patients were asked to secure replacement donors before their blood transfusion. 
This was most common among surgical patients, particularly for scheduled surgeries. The 
time elapsed between donation and transfusion varied. For example, one donor with a 
scheduled surgery said: 
 
 “They donated one week before my operation” (Male, 38 years, Surgery, SHS) 
 
In contrast, another donor received the blood one day after his replacement donor donated.  
 
Between multiple transfusions 
 
Patients receiving multiple units  were often asked to find replacement donors as needed. 
As patients received additional blood transfusions they were asked to find additional 
replacement donors. For example: 
 
“After the first one my brother came, after the second my other brother came, after the 
3rd one my sister came and after the 4th another sister came. Any time I was given blood I 
was told I have to find someone to come and replace.” (Female, 22 years, O&G, SHS) 
 
“I was first asked a week ago. I brought someone before the first transfusion. Then asked 
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to bring two more people as needed.” (Male, 56 years, Surgery, JHS) 
 
In one case, the patient received the first unit before finding a replacement donor but 
required additional transfusions and was told to find donors. According to this patient: 
 
“I got the first unit in 30 minutes. But they told me to get two people to come and donate 
blood. No one has come. I am still waiting for donors.” (Female, 39, O&G, JHS).  
 
Post-Transfusion 
 
Patients were sometimes asked to find a replacement donor post-transfusion. This was the 
case for one of the patients admitted in the Child Health unit: 
 
“My husband donated after my child’s transfusion” (Female [patient’s mother], unknown, 
Child Health, SHS) 
 
Number of people patients approached to donate blood 
 
The number of people that patients or their caregivers approached to act as replacement 
donors ranged from zero to six, whereas the number of people who successfully donated 
blood for a given patient ranged from zero to four. One patient was unable to find anyone to 
donate blood. Another patient was asked to find three replacement donors, but three had 
low Hb and could not donate therefore he approached three more individuals. In contrast, in 
some cases patients were able to find more replacement donors than requested. 
 
 
 
 
 
 
Relationship between patients and replacement donors 
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Immediate Family 
 
Most patients interviewed requested their immediate family members to act as their 
replacement donors. This included parents, siblings and children. 
 
Extended Family 
 
In some cases the replacement donors secured were more distantly related to the patient. 
For example, nieces, nephews, in-laws and other relatives donated for some of the patients 
interviewed. 
 
Other 
 
Friends 
 
In rare cases, patients said their friends or family’s friends had donated blood for them  
 
Tenants 
 
In one case, the replacement donors for the patient were her tenants. 
 
Difficulty securing replacement donors? 
 
“No difficulties” 
 
The majority of participants interviewed stated that they did not encounter any difficulties 
in finding the requested number of replacement donors. These patients relied on immediate 
family, extended family and friends to act as replacement donors. The number of donors 
these patients were requested to find varied from one to four. 
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“Some difficulty” 
 
Some patients did express some difficulties in finding replacement donors. The number of 
transfusions these patients received and the number of replacement donors they were 
requested to find varied between one and four. Most common was that the patient did not 
know anyone available to ask. Below are examples of these patients’ responses: 
 
 “Yes. It is difficult. I live alone.” (Male, 26 years, A&E, SHS) 
 
“My husband and two brothers are not around so I asked tenants. I don’t know when 
they will come.” (Female, 39 years, O&G, JHS) 
 
In one case, the patient had successfully found three replacement donors, but struggling to 
secure a fourth, as requested: 
 
“[No difficulties] to get the first three. My husband has now gone to our hometown in the 
Western region to find the fourth.” (Female, 35 years, Surgery, JHS). 
  
In another isolated case the patient suggested that he was having difficulty finding 
replacement donors who possessed the same blood type as the patient.  
 
“Yes. I have B+ and their blood is not B+. If they had B+ I could take their blood.” (Male, 
50 years, A&E, Primary) 
 
Gift/compensations provided by patients to replacement donors 
 
Donors were asked whether they had or would consider giving any type of gift or 
compensation to their replacement donors. Below are the results: 
 
 
None 
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Most patients said that they would not give their replacement donors any gifts or 
compensation. Generally this was due to the close relationship patients had with the donors, 
and thus patients did not feel obliged to provide any compensation. For example:  
 
“No [I did not give them anything] because they are my brothers and sisters.” (Female, 22 
years, O&G, SHS) 
 
“Oh, they are my good friend. I don’t have to give.” (Male, 36 years, Medicine, post-
secondary) 
 
 
Other 
 
Food – In some cases patients provided or planned to give their replacement donors with 
food items such as local food or soda drinks. In these cases, donors did not ask for any food 
items and patients provided this free willingly. For example: 
 
“If they donate I will give them milo or malt […] no, [the donors] did not ask for anything.” 
(Female, 39 years, O&G, JHS) 
 
Money – There were cases where patients compensated (or were willing to compensate) 
their donors with money. In one case the donor was having difficulty finding replacement 
donors and said he would be willing to negotiate a price with potential donors, though he 
was unsure of what would be a fair price. In another case, the patient’s grandmother gave 
the patient 10 Ghana Cedis to give to the donor (the patient’s brother-in-law), though the 
donor had not requested anything. In an isolated case, the patient provided monetary 
compensation to the donor because the donors had asked for it. According to this patient: 
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“I gave food before and after I will give money […] I gave them Banku, 40 cedis per 
donor […] the donors asked for the money.” (Male, 38 years, Surgery, SHS) 
 
In the above case, the three donors were the patient’s brother and cousins. In total the 
patient paid 120 cedis for three replacement donors. The patient’s own income was quoted 
as 20-30 cedis per day, meaning the patient spent 4-6 days worth of income to secure three 
replacement donors.  
 
Unsure -  In a couple of cases the patients were unsure if the donors had been provided 
with anything as their family members had helped find and secure the donors. 
 
8.3.3.4 Patient incurred costs associated with blood transfusion according to 
participants 
 
Unaware of any costs 
 
Unanimously, all participants were unaware of any costs associated with the blood 
transfusion. One participant had been told there may be lab costs but was not told an amount. 
Another participant responded that he had not been told about any costs but speculated that 
they would be added to the final bill.  
 
8.3.3.5 Patients feelings regarding transfusion 
 
Interestingly, none of the patients expressed any fears or concerns regarding their 
transfusion. Their main interest was for their health to improve and the fact that the 
clinicians had told them that the transfusion would help them was enough to satisfy them. 
When one patient was asked if and why he consented to a blood transfusion, he responded” 
 
“Yes, I did. He told me I am anaemic. I was told I would be strong [post transfusion]” (26 
year old male patient in Medicine Unit) 
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As mentioned in Chapter 2, there are some people who believe that donating blood might 
lead them to become infected with HIV or hepatitis, yet this was not a concern mentioned by 
any of the patients. This suggests either a high level of trust in the clinicians and health care 
system or fear of asking more details or lack of knowledge regarding transfusions.  
 
One patient was particularly concerned about some symptoms he experienced during and 
post transfusion: 
 
“I [was] told I lost a lot of blood. […]. After getting the blood I had difficulty stretching my 
leg. […] It is better than before, but during the transfusion I sometimes felt a bit of 
dizziness” (40 year old male patient based in the Medicine Unit; Transfused 5 times during 
that hospital visit at the time of interview) 
 
The same patient was asked whether he made the staff aware of the symptoms, and he 
replied ‘no’. The fact that the patient divulged this information to me and none of the staff 
members suggests that perhaps patients are less likely to share this information on their 
own and need to be asked specifically whether they are experiencing any symptoms. 
 
 
8.4 Discussion 
 
8.4.1 Communication between hospital staff and patients receiving blood 
transfusions 
 
There is limited information concerning communication between hospital staff and patients 
in Ghana, including the challenges both parties face. Ensuring patients understand their 
health situation and treatment options is crucial to achieving improved treatment adherence 
and better outcomes. While the focus of this study is blood transfusions, the results from the 
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patient interviews highlight some positive links of communications between staff and 
patients while also revealing the presence of a communication gap, which may be present in 
other aspects of patient care. 
 
8.4.1.1 Obtaining informed consent 
 
Obtaining informed consent is a commonly recommended guideline in national blood 
policies. Informed consent requires that patients have a good understanding of the 
procedure at hand. The results from the interviews with physicians and patients indicate 
that generally at KATH oral consent for blood transfusion is obtained from patients, though 
not enforced. There did not appear to be any relation between a doctor’s ranking and his/her 
responses. 
 
8.4.1.2 Explaining the need for blood 
 
According to the patients interviewed, most were made aware prior to transfusion that they 
required blood and were further explained the need for transfusion. This is an important 
aspect in obtaining consent. The information provided did not appear to be influenced by a 
patient gender, age or socioeconomic group. While it appears that the information provided 
to patients is not extensive, it is important that patients receive information that can be easily 
comprehended by those with poor health literacy.  
 
There were, however, a few cases where patients were not told why they required blood. 
This may be due to numerous reasons such as limited staff resources, or the patient was not 
coherent or conscious. Regardless, from ethical and policy standpoints, it is imperative that 
staff members strive to ensure patients are well versed in their need for blood prior to 
consenting to the transfusion.  
 
 
8.4.1.3 Lack of communication about the risks of blood transfusion 
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While patients were commonly made aware of their need for transfusion, they were not 
made aware of the risks of transfusion. Paling (2003) argues “Effective risk communication 
is the basis for informed patient consent for medical treatment”. Indeed, patient 
understanding of both the benefits and risks of a treatment is imperative before a patient 
can provide informed consent. Additionally, educating patients on potential adverse 
reactions can help them and their caregivers identify early symptoms and report them to the 
health care staff, therefore potentially improving patient care and outcome. 
 
According to some of the doctors interviewed, patients are explained the risks or adverse 
reactions associated with blood transfusions. However, other doctors openly admitted that 
the risks are not often discussed with patients. This may be due to the difficulty in explaining 
risks to those with poor health literacy. For example, a study in Mali researching challenges 
in obtaining informed consent found that 93% of the participants in a malaria vaccine trial 
did not have a good understanding of the study’s side effects (Krosin et al., 2006).  It is also 
possible that doctors limit providing patients with information on the risks of transfusion as 
they fear it will deter the patient from treatment even when risks are minimal, There are 
ways to effectively communicate the risks of treatment and their probabilities. For example, 
doctors are advised to communicated the risk of a medical procedure to the risks associated 
with a common every day task (e.g. driving) (Edwards, 2003; Picano, 2004).  
 
Interestingly, according to one doctor interviewed, risks were not always explained because 
more literate patients or parents may ask more questions, suggesting that the doctor was 
not entirely willing to spend more time explaining the risks obtaining informed consent, a 
scenario Picano (2004) describes among radiologists.  
 
Based on Paling’s definition, the results from patient and physician interviews indicate that 
informed consent is not consistently sought among patients receiving blood transfusions at 
KATH. Not only is consent itself not always sought, but also patients not always properly 
informed about the transfusion. While it can be difficult to adequately explain health and 
risks benefits of a treatment to those with limited health literacy, efforts must be made to do 
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so using appropriate jargon. Health care providers must work together to adequately inform 
patients of the risks and benefits of treatment and test patients’ understanding to ensure 
they have truly understood before requesting consent from patients. 
 
8.4.1.4 Informed consent for underage patients 
 
Note that two of the doctors who said informed consent is not routinely sought were based 
in the Child Health unit. This may be due to the laws that govern child health, as stated in 
‘The Children’s Act: Act 560’ by the Republic of Ghana(1998) where doctors do not require 
parents’ consent if a procedure or treatment is deemed to be in the child’s best interest. 
 
8.4.1.5 Patient Staff Communication Pathway 
 
Interestingly, the vast majority of patient participants did not approach staff with any 
questions about their blood transfusion. This may be due to the fact that they were satisfied 
with the information provided. However, since most patients interviewed were unaware of 
the risks associated with blood transfusion, it is possible that they were unsure of what to 
ask, assumed that they have been provided with all the necessary information or were 
uncomfortable asking staff questions. When probed as to why patients did not pose staff 
questions about their transfusions, most patients responded that they had nothing to ask.  
 
There were cases where patients experienced a potential adverse reaction during or post 
transfusion but did not report them to staff members. According to one patient he didn’t 
want to bother the staff while another stated that he was paid no attention. One patient said 
the symptoms ‘went away on [their] own’. These responses may indicate a gap in patient-
staff communication. Patients should feel comfortable in asking hospital staff questions and 
should feel that their concerns will be heard and addressed. Additionally, patients must not 
feel that their concerns are unimportant as they may neglect to communicate important 
details that may affect their health. 
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8.4.2 Patients’ experiences securing replacement donors 
 
Replacement donors remain common in most African countries and account for a 
considerable proportion of donors at KATH (34.3%), in spite of the hospital’s many 
initiatives to collect blood from volunteer donors.  75% of the patients interviewed were 
asked to find at least one replacement donor. The majority of patients who were not 
approached to find replacement donors were admitted in the Child Health unit. This was 
interesting given that while children often require less volume of blood, the Child Health unit 
accounts for a large proportion of blood usage at KATH. All patients interviewed in the 
surgery unit, however, were asked to find replacement donors. In some cases the surgery 
was scheduled and thus these patients may have more time to secure a donor. 
 
Time of year the interviews were conducted will also have affected who was asked to donate. 
During peak donation periods, patients will have been less likely to be asked to secure 
replacement donors. Interviews with physicians show that there is no specific policy on 
when to ask patients to find donors. Some may ask after every transfusion, some ask if the 
patient has received multiple transfusions (often knowing the blood bank will request for 
blood) and others only ask if the blood bank requests the patient secure replacement donors 
(this generally occurs when blood stocks are low).  
 
There did not appear to be a link between patient/caregiver education level or household 
income and whether they were asked to find a replacement donor, suggesting that there is 
likely little to no discrimination on who is asked to find donors based on socioeconomic 
status. 
 
8.4.2.1 Relationship between patients and replacement donors 
 
Most patients’ replacement donors were immediate family members. In some cases they 
were extended family or friends and in rarer cases they were associated through business or 
work or the donor was unable to find replacement donors.  
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These results highlight the importance of family in Ghana. Also, in most cases patients said 
they had little difficulty finding replacement donors. When probed as to whether they would 
provide gifts or compensation to the donors, most patients replied ‘No’, explaining that the 
donors were good friends or close family. This is an important finding as there has been little 
research in the area of patient experience in securing donors. Advocates of 100% voluntary 
donors sometimes argue that finding a replacement donor adds to the patient’s burden, but 
the qualitative results from this study that for many this is not the case. This may not be true 
in other locations but it suggests that there is an important place for replacement donors in 
Ghana. Studies have shown that they are no less safe than first time volunteer donors and if 
most patients do not find it difficult to secure replacement donors, in a country like Ghana 
where there is difficulty meeting blood demands, it may prove worthwhile to continue to 
include replacement donors.  
 
The KATH has an interesting policy where patients are provided with blood regardless of 
whether they find donors, so long as the blood is available. Thus, patients are not compelled 
to find donors, and when they do, it can be argued that they are volunteers. Staff do, however, 
need to communicate with patients to determine whether they are experiencing difficulties 
in finding donors and take appropriate steps. In a couple of cases, patients found more 
donors than transfusions they received. Encouraging patients to bring in more donors than 
the patient required may be one way of limiting times when blood is unavailable.  
 
8.4.2.1 Gifts and compensation from patients to replacement donors 
 
As noted above, most patients did not provide their donors with any gifts and 
compensations. Some gave their donors something to eat, drink or a small amount of money 
as a thank you, but this was not requested by donors and was done free willing by patients. 
Thus, it can be considered more as a gesture of appreciation rather than compensation. 
There were, however, some cases where patients admitted to compensating donors because 
they had asked for money or where patients struggling to find replacement donors said they 
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would be willing to negotiate a price with potential donors. This illustrates that in spite of 
the hospital’s best efforts to eliminate paid donation, it still occurs. It is therefore important 
that staff encourage patients to communicate with them if they are having difficulties finding 
donors. In such cases, it might be better to waive this request for such patients. Also, asking 
donors periodically whether they have had to compensate donors may help identify 
potential risky units from paid donors before they are transfused.  
 
8.4.3 Patient awareness of costs associated with blood transfusions 
 
None of the patients interviewed were aware of any costs associated with blood transfusions. 
At KATH, patients are not charged for the blood, but they are charged 30 Ghana Cedis for 
blood grouping and testing. Some patients stated that they expected to find out about any 
costs when their final bill is prepared suggesting that they were more concerned with their 
total medical costs.  
 
8.5 Limitations 
 
There are some limitations to the interviews conducted with patients, which may impact 
the results. They are listed below. 
 
1. Interviews were conducted with patients 24-48 hours post transfusion. Consequently, 
the information recorded is based on a patient’s knowledge during that time period. It 
is possible that patients were later approached by staff a) to find a replacement donor 
or b) with information about the costs associated with blood transfusion. 
2. Most patient interviews were conducted in Twi. While follow up questions were asked 
to ensure translation was correct, it is possible that certain elements may not translate 
to English appropriately. 
3. Interviews were conducted at different times of the year, thus blood stock levels would 
vary and influence which patients were asked to find a replacement donor. 
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8.6 Suggested guidelines to supplement existing policy 
 
Below is a list of proposed guidelines to aid in the implementation of existing policy and to 
improve transfusion patients’ experiences. 
 
1. Ensure informed consent is sought when possible (e.g. patient is conscious) 
2. Develop and implement a framework across the hospital outlining exactly what 
information must be provided to patients to obtain informed consent. E.g. 
• Why is a blood transfusion needed? 
• What are the benefits of a transfusion 
• What are the risks associated with transfusion? 
3. Educate patients and their caregivers on potential adverse reactions associated with 
blood transfusions and when to alert health care staff  
4. Create an open and safe patient-staff communication atmosphere. Some suggestions to 
achieve this are: 
• Keep patients thoroughly up to date on their care using appropriate jargon 
• Encourage patients to ask questions and to take part in the decision making 
process of their medial treatment 
• Address patients needs and concerns in a timely manner 
5. During blood shortages, advise all units and staff involved with transfusions to 
encourage patients receiving blood to secure replacement donors 
6. Actively communicate with patients to determine whether they are having any 
difficulties finding replacement donors. In such cases, reassure the patient that in 
critical cases they will receive blood even if they have not secured any replacement 
donors, so long as the blood is available. 
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8.7 Conclusion 
 
Educating patients on the risks associated with blood transfusion and obtaining informed 
consent are important in providing patients with the tools needed to make appropriate 
decisions about their medical care. To achieve this, more efforts are needed to improve 
communication between health care staff and patients. Though most participants did not 
find it difficult to secure a replacement donor, there were some who struggled and these 
people were more likely to provide some type of financial or material incentive to secure 
donors. Thus, while replacement donors should not be excluded when blood is needed, 
staff members must communicate frequently with patients to identify those at risk of 
securing donors using financial or material incentives.  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 9 –Discussions and Conclusions 
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9.1 Summary of findings 
 
The review of Ghanaian and other African national blood policy documents highlighted that 
many of the common policies in place are non-specific and can be implemented in a variety 
of ways. Each national blood service, must therefore, conduct local research and assess how 
to implement the policies in a manner that best meets their population’s needs. 
 
At KATH, donor counselling was regularly conducted, but the results from donor interviews 
indicated preferential areas of counselling from donors. Most notably donors wanted to 
know more about their general health status and learn more about the donation process as 
well as post donation care. By encouraging open communication with donors and regularly 
requesting donors for their input on donor counselling and the donation process, donor staff 
can continuously update their counselling framework to best meet donor needs.  
 
An estimated 20% of donors in this study did not complete the donation process. 50% of 
these (therefore 10% overall) were permanently deferred due to a positive HIV, HBV or HCV 
test. The remaining were either temporarily deferred due to low haemoglobin, hypertension 
or voluntarily left before completing the donation process. As discussed in Chapter 6, it is 
unclear exactly what the cut-off criteria for donors should be. To prevent unnecessary donor 
deferrals, clinicians and policy makers must work together to identify whether certain 
biological criteria (for example the systolic blood pressure cut off) can be safely modified to 
reduce the number of temporary deferrals. Staff members should also direct their efforts at 
encouraging temporary deferrals to return, as studies have shown they are less likely to. 
Finally, though a small number, 1.2% of donors left before making a donation. More research 
is needed to understand why this occurs so that it can be prevented in the future. 
 
Component usage is growing in KATH and this has been shown to be true elsewhere in Africa. 
Results from the interviews with prescribing doctors showed that doctors appreciate the 
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availability of components at KATH and would prescribe them more often than they do now, 
if they were always available. Ghana and other African nations will have to continuously 
reassess their population’s transfusion needs as the continent experiences a shift from 
increased prevalence of infectious and communicable disease to an increased prevalence of 
chronic diseases. However, national blood services will need to consider their resource 
limitations and determine how to maintain the best patient outcomes. 
 
Finally, while patients seem satisfied with their transfusions, the evidence from this study 
shows that greater efforts need to be directed at ensuring patients are made aware of the 
risks and benefits of transfusions and that proper consent is sought. As discussed in section 
3.5.1, it can be difficult to determine to what extent patients should be made aware of the 
risks of an intervention. The information provided should be based on the patient’s needs, 
current situation and values. The benefit of informing patients and their families of the 
common side effects and complications of blood transfusions is that they can also self-
monitor and raise alarm if any transfusion reactions occur. Interestingly, overall, patients 
did not find it as troublesome to secure replacement donors as I had anticipated. This is an 
important finding because Africa and other LMICs continue to rely on replacement donors 
to maintain their blood stocks. If patients find this difficult, the added stress may reduce their 
ability to heal as quickly. However, this does not appear to be the case in Kumasi, which may 
be due to a number of factors including the fact that KATH does not demand a replacement 
donor be found prior to transfusion and the fact that the family and community aspect of life 
is very strong in Ghana. 
 
9.2 Limitations of the study 
 
To begin with, only 15 national blood policy documents were obtained – representing 
approximately one third of Africa. Moreover, I did not receive responses from some of the 
people contacted in blood service departments. Thus, a) I was unable to determine if there 
is an actual paucity of national blood policy documents in Africa or if I was just unable to 
obtain them and b) it means the sub-objectives I developed are based on the policy 
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documents of a limited number of African countries. Any potential bias occurring from b) 
was limited by also reviewing WHO policy documents. 
 
In terms of better understanding the pros and cons of how things run in the donor clinic, it 
would have been useful to also incorporate the health care assistant perspective, but as 
mentioned earlier, they were less willing to participate in the study. Consequently, it meant 
that my qualitative data was obtained from ‘higher ranked’ staff who may be more or less 
likely to give a fair critique of the system, depending on how involved they were in 
developing it. 
 
In order to obtain more qualitative data, I chose to focus on one study site – KATH. The 
limitation of this is that it reduces the generalisability of the study.  However, one point I’ve 
tried to highlight in this thesis is that more regional or even hospital based studies are 
needed, because while some things may be common to a region, individual hospitals will 
serve a unique population and will therefore have their own unique needs to which a more 
general national policy will need to be tailored to. 
 
Another key limitation was the inability to adequately assess blood component demand as 
only the first request in a seven-day period was recorded at the blood bank. As mentioned 
earlier, a computerised system will help greatly in record keeping and data collection at 
KATH and will provide the hospital with a more accurate estimate of their needs so they can 
plan their mobile sessions and component production more precisely. 
 
9.3 Study strengths 
 
One of the strengths of this study is that it examined blood transfusions services from a 
holistic lens by looking at all vein-to-vein policies. By looking at the entire process form 
donation to transfusion, I was able to identify if there were any gaps in policy. This later 
informed sub-objectives 1-4, allowing for multiple parties’ views and perspectives to be 
shared. For example, in this study I obtained information from blood donors, transfusion 
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patients, clinicians prescribing blood transfusions, donor clinic staff members and 
laboratory staff involved in grouping, cross-matching and component production.  
 
The mixed methods methodology used in this study helped to provide a deeper 
understanding of the vein-to-vein process. The collection and analyses of quantitative data 
helped illustrate current trends in donor deferrals and component production and usage. It 
also highlighted weaker areas of record keeping, such as only recording the initial request 
for a blood component for a patient, which was important, as addressing this will aid the 
blood bank in collecting more accurate data with regards to blood component demands at 
KATH. The use of semi-structured interviews and focus groups as data collecting tools meant 
that I could collect more detailed information as well as clarify points that were unclear and 
further probe relevant points.  
 
9.4 Implications of findings 
 
1. Feasibility of WHO’s 100% volunteer, non-remunerated donor recommendations 
The WHO and 14/15 of the African national blood policy documents reviewed recommended 
that blood be exclusively collected from VNRD. As discussed in Chapter 2, this is 
recommendation is rooted in the belief that volunteer donors are safer than replacement 
donors, but currently the evidence indicates that this is untrue. While repeat donors have 
been shown to be the safest, there is no difference in blood safety between first time 
volunteer donors and first time replacement donors. There is, however, evidence that paid 
donors remain unsafe. 
 
Nevertheless, African blood services continue to be working towards a 100% VNRD pool, in 
spite of replacement donors being common. The results from interviews with replacement 
donors in this study indicate that donating for a friend or family member is a considerable 
motivating factor. Moreover, interviews with patients showed that in most cases patients did 
not find it difficult to secure a replacement donor. The interviews with patients indicate that 
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paid donation does still occur, but it appeared to be rare. This might be due to KATH’s policy 
of giving blood when needed (and if available), and asking for replacement donors after. 
Given that blood supply remains a challenging issue in most countries, African blood services 
should consider focusing on making replacement donors repeat donors rather than 
discouraging them from donating.  
One intervention that saw success in New Zealand was to inform donors of their blood type 
and the percentage of people in the national population with their blood type who donate 
blood. Those with O- blood (universal donors) were also given information about the 
advantages of their blood type. Donors who received this information were 43% more likely 
to return than those who did not (Chamla et al., 2006).  A similar intervention could be 
employed in Ghana via text message or phone calls. The intervention could also be delivered 
during donor counselling if the donor’s blood type is already known. 
 
2. Increasing the donor pool by altering donor selection criteria 
A study examining variations in blood pressure, weight and haemoglobin level selection 
criteria is necessary to determine criteria thresholds that are accurate, safe and yet as 
inclusive as possible. This study would require implementing different cut off points based 
on the variations seen in policy documents and in the literature and recording the number 
of adverse events following donation to determine whether altering the criteria does in fact 
impact donor health. To my knowledge no such study has ever been done and would be 
instrumental in a) providing evidence for the donor criteria set and b) limiting the number 
of temporary donor deferrals while maintaining donor safety. 
 
3. Meeting the demand for components 
Currently, KATH is working towards increasing component production. At the start of this 
study it was unclear the extent to which there was demand for blood components and for 
whole blood. However, the responses from clinicians clearly indicate that there is a demand 
for components that is still not being fully met and thus the blood bank at KATH is on the 
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right track. One suggestion, however, would be for the blood bank to record every single 
request for blood in a computer based system so that they can more accurately assess the 
demand for components and whole blood and aim to meet that demand. The production of 
components is costly and in countries with limited financial resources as well as storage 
issues, it is important resources are not wasted in producing a supply of components that 
exceeds demand. 
 
9.5 Conclusion 
 
International policy documents, like those published by the WHO, are helpful in providing a 
starting point or structure to national blood services, but it is important to recognise that 
different regions have different needs and thus the same approach will not produce the same 
results everywhere. The results from this study provide context specific information about 
blood transfusion services at KATH, which can help them implement national blood policies 
in a way that addresses their needs. Africa, however, is a large and diverse continent and it 
is impossible to know whether the recommendations made in this thesis would be helpful 
elsewhere. Thus, similar studies should be conducted across the African continent to better 
understand local needs so that policies can be developed and implemented in a manner that 
meets the given populations’ needs.  
References 
National blood policy documents reviewed 
 
Government of Malawi - Ministry of Health, (2012). Guidelines for safe blood transfusion. 
La République de Madagascar - Ministère de la Santé, (1999). Politique nationale de la transfusion 
sanguine a Madagascar. 
 217 
Lesotho Blood Transfusion Services - Ministry of Health and Social Welfare, (2006). National Blood 
Transfusion Policy. 
Ministère de la Santé du Bénin, (n.d.). Manuel Qualité du SNTS. 
Nigerian Federal Ministry of Health - National Blood Transfusion Service, (2006). Nigerian National 
Blood Policy. 
Republic of Ghana - Ministry of Health, (2006). National Blood Policy for the Health Sector. 
Republic of Namibia - Ministry of Health and Social Services, (2007). National Blood Policy. 
Republic of Uganda - Ministry of Health, (2005). National Blood Transfusion Policy. 
Republic of Zimbabwe, (n.d.). National Blood Policy of the Republic Of Zimbabwe. 
République Algérienne Démocratique et Populaire Ministère de la Santé, de la Population et de la 
Reforme  Hospitalière: Agence de Sang, (2005). Les bonnes pratiques transfusionnelles. 
République Algérienne Démocratique et Populaire Ministère de la Santé. 
République du Cameroun - Ministère de la Santé Publique, (2012). Politique Nationale de 
Transfusion Sanguine. 
République du Sénégal: Ministère de la Santé et de la Prévention Médical - Centre National de 
transfusion Sanguine, (2006). Politique nationale de transfusion sanguine du Senegal. 
République Togolaise - Ministère de la Santé, (1999). Politique Nationale de Transfusion Sanguine. 
The United Republic of Tanzania Ministry of Health, (2005). Tanzania National Blood Transfusion 
Service Policy Guidelines. 
Western Province Blood Transfusion Service (WPBTS) and South African National Blood Service 
(SANBS), (2013). Standards of Practice for Blood Transfusion in South Africa – 6th edition. 
 
 218 
Other references 
 
Addo, J., Agyemang, C., Smeeth, L., de-Graft Aikins, A., Edusei, A. and Ogedegbe, O. (2012). A review 
of population-based studies on hypertension in Ghana. Ghana Medical Journal, 46(2 
(Supplemental), pp.4-11. 
Adjei, A., Kudzi, W., Armah, H., Adiku, T., Amoah, A. and Ansah, J. (2003). Prevalence of antibodies to 
syphilis among blood donors in Accra, Ghana. Japanese Journal of Infectious Disease, 13(4), 
pp.260-265. 
AfSBT, 2011. Africa Society for Blood Transfusion. [online} Available at: 
<http://www.afsbt.org/index.php > [Accessed 28 August 2012]. 
Agbovi, K., Kolou, M., Fétéké, L., Haudrechy, D., North, M. and Ségbéna, A. (2017). Étude 
des connaissances, attitudes et pratiques en matière de don de sang. Enquête sociologique 
dans la population de Lomé (Togo). 
Alaishuski, L., Grim, R. and Domen, R. (2008). The informed consent process in whole blood 
donation. Archives of Pathology & Laboratory Medicine, 132(6), pp.947-951. 
Alinon, K., Gbati, K., Sorum, P. and Mullet, E. (2013). Emotional-motivational barriers to blood 
donation among Togolese adults: a structural approach. Transfusion Medicine, 24(1), pp.21-26. 
Allain, J. (2011). Moving on from voluntary non-remunerated donors: who is the best blood donor?. 
British Journal of Haematology, 154(6), pp.763-769. 
Allain, J., Owusu-Ofori, S. and Bates, I. (2004). Blood Transfusion in Sub-Saharan Africa. Transfusion 
Alternatives in Transfusion Medicine, 6(1), pp.16-23. 
Allain, J., Sarkodie, F., Asenso-Mensah, K. and Owusu-Ofori, S. (2010). Relative safety of first-time 
volunteer and replacement donors in West Africa. Transfusion, 50(2), pp.340-343. 
Allain, J., Sarkodie, F., Boateng, P., Asenso, K., Kyeremateng, E. and Owusu-Ofori, S. (2008). A pool of 
repeat blood donors can be generated with little expense to the blood center in sub-Saharan 
Africa. Transfusion, 48(4), pp.735-741. 
 219 
American Red Cross. (2016). Red Cross Encourages Type O Negative Blood Donors to Give. [online] 
Available at: http:// [Accessed 19 Jan. 2017]. 
Ampofo, W., Nii-Trebi, N., Ansah, J., Abe, K., Naito, H., Aidoo, S., Nuvor, V., Brandful, J., Yamamoto, N., 
Ofori-Adjei, D. and Ishikawa, K. (2002). Prevalence of Blood-Borne Infectious Diseases in Blood 
Donors in Ghana. Journal of Clinical Microbiology, 40(9), pp.3523-3525. 
Anon, (2008). World Health Statistics. [online] Available at: 
http://www.who.int/gho/publications/world_health_statistics/EN_WHS08_Full.pdf [Accessed 
6 Oct. 2014]. 
Arslan, Ö. (2007). Whole blood donor deferral rate and characteristics of the Turkish population. 
Transfusion Medicine, 17(5), pp.379-383. 
Bahadur, S., Jain, S., Goel, R., Pahuja, S. and Jain, M. (2009). Analysis of blood donor deferral 
characteristics in Delhi, India. The Southeast Asian Journal of Tropical Medicine and Public 
Health, 40(5), pp.1087-1091. 
Baig, M., Habib, H., Haji, A., Alsharief, F., Noor, A. and Makki, R. (2013). Knowledge, misconceptions 
and motivations towards blood donation among university students in Saudi Arabia. Pakistan 
Journal of Medical Sciences, 29(6). 
Bani, M. and Giussani, B. (2010). Gender differences in giving blood: a review of the literature. Blood 
Transfusion, 8(4), pp.278-287. 
Barimah, K. and Mensah, J. (2013). Ghana’s National Health Insurance Scheme: Insights from 
Members, Administrators and Health Care Providers. Journal of Health Care for the Poor and 
Underserved, 24(3), pp.1378-1390. 
Bates, I. and Hassall, O. (2010). Should we neglect or nurture replacement blood donors in sub-
Saharan Africa?. Biologicals, 38(1), pp.65-67. 
Bates, I., Chapotera, G., McKew, S. and van den Broek, N. (2008). Maternal mortality in sub-Saharan 
Africa: the contribution of ineffective blood transfusion services. BJOG: An International Journal 
of Obstetrics & Gynaecology, 115(11), pp.1331-1339. 
 220 
Bates, I., Manyasi, G. and Lara, A. (2007). Reducing replacement donors in Sub-Saharan Africa: 
challenges and affordability. Transfusion Medicine, 17(6), pp.434-442. 
Beutler, E. (2005). Hematologic differences between African-Americans and whites: the roles of 
iron deficiency and  -thalassemia on hemoglobin levels and mean corpuscular volume. Blood, 
106(2), pp.740-745. 
Blanchet, N., Fink, G. and Osei-Akoto, I. (2012). The Effect of Ghana's National Health Insurance 
Scheme on Health Care Utilisation. Ghana Medical Journal, 46(2), pp.76-84. 
Bloch, E., Vermeulen, M. and Murphy, E. (2012). Blood Transfusion Safety in Africa: A Literature 
Review of Infectious Disease and Organizational Challenges. Transfusion Medicine Reviews, 
26(2), pp.164-180. 
Bugge, H., Karlsen, N., Oydna, E., Rake, M., Wexels, N., Bendabenda, J., Roald, B., Heier, H., Chisuwo, L. 
and Jourdan, P. (2012). A study of blood transfusion services at a district hospital in Malawi. 
Vox Sanguinis, 104(1), pp.37-45. 
CFIR – Consolidated Framework for Implementation Research. (2009). [online] Available at: 
http://www.cfirguide.org/ [Accessed 4 Aug. 2014]. 
 
Creswell, J. (2009). Research design. 1st ed. Thousand Oaks, Calif.: Sage. 
Chamla, J., Leland, L. and Walsh, K. (2006). Eliciting repeat blood donations: tell early career donors 
why their blood type is special and more will give again. Vox Sanguinis, 90(4), pp.302-307. 
 
Cunha, L., Plouzeau, C., Ingrand, P., Gudo, J., Ingrand, I., Mondlane, J., Beauchant, M. and Agius, G. 
(2007). Use of replacement blood donors to study the epidemiology of major blood-borne 
viruses in the general population of Maputo, Mozambique. Journal of Medical Virology, 79(12), 
pp.1832-1840. 
 
Custer, B., Chinn, A., Hirschler, N., Busch, M. and Murphy, E. (2007). The consequences of temporary 
deferral on future whole blood donation. Transfusion, 47(8), pp.1514-1523. 
 
 221 
Custer, B., Schlumpf, K., Wright, D., Simon, T., Wilkinson, S. and Ness, P. (2010). Donor return after 
temporary deferral. Transfusion, 51(6), pp.1188-1196. 
Data.worldbank.org. (2017). Ghana | Data. [online] Available at: 
http://data.worldbank.org/country/ghana [Accessed 22 Nov. 2012]. 
de-Graft Aikins, A. (2007). Ghana's neglected chronic disease epidemic: a developmental challenge. 
Ghana Medical Journal, 41(4), pp.154-159. 
Diarra, A., Kouriba, B., Baby, M., Murphy, E. and Lefrere, J. (2009). HIV, HCV, HBV and syphilis rate of 
positive donations among blood donations in Mali: Lower rates among volunteer blood 
donors. Transfusion Clinique et Biologique, 16(5-6), pp.444-447. 
Dolea, C., AbouZahr, C. and Stein, C. (2003). Global burden of maternal haemorrhage in the year 
2000. [online] World Health Organization. Available at: 
http://www.who.int/healthinfo/statistics/bod_maternalhaemorrhage.pdf [Accessed 12 Nov. 
2012]. 
Drislane, F., Akpalu, A. and Wegdam, H. (2014). The Medical System in Ghana. The Yale Journal of 
Biology and Medicine, 87(3), pp.321-326. 
Duboz, P., Macia, E. and Cunéo, B. (2010). Sociodemographic and attitudinal factors to blood 
donation in the urban population of Dakar, Senegal. Transfusion, 50(12), pp.2713-2720. 
Edwards, A. (2003). Communicating risks. BMJ, 327(7417), pp.691-692. 
Eligibility for blood donation. (2009). 1st ed. Washington, DC: Pan American Health Organization, 
p.42. 
Field, S. and Allain, J. (2007). Transfusion in sub-Saharan Africa: does a Western model fit?. Journal 
of Clinical Pathology, 60(10), pp.1073-1075. 
France, C., France, J., Kowalsky, J. and Cornett, T. (2010). Education in donation coping strategies 
encourages individuals to give blood: further evaluation of a donor recruitment brochure. 
Transfusion, 50(1), pp.85-91. 
 222 
Fuenfer, M., Creamer, K. and Lenhart, M. (2010). Pediatric surgery and medicine for hostile 
environments. Washington, DC: Borden Institute, Walter Reed Army Medical Center. 
Ghana AIDS Commission, (2014). 2014 Status Report. [online] Available at: 
http://www.ghanaids.gov.gh/gac1/pubs/2014%20STATUS%20REPORT.pdf [Accessed 12 
Apr. 2016]. 
Ghanahealthservice.org. (2015). About Us |  Ghana Health Service. [online] Available at: 
http://www.ghanahealthservice.org/ghs-category.php?cid=2 [Accessed 10 Jul. 2015]. 
GMC (2017). GMC | Consent guidance: Discussing side effects, complications and other risks. [online] 
Available at: https://www.gmc-
uk.org/guidance/ethical_guidance/consent_guidance_discussing_side_effects_and_complicatio
ns.asp [Accessed 10 Nov. 2017]. 
Guirguis-Younger, M., Runnels, V., Aubry, T. and Turnbull, J. (2006). Carrying out a social autopsy of 
deaths of persons who are homeless. Evaluation and Program Planning, 29(1), pp.44-54. 
Hensher, M. and Jefferys, E. (2000). Financing blood transfusion services in sub-Saharan Africa: a 
role for user fees?. Health Policy and Planning, 15(3), pp.287-295. 
Hijji, B., Parahoo, K., Hussein, M. and Barr, O. (2012). Knowledge of blood transfusion among nurses. 
Journal of Clinical Nursing, 22(17-18), pp.2536-2550. 
Hopkins, W. (1998). Sportscience: Quantitative Research Design. [online] Sportsci.org. Available at: 
http://www.sportsci.org/resource/design/design.html [Accessed 23 Nov. 2012]. 
Jacobs, B. and Mercer, A. (1999). Feasibility of Hospital-Based Blood Banking: A Tanzanian Case 
Study. Health Policy and Planning, 14(4), pp.354-362. 
Javadzadeh Shahshahani, H. (2007). Why don’t women volunteer to give blood? A study of 
knowledge, attitude and practice of women about blood donation, Yazd, Iran, 2005. 
Transfusion Medicine, 17(6), pp.451-454. 
 223 
Javadzadeh Shahshahani, H., Yavari, M., Attar, M. and Ahmadiy?h, M. (2006). Knowledge, attitude 
and practice study about blood donation in the urban population of Yazd, Iran, 2004. 
Transfusion Medicine, 16(6), pp.403-409. 
Karp, J. and King, K. (2010). International variation in volunteer whole blood donor eligibility 
criteria. Transfusion, 50(2), pp.507-513. 
Kasraian, L. and Maghsudlu, M. (2012). Blood donors' attitudes towards incentives: influence on 
motivation to donate. Blood Transfusion, 10(2), pp.186-190. 
Kimani, D., Mwangi, J., Mwangi, M., Bunnell, R., Kellogg, T., Oluoch, T., Gichangi, A., Kaiser, R., Mugo, 
N., Odongo, T., Oduor, M. and Marum, L. (2011). Blood donors in Kenya: a comparison of 
voluntary and family replacement donors based on a population-based survey. Vox Sanguinis, 
100(2), pp.212-218. 
Komfo Anokye Teaching Hospital. (2015). About us: Our History. [online] Available at: 
http://www.kathhsp.org/about.html [Accessed 19 Aug. 2015]. 
Komfo Anokye Teaching Hospital. (2011). Komfo Anokye Teaching Hospital Annual Report – 2011: 
Chapter 18: Transfusion Medicine Unit.  
Koster, J. and Hassall, O. (2011). Attitudes towards blood donation and transfusion in Bamenda, 
Republic of Cameroon. Transfusion Medicine, 21(5), pp.301-307. 
Kotoh, A. and Van der Geest, S. (2016). Why are the poor less covered in Ghana’s national health 
insurance? A critical analysis of policy and practice. International Journal for Equity in Health, 
15(1). 
Kouao, M., Dembelé, B., N'Goran, L., Konaté, S., Bloch, E., Murphy, E. and Lefrère, J. (2012). Reasons 
for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast. Transfusion, 
52(7pt2), pp.1602-1606. 
Krosin, M., Klitzman, R., Levin, B., Cheng, J. and Ranney, M. (2006). Problems in comprehension of 
informed consent in rural and peri-urban Mali, West Africa. Clinical Trials, 3(3), pp.306-313. 
 224 
Lal, R. and Stewart, B. (2012). Soil water and agronomic productivity. 1st ed. Boca Raton, FL: CRC 
Press, p.30. 
Laperche, S. (2012). Multinational assessment of blood-borne virus testing and transfusion safety 
on the African continent. Transfusion, 53(4), pp.816-826. 
Lara, A., Kandulu, J., Chisuwo, L., Kashoti, A., Mundy, C. and Bates, I. (2007). Laboratory costs of a 
hospital-based blood transfusion service in Malawi. Journal of Clinical Pathology, 60(10), 
pp.1117-1120. 
Loua, A. and Nze Nkoure, G. (2010). Relative safety of first-time volunteer and replacement donors 
in Guinea. Transfusion, 50(8), pp.1850-1851. 
Lownik, E., Riley, E., Konstenius, T., Riley, W. and McCullough, J. (2012). Knowledge, attitudes and 
practices surveys of blood donation in developing countries. Vox Sanguinis, 103(1), pp.64-74. 
Maghsudlu, M., Nasizadeh, S., Abolghasemi, H. and Ahmadyar, S. (2009). Blood donation and donor 
recruitment in Iran from 1998 through 2007: ten years' experience. Transfusion, 49(11), 
pp.2346-2351. 
 
Mayo Clinic. (2016). Blood donation Risks - Mayo Clinic. [online] Available at: 
http://www.mayoclinic.org/tests-procedures/blood-donation/basics/risks/prc-20020069 
[Accessed 7 Dec. 2016]. 
Mbanya, D., Takam, D. and Ndumbe, P. (2003). Serological findings amongst first-time blood donors 
in Yaounde, Cameroon: is safe donation a reality or a myth?. Transfusion Medicine, 13(5), 
pp.267-273. 
Messina, J., Humphreys, I., Flaxman, A., Brown, A., Cooke, G., Pybus, O. and Barnes, E. (2014). Global 
distribution and prevalence of hepatitis C virus genotypes. Hepatology, 61(1), pp.77-87. 
Minga, A., Dohoun, L., Abo, Y., Coulibaly, A., Konaté, S., Ouattara, H., N'Guessan, B., Dabis, F., Salamon, 
R. and Lewden, C. (2010). Risk behaviors in volunteer blood donors who seroconverted for 
HIV, Abidjan, Côte d'Ivoire 1997 to 2005. Transfusion, 50(4), pp.888-893. 
 225 
Moore, A., Herrera, G., Nyamongo, J., Lackritz, E., Granade, T., Nahlen, B., Oloo, A., Opondo, G., Muga, 
R. and Janssen, R. (2001). Estimated risk of HIV transmission by blood transfusion in Kenya. 
The Lancet, 358(9282), pp.657-660. 
Murray, C. and Lopez, A. (1996). The global burden of disease. 1st ed. [Cambridge, Mass.]: Published 
by the Harvard School of Public Health on behalf of the World Health Organization and the 
World Bank. 
Nair, S. and Mammen, J. (2015). Repeat voluntary non-remunerated blood donor is the best quality 
indicator for blood safety. Indian Journal of Medical Research, 141(6), p.749. 
National Blood Service, Ghana, (2009). Clinical Blood Transfusion Policy. 
National Blood Service (Ghana). (2017). National Blood Service, Ghana — Providing Safe Blood That 
Saves Lives. [online] Available at: http://nbsghana.org [Accessed 31 Jan. 2017]. 
Nchinda, E., Tagny, C. and Mbanya, D. (2012). Blood donor haemovigilance in Yaoundé, Cameroon. 
Transfusion Medicine, 22(4), pp.257-261. 
Nébié, K., Olinger, C., Kafando, E., Dahourou, H., Diallo, S., Kientega, Y., Domo, Y., Kienou, K., Ouattara, 
S., Sawadogo, I., Ky, L. and Muller, C. (2007). Faible niveau de connaissances des donneurs de 
sang au Burkina Faso ; une entrave potentielle à la sécurité transfusionnelle. Transfusion 
Clinique et Biologique, 14(5), pp.446-452. 
Nébié, K., Ouattara, S., Sanou, M., Kientega, Y., Dahourou, H., Ky, L., Kienou, K., Diallo, S., Bigirimana, 
F., Fretz, C., Murphy, E. and Lefrère, J. (2011). Poor procedures and quality control among 
nonaffiliated blood centers in Burkina Faso: an argument for expanding the reach of the 
national blood transfusion center. Transfusion, 51(7pt2), pp.1613-1618. 
NHIA. (2015). National Health Insurance Scheme. [online] Available at: 
http://www.nhis.gov.gh/nhia.aspx [Accessed 23 Oct. 2015]. 
NHS Blood and Transplant. (2016). Blood components. [online] Available at: 
https://www.blood.co.uk/why-give-blood/how-blood-is-used/blood-components/ [Accessed 
18 Oct. 2016]. 
 226 
Nkrumah, B., Owusu, M. and Averu, P. (2011). Hepatitis B and C viral infections among blood 
donors. A retrospective study from a rural community of Ghana. BMC Research Notes, 4(1), 
p.529. 
Nwagbo, D., Nwakoby, B., Akpala, C., Chukudebelu, W., Ikeme, A., Okaro, J., Onah, B., Okeke, V., 
Egbuciem, P. and Ikeagu, A. (1997). Establishing a blood bank at a small hospital, in Anambra 
State, Nigeria. International Journal of Gynecology & Obstetrics, 59, pp.S135-S139. 
Nyarwornota, V., Aryeetey, R., Bosomprah, S. and Aikins, M. (2013). An Exploratory Study of 
Physical Activity and Over-Weight in Two Senior High Schools in The Accra Metropolis. Ghana 
Medical Journal, 47(4), pp.197-203. 
Osaro, E., Isaac, Z., Abdulrahaman, Y., Ndakotsu, M., Ikhuenbor, D. B., Aghedo, F., Ibrahim, K. K. and 
Ibrahim, S.(2013). Female Gender Participation in the Blood Donation Process in Resource 
Poor Settings: Case study of Sokoto in North Western Nigeria. Journal of Blood Disorders & 
Transfusion, 05(01). 
Olaiya, M., Alakija, W., Ajala, A. and Olatunji, R. (2004). Knowledge, attitudes, beliefs and 
motivations towards blood donations among blood donors in Lagos, Nigeria. Transfusion 
Medicine, 14(1), pp.13-17. 
Osaro, E. and Adias, T. (2011). The challenges of meeting the blood transfusion requirements in 
Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. Journal of 
Blood Medicine, p.7. 
Owusu-Ofori, S., Temple, J., Sarkodie, F., Anokwa, M., Candotti, D. and Allain, J. (2005). Predonation 
screening of blood donors with rapid tests: implementation and efficacy of a novel approach to 
blood safety in resource-poor settings. Transfusion, 45(2), pp.133-140. 
Palinkas, L., Horwitz, S., Green, C., Wisdom, J., Duan, N. and Hoagwood, K. (2013). Purposeful 
Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation 
Research. Administration and Policy in Mental Health and Mental Health Services Research, 
42(5), pp.533-544. 
 227 
Palmboom, G., Willems, D., Janssen, N. and de Haes, J. (2007). Doctor's views on disclosing or 
withholding information on low risks of complication. Journal of Medical Ethics, 33(2), pp.67-
70. 
Picano, E. (2004). Informed consent and communication of risk from radiological and nuclear 
medicine examinations: how to escape from a communication inferno. BMJ, 329(7470), 
pp.849-851. 
Pitman, J., Wilkinson, R., Liu, Y., von Finckenstein, B., Smit Sibinga, C., Lowrance, D., Marfin, A., 
Postma, M., Mataranyika, M. and Basavaraju, S. (2015). Blood Component Use in a Sub-Saharan 
African Country: Results of a 4-Year Evaluation of Diagnoses Associated With Transfusion 
Orders in Namibia. Transfusion Medicine Reviews, 29(1), pp.45-51. 
Planet, L. (2017). Map of Ghana. [online] Lonelyplanet.com. Available at: 
http://www.lonelyplanet.com/maps/africa/ghana/ [Accessed 17 Feb. 2013]. 
Polonsky, M., Renzaho, A. and Brijnath, B. (2011). Barriers to blood donation in African 
communities in Australia: the role of home and host country culture and experience. 
Transfusion, 51(8), pp.1809-1819. 
Pottle, J., Staves, J. and Curry, N. (2011). Transfusion delays: an audit of transfusion practice for 
major blood loss in a UK teaching hospital. Transfusion Medicine, 22(1), pp.71-72. 
Reddy, R. (2012). Blood donation patterns and challenges in Southern Africa. ISBT Science Series, 
7(1), pp.296-299. 
Reich, P., Roberts, P., Laabs, N., Chinn, A., McEvoy, P., Hirschler, N. and Murphy, E. (2006). A 
randomized trial of blood donor recruitment strategies. Transfusion, 46(7), pp.1090-1096. 
Republic of Ghana, (1998). https://doi.org/10.1136/bmj.329.7470.849. 
Republic of Ghana, (1998). The Children's Act. 
Roysam, V. (2017). We were denied blood until we got donors: the dark side of blood donation no one 
talks about. [online] YourStory.com. Available at: 
https://yourstory.com/2017/06/replacement-blood-donation/ [Accessed 10 Oct. 2017]. 
 228 
 
S., Uma, R., Arun and P., Arumugam. (2013). The Knowledge, Attitude and Practice Towards Blood 
Donation Among Voluntary Blood Donors in Chennai, India. Journal of Clinical and Diagnostic 
Research. 
 
Salaudeen, A. and Odeh, E. (2011). Knowledge and behavior towards voluntary blood donation 
among students of a tertiary institution in Nigeria. Nigerian Journal of Clinical Practice, 14(3), 
p.303. 
Sengeh, P., Samai, O., Sidique, S., Kebbie, A., Fofana, P. and Stephens, S. (1997). Improving blood 
availability in a district hospital, Bo, Sierra Leone. International Journal of Gynecology & 
Obstetrics, 59, pp.S127-S134. 
South African National Blood Service, (2012). Integrated blood safety. 
Spinella, P., Perkins, J., Grathwohl, K., Beekley, A. and Holcomb, J. (2009). Warm Fresh Whole Blood 
Is Independently Associated With Improved Survival for Patients With Combat-Related 
Traumatic Injuries. The Journal of Trauma: Injury, Infection, and Critical Care, 66(Supplement), 
pp.S69-S76. 
StatsGhana. (2012). Population by region, district, age groups and sex, 2010. [online] Available at: 
http://www.statsghana.gov.gh/docfiles/pop_by_region_district_age_groups_and_sex_2010.pdf 
[Accessed 13 Jan. 2013]. 
StatsGhana. (2012). 2010 Population & Housing Census: Summary Report of Final Results. [online] 
Available at: 
http://www.statsghana.gov.gh/docfiles/2010phc/Census2010_Summary_report_of_final_resu
lts.pdf [Accessed 22 Jan. 2013]. 
Systematic review identifies main causes of maternal mortality and morbidity. (2005). Progress 
Report in Reproductive Health, 71, pp.5-8. 
Tagny, C., Mbanya, D., Tapko, J. and Lefrère, J. (2008). Blood safety in Sub-Saharan Africa: a multi-
factorial problem. Transfusion, 48(6), pp.1256-1261. 
 229 
Tagny, C., Owusu-Ofori, S., Mbanya, D. and Deneys, V. (2010). The blood donor in sub-Saharan 
Africa: a review. Transfusion Medicine, 20(1), pp.1-10. 
Tazi-Mokha, A., Soulaymani, A., Mokhtari, A. and Alami, R. (2012). Blood donation in Morocco: a 20-
year retrospective study of blood collection in the Rabat blood centre. Transfusion Medicine, 
22(3), pp.173-180. 
Trouern-Trend, J., Cable, R., Badon, S., Newman, B. and Popovsky, M. (1999). A case-controlled 
multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, 
weight, blood pressure, and pulse. Transfusion, 39(3), pp.316-320. 
UNICEF. (2013). At a Glance: Ghana - Statistics. [online] Available at: 
https://www.unicef.org/infobycountry/ghana_statistics.html [Accessed 19 Sep. 2014]. 
van Hulst, M., Sagoe, K., Vermande, J., van der Schaaf, I., van der Tuuk Adriani, W., Torpey, K., Ansah, 
J., Mingle, J., Sibinga, C. and Postma, M. (2017). Cost-Effectiveness of HIV Screening of Blood 
Donations in Accra (Ghana). 
Walana, W., Hokey, P. and Ahiaba, S. (2014). Sero-Prevalence of Hepatitis B Virus Infection among 
Blood Donors: A Retrospective Study in the Kintampo Municipal Hospital, Ghana. Open Journal 
of Medical Microbiology, 04(01), pp.64-69. 
Wang, W. and Dwan, K. (2013). Blood transfusion for preventing primary and secondary stroke in 
people with sickle cell disease. Cochrane Database Sytematic Review. 
Wfp.org. (2016). Ghana | WFP | United Nations World Food Programme - Fighting Hunger 
Worldwide. [online] Available at: http://www.wfp.org/node/3467 [Accessed 22 Aug. 2016]. 
World Health Organization. (2001). Developing a National Policy and Guidelines on the Clinical Use of 
Blood [online] Available at: 
http://www.who.int/bloodsafety/clinical_use/en/who_bct_bts_01_3.pdf  [Accessed 15 Aug. 
2012]. 
World Health Organization. (2001). The Clinical Use of Blood. [online] Available at: 
http://www.who.int/bloodsafety/clinical_use/en/Handbook_EN.pdf [Accessed 18 Aug. 2012]. 
 230 
World Health Organization. (2002). The Blood Cold Chain: Guide to the selection and procurement of 
equipment and accessories. [online] Available at: 
http://www.who.int/medical_devices/publications/en/Blood_Cold_Chain.pdf [Accessed 15 
Nov. 2012]. 
World Health Organization. (2003). The Africa Malaria Report. [online] Available at: 
http://whqlibdoc.who.int/hq/2003/WHO_CDS_MAL_2003.1093.pdf [Accessed 9 Oct. 2012]. 
World Health Organization. (2005). Worldwide prevalence of anaemia 1993–2005. [online] Available 
at: http://apps.who.int/iris/bitstream/10665/43894/1/9789241596657_eng.pdf [Accessed 
16 Aug. 2014]. 
World Health Organization. (2007). Blood Donations per 1000 population. [online] Available at: 
http://www.who.int/mediacentre/factsheets/donations_per1000_population_20091110.pdf 
[Accessed 18 Aug. 2014]. 
World Health Organization. (2007). Blood safety and availability. [online] Available at: 
http://www.who.int/mediacentre/factsheets/fs279/en/index.html [Accessed 17 Dec. 2011]. 
World Health Organization. (2009). Screening Donated Blood for Transfusion Transmissible 
Infections Recommendations. [online] Available at: 
http://www.who.int/bloodsafety/ScreeningTTI.pdf  [Accessed 15 Aug. 2012]. 
World Health Organization. (2010). Towards 100% voluntary blood donation: A global framework 
for action. [online] Available at: 
http://www.who.int/bloodsafety/publications/9789241599696_eng.pdf?ua=1 [Accessed 20 
Jul. 2014]. 
World Health Organization. (2012). [online] Available at: 
http://www.who.int/malaria/high_risk_groups/infants/en/index.html [Accessed 10 Nov. 
2012]. 
 
World Health Organization. (2012). Maternal mortality. [online] Available at: 
http://www.who.int/mediacentre/factsheets/fs348/en/ [Accessed 15 Aug. 2012]. 
 231 
 
World Health Organization, (2013). Global policy report on the prevention and control of viral 
hepatitis in WHO member states. 
Yankah, J. (1965). Observation on the Frequency of A. B. O. and Rh Blood Groups in Leprosy and 
Non-Leprosy People in Ghana. Leprosy Review, 36(2). 
 
Zou, S., Musavi, F., Notari, E., Rios, J., Trouern-Trend, J. and Fang, C. (2008). Donor deferral and 
resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. 
Transfusion, 48(12), pp.2531-2539. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1 
Ethics approval from Committee on Human Research Publications and Ethics, 
Kwame Nkrumah University of Science and Technology  
 
 232 
 
Appendix 2  
Ethics approval from Liverpool School of Tropical Medicine 
 
 233 
 
Appendix 3 
 
Participant Consent Form 
 
 234 
 
 
 235 
 
 236 
 
 237 
Appendix 4 
 
Donor Clinical Record Form 
 
 
 238 
Appendix 5 
Transfusion Request Form 
 
 
 239 
Appendix 6 
Transfusion Monitoring Form 
 
 240 
Appendix 7 
Donor health and risk assessment 
 
 
 
 241 
 
 
 
 242 
Appendix 8 
 
Donor Interview Template 
 
1. Are you currently donating blood as a volunteer or for someone in hospital (e.g. as a 
replacement donor) (→Define the different types of donors for the participant).  
2. Please describe how you were recruited to donate blood and the donation process. 
a. Probing questions  
• Who recruited you?  
• Where did you donate?  
• How long was the process?  
• How long were the wait times?  
• Were you provided with anything after donation? 
o In pilot study donors seemed confused by this question – clarified by 
giving examples – t-shirt, food, pens etc.  
3. Did you encounter any difficulties (i.e. during the donation experience)? 
a. This question may be used to follow up on any difficulties mentioned by the donor 
in response to question two and the donation process 
4. What motivated you to donate blood?  
5. What expectations did you have regarding blood donation prior to your first donation? 
a. Probe further if they say none (this occurred in the pilot). Move to specific 
questions if needed (e.g. did you expect it would be painful, did you expect to have 
to provide any information, how long did you expect the process would take). 
6. Are there any positive or negative experiences from today you’d like to discuss? 
a. Try and connect this to the donor’s expectations if relevant 
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Appendix 9 
 
Donor Questionnaire  
 
1. Sex: 
 
Male   Female 
2. What is your age? 
 
    years 
3. How many times have you donated blood before? 
 
         
4. How did you first learn about blood donation? 
              
             
        
 
5. How were you recruited to donate blood (this time)? 
             
6. How efficient did you find the donation process? Please justify your answer. 
 
              
              
7. Will you donate blood again in the near future? 
 
Yes    No 
 
Why or why not?            
              
 244 
Appendix 10 
Donor Focus Group outline 
 
• Size: 6-10 people 
• Population: Blood donors. My plan is to conduct the following focus groups – one with 
students (SHS or University), one with replacement donors, one at a church mobile session, 
one at a mosque mobile session and one at an FM drive. 
• Prior to discussion: I will record basic socio-demographic information (i.e. age, sex, 
marital status, religion and occupation). 
• Translation: For most of the focus groups I will require the assistance of a translator. I will 
request the translator to translate on the spot so that I can probe when necessary.  
 
Discussion Points 
 
• What are the main reasons people donate blood?  
 
• Have you or anyone you know received a gift for donating blood when donating for a 
patient? (Probe – what type of gift? Donor/Patient relationship?) 
 
 
• What expectations do donors have regarding the donation process? 
o How many of you expected donation to be painful 
o How many of you expected the process to be more difficult? In what way? 
o How many expected to receive more information? What kind of information? 
 
• What were your thoughts on the health and risk assessment questionnaire? (Probe – were 
questions too long? Did they make you uncomfortable? Were any of the questions difficult 
to answer?) 
 
• Did you receive any information about post-donation care (ex: regarding diet and exercise) 
 
• Were you informed of when you will be able to donate blood next? 
 
• Which of the following pieces of information do you think is the most important for donors 
to receive? Second most important? Third most important?  
o STD status 
o Blood group 
o My general health status 
o The benefits of blood donation 
o The risks of blood donation 
o The amount of time the donation process will take 
o The steps involved in the donation process 
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o Dietary recommendations post donation 
o Physical activity permitted post donation 
o The time it will take to regain the blood lost 
o Information on how to replace the blood lost 
o The maximum blood I can donate 
o When I can next donate 
 
• Is there any other important information you feelsdonors should be give during the 
donation process? 
 
• Under what circumstances would you donate blood again?  
 
• Under what circumstances would you consider donating blood again? (Probe – if 
friend/family member requires blood, if someone paid you to donate, at a blood drive…) 
 
• Are you more likely to donate blood at the hospital’s donor clinic, at school/work, at a 
church/mosque/other place of worship, or at a blood drive hosted by a radio/TV station? 
 
• What would prevent you or other donors from donating again? (Probe: Pain, lack of time, 
lack of money, fear of finding out blood status…) 
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Appendix 11 
 
Clinician Interview Guide 
 
What is your current position? 
 
Do you rotate between the different units? 
 
Do you know if currently, consent is required before giving transfusions? [If so, is it oral or 
written consent?] 
  
Do you know if blood components are available at the hospital, and if so which 
components? 
 
How often in this hospital speciality do you prescribe blood or blood components? 
 
What do you prescribe the most often?  
 
Is this because it is most needed or because it is more readily available? 
 
What do you prescribe the various blood components for? [List the ones mentioned by 
participant] 
 
Do you know if there are currently any guidelines on blood component prescription and 
usage? 
 
Are there any other issues with blood services or obtaining blood that you would like to 
discuss. 
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So when it comes to asking mothers or family members to find replacement donors here, 
do you always ask them before a blood transfusion or do you ask them when the blood 
bank tells you there is not enough blood and requests you to ask the patient to find donors? 
 
Is there anything else you would like to discuss? 
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Appendix 12 
 
Donor Clinic Staff Interview Guide 
 
What is your current position at the donor clinic? 
 
What is your role and what are your responsibilities? 
 
Who is currently given pre-donation counselling? [probe further – is it given only to high 
risk individuals or all donors?] 
 
When is pre-donation counselling given? 
 
What information do you give in the pre-donation counselling? 
 
How was the pre-donation counselling framework developed? 
 
Do you give post-donation counselling? 
 
What information is given in post-donation counselling? 
 
How was the post-donation counselling developed? 
 
Do you have any suggestions on how donor counselling can be improved? 
 
Do you have any other suggestions for the donor clinic? 
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Appendix 13 
 
Blood bank staff interview guide 
 
Please describe your role at the blood bank? 
How long have you been working in blood banks (either at KATH or elsewhere)? 
Please describe how blood donors are recruited. 
What challenges do you face in recruiting donors? (or what challenges does the donor clinic 
face? 
Who collects the blood from the donor? 
Please describe how the blood is stored. 
What measures are in place to ensure proper storage in case of a power failure? 
What is the maximum length of time blood is stored? 
What challenges do you encounter in recruiting donors/collecting blood/storing blood? 
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Appendix 14 
 
Patient Interview Guide 
 
How many transfusions have you had while you’ve been in the hospital this time?  
 
Do you know why you needed the transfusion(s)? 
 
Were you told before the transfusion that you would be receiving blood? 
 
What were you told about the transfusion? 
 
Were you told any other information about the transfusion? Example, benefits, side effects? 
 
Did you have any questions for the staff about the transfusion? 
 
Did you have difficulty obtaining blood at any point? 
 
How long did it take for you to receive your transfusion?  
 
Were you asked to find someone to donate blood? 
 
Are you aware of any costs associated with the transfusion? 
 
Were there any issues relating to the blood transfusion you’d like to discuss 
 
For statistical purposes – you don’t need to answer this – what is the highest level of 
education you have achieved? 
 
What is your household income? 
 
